smpdb_id,name,category,parent_key
SMP0000278,Lepirudin Action Pathway,drug_action,DB00001
SMP0000474,Cetuximab Action Pathway,drug_action,DB00002
SMP0000277,Bivalirudin Action Pathway,drug_action,DB00006
SMP0000280,Alteplase Action Pathway,drug_action,DB00009
SMP0000284,Urokinase Action Pathway,drug_action,DB00013
SMP0000285,Reteplase Action Pathway,drug_action,DB00015
SMP0000281,Anistreplase Action Pathway,drug_action,DB00029
SMP0000283,Tenecteplase Action Pathway,drug_action,DB00031
SMP0000265,Abciximab Action Pathway,drug_action,DB00054
SMP0000266,Eptifibatide Action Pathway,drug_action,DB00063
SMP0000476,Trastuzumab Action Pathway,drug_action,DB00072
SMP0000282,Streptokinase Action Pathway,drug_action,DB00086
SMP0000420,Bevacizumab Action Pathway,drug_action,DB00112
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00114
SMP0000003,Argininosuccinic Aciduria,disease,DB00114
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00114
SMP0000006,Tyrosine Metabolism,metabolic,DB00114
SMP0000009,Ammonia Recycling,metabolic,DB00114
SMP0000012,Catecholamine Biosynthesis,metabolic,DB00114
SMP0000016,Propanoate Metabolism,metabolic,DB00114
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00114
SMP0000021,Taurine and Hypotaurine Metabolism,metabolic,DB00114
SMP0000024,Porphyrin Metabolism,metabolic,DB00114
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00114
SMP0000044,Histidine Metabolism,metabolic,DB00114
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB00114
SMP0000072,Glutamate Metabolism,metabolic,DB00114
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00114
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00114
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00114
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00114
SMP0000186,Glutaric Aciduria Type I,disease,DB00114
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00114
SMP0000191,Histidinemia,disease,DB00114
SMP0000218,Tyrosinemia Type I,disease,DB00114
SMP0000239,Saccharopinuria/Hyperlysinemia II,disease,DB00114
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00114
SMP0000348,Globoid Cell Leukodystrophy,disease,DB00114
SMP0000360,Hyperprolinemia Type II,disease,DB00114
SMP0000361,Hyperprolinemia Type I,disease,DB00114
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB00114
SMP0000429,Disulfiram Action Pathway,drug_action,DB00114
SMP0000465,Carnitine Synthesis,metabolic,DB00114
SMP0000033,Methionine Metabolism,metabolic,DB00116
SMP0000144,Adenosine Deaminase Deficiency,disease,DB00116
SMP0000168,AICA-Ribosiduria,disease,DB00116
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB00116
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB00116
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00116
SMP0000244,Sarcosinemia,disease,DB00116
SMP0000427,Azathioprine Action Pathway,drug_action,DB00116
SMP0000430,Thioguanine Action Pathway,drug_action,DB00116
SMP0000432,Methotrexate Action Pathway,drug_action,DB00116
SMP0000513,Xanthinuria Type II,disease,DB00116
SMP0000724,"Folate Malabsorption, Hereditary",disease,DB00116
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00116
SMP0000009,Ammonia Recycling,metabolic,DB00116
SMP0000044,Histidine Metabolism,metabolic,DB00116
SMP0000050,Purine Metabolism,metabolic,DB00116
SMP0000123,Betaine Metabolism,metabolic,DB00116
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00116
SMP0000191,Histidinemia,disease,DB00116
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00116
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00116
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00116
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00116
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00116
SMP0000543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00116
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00116
SMP0000053,Folate Metabolism,metabolic,DB00116
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00116
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00116
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00116
SMP0000247,Azithromycin Action Pathway,drug_action,DB00117
SMP0000249,Clindamycin Action Pathway,drug_action,DB00117
SMP0000250,Erythromycin Action Pathway,drug_action,DB00117
SMP0000255,Kanamycin Action Pathway,drug_action,DB00117
SMP0000256,Neomycin Action Pathway,drug_action,DB00117
SMP0000257,Netilmicin Action Pathway,drug_action,DB00117
SMP0000259,Streptomycin Action Pathway,drug_action,DB00117
SMP0000262,Clomocycline Action Pathway,drug_action,DB00117
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB00117
SMP0000711,Tobramycin Action Pathway,drug_action,DB00117
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB00117
SMP0000009,Ammonia Recycling,metabolic,DB00117
SMP0000044,Histidine Metabolism,metabolic,DB00117
SMP0000191,Histidinemia,disease,DB00117
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00117
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00117
SMP0000254,Gentamicin Action Pathway,drug_action,DB00117
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00117
SMP0000294,Tetracycline Action Pathway,drug_action,DB00117
SMP0000713,Arbekacin Action Pathway,drug_action,DB00117
SMP0000715,Methylhistidine Metabolism,metabolic,DB00117
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00117
SMP0000731,Josamycin Action Pathway,drug_action,DB00117
SMP0000007,beta-Alanine Metabolism,metabolic,DB00117
SMP0000252,Telithromycin Action Pathway,drug_action,DB00117
SMP0000253,Amikacin Action Pathway,drug_action,DB00117
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00117
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00117
SMP0000291,Doxycycline Action Pathway,drug_action,DB00117
SMP0000292,Minocycline Action Pathway,drug_action,DB00117
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00118
SMP0000006,Tyrosine Metabolism,metabolic,DB00118
SMP0000012,Catecholamine Biosynthesis,metabolic,DB00118
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00118
SMP0000044,Histidine Metabolism,metabolic,DB00118
SMP0000123,Betaine Metabolism,metabolic,DB00118
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00118
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00118
SMP0000191,Histidinemia,disease,DB00118
SMP0000218,Tyrosinemia Type I,disease,DB00118
SMP0000327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00118
SMP0000360,Hyperprolinemia Type II,disease,DB00118
SMP0000361,Hyperprolinemia Type I,disease,DB00118
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00118
SMP0000429,Disulfiram Action Pathway,drug_action,DB00118
SMP0000465,Carnitine Synthesis,metabolic,DB00118
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00118
SMP0000715,Methylhistidine Metabolism,metabolic,DB00118
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00118
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB00118
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB00118
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB00118
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB00118
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB00118
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB00118
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB00118
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB00118
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00118
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB00118
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB00118
SMP0000013,Cysteine Metabolism,metabolic,DB00119
SMP0000040,Glycolysis,metabolic,DB00119
SMP0000045,Amino Sugar Metabolism,metabolic,DB00119
SMP0000055,Alanine Metabolism,metabolic,DB00119
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00119
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00119
SMP0000350,Pyruvate Carboxylase Deficiency,disease,DB00119
SMP0000385,Homocarnosinosis,disease,DB00119
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00119
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB00119
SMP0000531,"Glycogenosis, Type VII. Tarui Disease",disease,DB00119
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB00119
SMP0000559,Pyruvate Kinase Deficiency,disease,DB00119
SMP0000560,Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1),disease,DB00119
SMP0000573,"Glycogenosis, Type IB",disease,DB00119
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB00119
SMP0000722,"Cystinosis, Ocular Nonnephropathic",disease,DB00119
SMP0002295,The Oncogenic Action of Fumarate,disease,DB00119
SMP0002358,The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB00119
SMP0000001,Citrullinemia Type I,disease,DB00119
SMP0000059,Urea Cycle,metabolic,DB00119
SMP0000127,Glucose-Alanine Cycle,metabolic,DB00119
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00119
SMP0000205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00119
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00119
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00119
SMP0000244,Sarcosinemia,disease,DB00119
SMP0000313,Lactic Acidemia,disease,DB00119
SMP0000352,Primary Hyperoxaluria Type I,disease,DB00119
SMP0000357,Argininemia,disease,DB00119
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB00120
SMP0000206,Phenylketonuria,disease,DB00120
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB00120
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB00120
SMP0000066,Biotin Metabolism,metabolic,DB00121
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00121
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00121
SMP0000198,Malonic Aciduria,disease,DB00121
SMP0000200,Methylmalonic Aciduria,disease,DB00121
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00121
SMP0000313,Lactic Acidemia,disease,DB00121
SMP0000352,Primary Hyperoxaluria Type I,disease,DB00121
SMP0000374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB00121
SMP0000466,Transfer of Acetyl Groups into Mitochondria,metabolic,DB00121
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00121
SMP0000546,Congenital Lactic Acidosis,disease,DB00121
SMP0000547,Fumarase Deficiency,disease,DB00121
SMP0000548,Mitochondrial Complex II Deficiency,disease,DB00121
SMP0000549,2-Ketoglutarate Dehydrogenase Complex Deficiency,disease,DB00121
SMP0000562,"Fructose-1,6-diphosphatase Deficiency",disease,DB00121
SMP0000563,Triosephosphate Isomerase,disease,DB00121
SMP0000567,Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00121
SMP0000654,Warburg Effect,metabolic,DB00121
SMP0002291,The Oncogenic Action of 2-Hydroxyglutarate,disease,DB00121
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00121
SMP0000055,Alanine Metabolism,metabolic,DB00121
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00121
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB00121
SMP0000199,Maple Syrup Urine Disease,disease,DB00121
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB00121
SMP0000236,Propionic Acidemia,disease,DB00121
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB00121
SMP0000238,Isovaleric Aciduria,disease,DB00121
SMP0000350,Pyruvate Carboxylase Deficiency,disease,DB00121
SMP0000123,Betaine Metabolism,metabolic,DB00122
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00122
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00122
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB00122
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB00122
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB00122
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB00122
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB00122
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB00122
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB00122
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB00122
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB00122
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB00122
SMP0014245,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0),metabolic,DB00122
SMP0014248,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0),metabolic,DB00122
SMP0014249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB00122
SMP0014255,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB00122
SMP0014267,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z))",metabolic,DB00122
SMP0014272,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0),metabolic,DB00122
SMP0014274,Phosphatidylcholine Biosynthesis PC(15:0/14:0),metabolic,DB00122
SMP0014277,Phosphatidylcholine Biosynthesis PC(15:0/16:0),metabolic,DB00122
SMP0014278,Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)),metabolic,DB00122
SMP0014279,Phosphatidylcholine Biosynthesis PC(15:0/18:0),metabolic,DB00122
SMP0014287,Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)),metabolic,DB00122
SMP0014290,"Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z))",metabolic,DB00122
SMP0014291,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB00122
SMP0014294,Phosphatidylcholine Biosynthesis PC(15:0/22:0),metabolic,DB00122
SMP0014300,"Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB00122
SMP0014303,Phosphatidylcholine Biosynthesis PC(16:0/14:0),metabolic,DB00122
SMP0000066,Biotin Metabolism,metabolic,DB00123
SMP0000719,2-Aminoadipic 2-Oxoadipic Aciduria,disease,DB00123
SMP0000037,Lysine Degradation,metabolic,DB00123
SMP0000528,Hyperlysinemia II or Saccharopinuria,disease,DB00123
SMP0000564,"Multiple Carboxylase Deficiency, Neonatal or Early Onset Form",disease,DB00123
SMP0000571,Pyridoxine Dependency with Seizures,disease,DB00123
SMP0000174,Biotinidase Deficiency,disease,DB00123
SMP0000186,Glutaric Aciduria Type I,disease,DB00123
SMP0000239,Saccharopinuria/Hyperlysinemia II,disease,DB00123
SMP0000465,Carnitine Synthesis,metabolic,DB00123
SMP0000527,"Hyperlysinemia I, Familial",disease,DB00123
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00125
SMP0000003,Argininosuccinic Aciduria,disease,DB00125
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00125
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00125
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00125
SMP0000360,Hyperprolinemia Type II,disease,DB00125
SMP0000361,Hyperprolinemia Type I,disease,DB00125
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00125
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00125
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00125
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00125
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00125
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB00125
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00125
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00125
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB00125
SMP0000001,Citrullinemia Type I,disease,DB00125
SMP0000059,Urea Cycle,metabolic,DB00125
SMP0000067,Aspartate Metabolism,metabolic,DB00125
SMP0000175,Canavan Disease,disease,DB00125
SMP0000192,Hypoacetylaspartia,disease,DB00125
SMP0000205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00125
SMP0000207,Prolidase Deficiency (PD),disease,DB00125
SMP0000208,Prolinemia Type II,disease,DB00125
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00125
SMP0000244,Sarcosinemia,disease,DB00125
SMP0000357,Argininemia,disease,DB00125
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00125
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00125
SMP0063777,Nitric Oxide Signaling Pathway,signaling,DB00125
SMP0000030,Oxidation of Branched-Chain Fatty Acids,metabolic,DB00126
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00126
SMP0002295,The Oncogenic Action of Fumarate,disease,DB00126
SMP0000006,Tyrosine Metabolism,metabolic,DB00126
SMP0000012,Catecholamine Biosynthesis,metabolic,DB00126
SMP0000218,Tyrosinemia Type I,disease,DB00126
SMP0000429,Disulfiram Action Pathway,drug_action,DB00126
SMP0000450,Phytanic Acid Peroxisomal Oxidation,metabolic,DB00126
SMP0000465,Carnitine Synthesis,metabolic,DB00126
SMP0002292,The Oncogenic Action of Succinate,disease,DB00126
SMP0000169,Alkaptonuria,disease,DB00126
SMP0000190,Hawkinsinuria,disease,DB00126
SMP0000451,Refsum Disease,disease,DB00126
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00126
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB00126
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00126
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00126
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB00127
SMP0000129,Malate-Aspartate Shuttle,metabolic,DB00128
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00128
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00128
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00128
SMP0000385,Homocarnosinosis,disease,DB00128
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB00128
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00128
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00128
SMP0000512,Xanthinuria Type I,disease,DB00128
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB00128
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB00128
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00128
SMP0000003,Argininosuccinic Aciduria,disease,DB00128
SMP0000006,Tyrosine Metabolism,metabolic,DB00128
SMP0000009,Ammonia Recycling,metabolic,DB00128
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00128
SMP0000050,Purine Metabolism,metabolic,DB00128
SMP0000072,Glutamate Metabolism,metabolic,DB00128
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00128
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00128
SMP0000218,Tyrosinemia Type I,disease,DB00128
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00128
SMP0000360,Hyperprolinemia Type II,disease,DB00128
SMP0000361,Hyperprolinemia Type I,disease,DB00128
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00128
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00128
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00128
SMP0000429,Disulfiram Action Pathway,drug_action,DB00128
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00128
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00128
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00129
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00129
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00129
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00129
SMP0000003,Argininosuccinic Aciduria,disease,DB00129
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00129
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00129
SMP0000360,Hyperprolinemia Type II,disease,DB00129
SMP0000361,Hyperprolinemia Type I,disease,DB00129
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00129
SMP0000001,Citrullinemia Type I,disease,DB00129
SMP0000059,Urea Cycle,metabolic,DB00129
SMP0000205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00129
SMP0000207,Prolidase Deficiency (PD),disease,DB00129
SMP0000208,Prolinemia Type II,disease,DB00129
SMP0000357,Argininemia,disease,DB00129
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00129
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB00129
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00129
SMP0000045,Amino Sugar Metabolism,metabolic,DB00130
SMP0000126,Phenylacetate Metabolism,metabolic,DB00130
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00130
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00130
SMP0000385,Homocarnosinosis,disease,DB00130
SMP0000512,Xanthinuria Type I,disease,DB00130
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB00130
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB00130
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB00130
SMP0002358,The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB00130
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00130
SMP0000003,Argininosuccinic Aciduria,disease,DB00130
SMP0000009,Ammonia Recycling,metabolic,DB00130
SMP0000046,Pyrimidine Metabolism,metabolic,DB00130
SMP0000050,Purine Metabolism,metabolic,DB00130
SMP0000072,Glutamate Metabolism,metabolic,DB00130
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB00130
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00130
SMP0000216,Sialuria or French Type Sialuria,disease,DB00130
SMP0000217,Sialuria or French Type Sialuria,disease,DB00130
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB00130
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00130
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00130
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00130
SMP0000390,Tay-Sachs Disease,disease,DB00130
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00130
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00130
SMP0002298,Glutaminolysis and Cancer,disease,DB00130
SMP0002359,The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB00130
SMP0000001,Citrullinemia Type I,disease,DB00130
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00131
SMP0000003,Argininosuccinic Aciduria,disease,DB00131
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00131
SMP0000009,Ammonia Recycling,metabolic,DB00131
SMP0000016,Propanoate Metabolism,metabolic,DB00131
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00131
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00131
SMP0000031,Pentose Phosphate Pathway,metabolic,DB00131
SMP0000044,Histidine Metabolism,metabolic,DB00131
SMP0000050,Purine Metabolism,metabolic,DB00131
SMP0000051,Fatty Acid Metabolism,metabolic,DB00131
SMP0000060,Pyruvate Metabolism,metabolic,DB00131
SMP0000072,Glutamate Metabolism,metabolic,DB00131
SMP0000073,Butyrate Metabolism,metabolic,DB00131
SMP0000076,Thiamine Metabolism,metabolic,DB00131
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00131
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00131
SMP0000191,Histidinemia,disease,DB00131
SMP0000196,Leigh Syndrome,disease,DB00131
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00131
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB00131
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00131
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00131
SMP0000254,Gentamicin Action Pathway,drug_action,DB00131
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00131
SMP0000294,Tetracycline Action Pathway,drug_action,DB00131
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB00131
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00131
SMP0000360,Hyperprolinemia Type II,disease,DB00131
SMP0000361,Hyperprolinemia Type I,disease,DB00131
SMP0000018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00132
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00133
SMP0000009,Ammonia Recycling,metabolic,DB00133
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00133
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00133
SMP0000348,Globoid Cell Leukodystrophy,disease,DB00133
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00133
SMP0015056,Phosphatidylethanolamine Biosynthesis PE(14:0/14:0),metabolic,DB00133
SMP0015057,Phosphatidylethanolamine Biosynthesis PE(14:0/14:1(9Z)),metabolic,DB00133
SMP0015058,Phosphatidylethanolamine Biosynthesis PE(14:0/15:0),metabolic,DB00133
SMP0015062,Phosphatidylethanolamine Biosynthesis PE(14:0/18:1(11Z)),metabolic,DB00133
SMP0015063,Phosphatidylethanolamine Biosynthesis PE(14:0/18:1(9Z)),metabolic,DB00133
SMP0015074,"Phosphatidylethanolamine Biosynthesis PE(14:0/20:4(8Z,11Z,14Z,17Z))",metabolic,DB00133
SMP0015077,Phosphatidylethanolamine Biosynthesis PE(14:0/22:1(13Z)),metabolic,DB00133
SMP0015078,"Phosphatidylethanolamine Biosynthesis PE(14:0/22:2(13Z,16Z))",metabolic,DB00133
SMP0015084,Phosphatidylethanolamine Biosynthesis PE(14:0/24:1(15Z)),metabolic,DB00133
SMP0015086,Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/14:1(9Z)),metabolic,DB00133
SMP0015092,Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:1(9Z)),metabolic,DB00133
SMP0015094,"Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:3(6Z,9Z,12Z))",metabolic,DB00133
SMP0015095,"Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB00133
SMP0015097,Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:0),metabolic,DB00133
SMP0015101,"Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:3(8Z,11Z,14Z))",metabolic,DB00133
SMP0015103,"Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))",metabolic,DB00133
SMP0015109,"Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB00133
SMP0015112,Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/24:0),metabolic,DB00133
SMP0015114,Phosphatidylethanolamine Biosynthesis PE(15:0/14:0),metabolic,DB00133
SMP0015116,Phosphatidylethanolamine Biosynthesis PE(15:0/15:0),metabolic,DB00133
SMP0015117,Phosphatidylethanolamine Biosynthesis PE(15:0/16:0),metabolic,DB00133
SMP0015119,Phosphatidylethanolamine Biosynthesis PE(15:0/18:0),metabolic,DB00133
SMP0015120,Phosphatidylethanolamine Biosynthesis PE(15:0/18:1(11Z)),metabolic,DB00133
SMP0015121,Phosphatidylethanolamine Biosynthesis PE(15:0/18:1(9Z)),metabolic,DB00133
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00134
SMP0000123,Betaine Metabolism,metabolic,DB00134
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00134
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00134
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00134
SMP0000254,Gentamicin Action Pathway,drug_action,DB00134
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00134
SMP0000294,Tetracycline Action Pathway,drug_action,DB00134
SMP0000713,Arbekacin Action Pathway,drug_action,DB00134
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00134
SMP0000731,Josamycin Action Pathway,drug_action,DB00134
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00134
SMP0000033,Methionine Metabolism,metabolic,DB00134
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB00134
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00134
SMP0000244,Sarcosinemia,disease,DB00134
SMP0000252,Telithromycin Action Pathway,drug_action,DB00134
SMP0000253,Amikacin Action Pathway,drug_action,DB00134
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00134
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00134
SMP0000291,Doxycycline Action Pathway,drug_action,DB00134
SMP0000292,Minocycline Action Pathway,drug_action,DB00134
SMP0000295,Lymecycline Action Pathway,drug_action,DB00134
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB00134
SMP0000712,Tigecycline Action Pathway,drug_action,DB00134
SMP0000714,Paromomycin Action Pathway,drug_action,DB00134
SMP0000727,Methacycline Action Pathway,drug_action,DB00134
SMP0000728,Lincomycin Action Pathway,drug_action,DB00134
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB00134
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00134
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00135
SMP0000206,Phenylketonuria,disease,DB00135
SMP0000006,Tyrosine Metabolism,metabolic,DB00135
SMP0000012,Catecholamine Biosynthesis,metabolic,DB00135
SMP0000218,Tyrosinemia Type I,disease,DB00135
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB00135
SMP0000429,Disulfiram Action Pathway,drug_action,DB00135
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB00135
SMP0000169,Alkaptonuria,disease,DB00135
SMP0000190,Hawkinsinuria,disease,DB00135
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB00135
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00135
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB00135
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00135
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00135
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB00135
SMP0000071,Ketone Body Metabolism,metabolic,DB00139
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00139
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00139
SMP0000200,Methylmalonic Aciduria,disease,DB00139
SMP0000207,Prolidase Deficiency (PD),disease,DB00139
SMP0000208,Prolinemia Type II,disease,DB00139
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00139
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00139
SMP0000451,Refsum Disease,disease,DB00139
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00139
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00139
SMP0000546,Congenital Lactic Acidosis,disease,DB00139
SMP0000547,Fumarase Deficiency,disease,DB00139
SMP0000548,Mitochondrial Complex II Deficiency,disease,DB00139
SMP0000549,2-Ketoglutarate Dehydrogenase Complex Deficiency,disease,DB00139
SMP0000567,Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00139
SMP0000654,Warburg Effect,metabolic,DB00139
SMP0002291,The Oncogenic Action of 2-Hydroxyglutarate,disease,DB00139
SMP0000030,Oxidation of Branched-Chain Fatty Acids,metabolic,DB00139
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00139
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00139
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB00139
SMP0000199,Maple Syrup Urine Disease,disease,DB00139
SMP0000236,Propionic Acidemia,disease,DB00139
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB00139
SMP0000238,Isovaleric Aciduria,disease,DB00139
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00139
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB00139
SMP0000385,Homocarnosinosis,disease,DB00139
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00139
SMP0000070,Riboflavin Metabolism,metabolic,DB00140
SMP0000045,Amino Sugar Metabolism,metabolic,DB00141
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB00141
SMP0000216,Sialuria or French Type Sialuria,disease,DB00141
SMP0000217,Sialuria or French Type Sialuria,disease,DB00141
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB00141
SMP0000390,Tay-Sachs Disease,disease,DB00141
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00142
SMP0000003,Argininosuccinic Aciduria,disease,DB00142
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00142
SMP0000006,Tyrosine Metabolism,metabolic,DB00142
SMP0000009,Ammonia Recycling,metabolic,DB00142
SMP0000016,Propanoate Metabolism,metabolic,DB00142
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00142
SMP0000044,Histidine Metabolism,metabolic,DB00142
SMP0000050,Purine Metabolism,metabolic,DB00142
SMP0000072,Glutamate Metabolism,metabolic,DB00142
SMP0000084,Etodolac Action Pathway,drug_action,DB00142
SMP0000085,Ketoprofen Action Pathway,drug_action,DB00142
SMP0000086,Ibuprofen Action Pathway,drug_action,DB00142
SMP0000096,Celecoxib Action Pathway,drug_action,DB00142
SMP0000101,Suprofen Action Pathway,drug_action,DB00142
SMP0000104,Indomethacin Action Pathway,drug_action,DB00142
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00142
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00142
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00142
SMP0000186,Glutaric Aciduria Type I,disease,DB00142
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00142
SMP0000191,Histidinemia,disease,DB00142
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00142
SMP0000216,Sialuria or French Type Sialuria,disease,DB00142
SMP0000217,Sialuria or French Type Sialuria,disease,DB00142
SMP0000218,Tyrosinemia Type I,disease,DB00142
SMP0000239,Saccharopinuria/Hyperlysinemia II,disease,DB00142
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB00142
SMP0000289,Diflunisal Action Pathway,drug_action,DB00142
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00142
SMP0000077,Piroxicam Action Pathway,drug_action,DB00143
SMP0000087,Rofecoxib Action Pathway,drug_action,DB00143
SMP0000093,Diclofenac Action Pathway,drug_action,DB00143
SMP0000094,Sulindac Action Pathway,drug_action,DB00143
SMP0000114,Nabumetone Action Pathway,drug_action,DB00143
SMP0000116,Valdecoxib Action Pathway,drug_action,DB00143
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00143
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB00143
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00143
SMP0000500,5-Oxoprolinase Deficiency,disease,DB00143
SMP0000567,Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00143
SMP0000692,Antipyrine Action Pathway,drug_action,DB00143
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB00143
SMP0000702,Nepafenac Action Pathway,drug_action,DB00143
SMP0000015,Glutathione Metabolism,metabolic,DB00143
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB00143
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB00143
SMP0000098,Ketorolac Action Pathway,drug_action,DB00143
SMP0000102,Bromfenac Action Pathway,drug_action,DB00143
SMP0000106,Meloxicam Action Pathway,drug_action,DB00143
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB00143
SMP0000113,Oxaprozin Action Pathway,drug_action,DB00143
SMP0000120,Naproxen Action Pathway,drug_action,DB00143
SMP0000143,5-Oxoprolinuria,disease,DB00143
SMP0000337,Glutathione Synthetase Deficiency,disease,DB00143
SMP0000385,Homocarnosinosis,disease,DB00143
SMP0000447,Cyclophosphamide Action Pathway,drug_action,DB00143
SMP0000559,Pyruvate Kinase Deficiency,disease,DB00143
SMP0000604,Cyclophosphamide Metabolism Pathway,drug_metabolism,DB00143
SMP0000640,Acetaminophen Metabolism Pathway,drug_metabolism,DB00143
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB00144
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB00144
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB00144
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB00144
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB00144
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB00144
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB00144
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB00144
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00144
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB00144
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB00144
SMP0014245,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0),metabolic,DB00144
SMP0014248,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0),metabolic,DB00144
SMP0014249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB00144
SMP0014255,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB00144
SMP0014267,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z))",metabolic,DB00144
SMP0014272,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0),metabolic,DB00144
SMP0014274,Phosphatidylcholine Biosynthesis PC(15:0/14:0),metabolic,DB00144
SMP0014277,Phosphatidylcholine Biosynthesis PC(15:0/16:0),metabolic,DB00144
SMP0014278,Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)),metabolic,DB00144
SMP0014279,Phosphatidylcholine Biosynthesis PC(15:0/18:0),metabolic,DB00144
SMP0014287,Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)),metabolic,DB00144
SMP0014290,"Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z))",metabolic,DB00144
SMP0014291,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB00144
SMP0014294,Phosphatidylcholine Biosynthesis PC(15:0/22:0),metabolic,DB00144
SMP0014300,"Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB00144
SMP0014303,Phosphatidylcholine Biosynthesis PC(16:0/14:0),metabolic,DB00144
SMP0014304,Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)),metabolic,DB00144
SMP0014306,Phosphatidylcholine Biosynthesis PC(16:0/16:0),metabolic,DB00144
SMP0014310,Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)),metabolic,DB00144
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00145
SMP0000009,Ammonia Recycling,metabolic,DB00145
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00145
SMP0000024,Porphyrin Metabolism,metabolic,DB00145
SMP0000050,Purine Metabolism,metabolic,DB00145
SMP0000072,Glutamate Metabolism,metabolic,DB00145
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00145
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00145
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00145
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB00145
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00145
SMP0000360,Hyperprolinemia Type II,disease,DB00145
SMP0000361,Hyperprolinemia Type I,disease,DB00145
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00145
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00145
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00145
SMP0000465,Carnitine Synthesis,metabolic,DB00145
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB00145
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00145
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00145
SMP0000720,27-Hydroxylase Deficiency,disease,DB00145
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB00145
SMP0000033,Methionine Metabolism,metabolic,DB00145
SMP0000035,Bile Acid Biosynthesis,metabolic,DB00145
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00145
SMP0000144,Adenosine Deaminase Deficiency,disease,DB00145
SMP0000168,AICA-Ribosiduria,disease,DB00145
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB00145
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB00145
SMP0000207,Prolidase Deficiency (PD),disease,DB00145
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00147
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00147
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00147
SMP0000524,Isovaleric Acidemia,disease,DB00147
SMP0000017,Vitamin B6 Metabolism,metabolic,DB00147
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00147
SMP0000200,Methylmalonic Aciduria,disease,DB00147
SMP0000503,Hypophosphatasia,disease,DB00147
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00147
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00147
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00147
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB00147
SMP0000199,Maple Syrup Urine Disease,disease,DB00147
SMP0000236,Propionic Acidemia,disease,DB00147
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB00147
SMP0000238,Isovaleric Aciduria,disease,DB00147
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB00147
SMP0000521,3-Hydroxyisobutyric Acid Dehydrogenase Deficiency,disease,DB00147
SMP0000522,3-Hydroxyisobutyric Aciduria,disease,DB00147
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00148
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00148
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00148
SMP0000360,Hyperprolinemia Type II,disease,DB00148
SMP0000361,Hyperprolinemia Type I,disease,DB00148
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00148
SMP0000207,Prolidase Deficiency (PD),disease,DB00148
SMP0000208,Prolinemia Type II,disease,DB00148
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00148
SMP0000244,Sarcosinemia,disease,DB00148
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00148
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00148
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00148
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00148
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00148
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00148
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB00148
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00148
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00148
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB00148
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00149
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00149
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00149
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00149
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00149
SMP0000254,Gentamicin Action Pathway,drug_action,DB00149
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00149
SMP0000294,Tetracycline Action Pathway,drug_action,DB00149
SMP0000524,Isovaleric Acidemia,disease,DB00149
SMP0000713,Arbekacin Action Pathway,drug_action,DB00149
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00149
SMP0000731,Josamycin Action Pathway,drug_action,DB00149
SMP0002298,Glutaminolysis and Cancer,disease,DB00149
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00149
SMP0000200,Methylmalonic Aciduria,disease,DB00149
SMP0000252,Telithromycin Action Pathway,drug_action,DB00149
SMP0000253,Amikacin Action Pathway,drug_action,DB00149
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00149
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00149
SMP0000291,Doxycycline Action Pathway,drug_action,DB00149
SMP0000292,Minocycline Action Pathway,drug_action,DB00149
SMP0000295,Lymecycline Action Pathway,drug_action,DB00149
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00149
SMP0000712,Tigecycline Action Pathway,drug_action,DB00149
SMP0000714,Paromomycin Action Pathway,drug_action,DB00149
SMP0000727,Methacycline Action Pathway,drug_action,DB00149
SMP0000728,Lincomycin Action Pathway,drug_action,DB00149
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB00149
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00149
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00149
SMP0000063,Tryptophan Metabolism,metabolic,DB00150
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00151
SMP0000021,Taurine and Hypotaurine Metabolism,metabolic,DB00151
SMP0000072,Glutamate Metabolism,metabolic,DB00151
SMP0000080,Polythiazide Action Pathway,drug_action,DB00151
SMP0000088,Bumetanide Action Pathway,drug_action,DB00151
SMP0000091,Quinethazone Action Pathway,drug_action,DB00151
SMP0000110,Indapamide Action Pathway,drug_action,DB00151
SMP0000121,Trichlormethiazide Action Pathway,drug_action,DB00151
SMP0000134,Spironolactone Action Pathway,drug_action,DB00151
SMP0000135,Eplerenone Action Pathway,drug_action,DB00151
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00151
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00151
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB00151
SMP0000027,Pantothenate and CoA Biosynthesis,metabolic,DB00151
SMP0000033,Methionine Metabolism,metabolic,DB00151
SMP0000078,Chlorothiazide Action Pathway,drug_action,DB00151
SMP0000090,Bendroflumethiazide Action Pathway,drug_action,DB00151
SMP0000097,Ethacrynic Acid Action Pathway,drug_action,DB00151
SMP0000103,Cyclothiazide Action Pathway,drug_action,DB00151
SMP0000108,Hydroflumethiazide Action Pathway,drug_action,DB00151
SMP0000122,Chlorthalidone Action Pathway,drug_action,DB00151
SMP0000133,Amiloride Action Pathway,drug_action,DB00151
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB00151
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB00151
SMP0000184,Glucose Transporter Defect (SGLT2),disease,DB00151
SMP0000193,Iminoglycinuria,disease,DB00151
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB00151
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00151
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00151
SMP0000244,Sarcosinemia,disease,DB00151
SMP0000076,Thiamine Metabolism,metabolic,DB00152
SMP0000018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00154
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00155
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00155
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00155
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00155
SMP0000003,Argininosuccinic Aciduria,disease,DB00155
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00155
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00155
SMP0000360,Hyperprolinemia Type II,disease,DB00155
SMP0000361,Hyperprolinemia Type I,disease,DB00155
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00155
SMP0000001,Citrullinemia Type I,disease,DB00155
SMP0000059,Urea Cycle,metabolic,DB00155
SMP0000067,Aspartate Metabolism,metabolic,DB00155
SMP0000175,Canavan Disease,disease,DB00155
SMP0000192,Hypoacetylaspartia,disease,DB00155
SMP0000205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00155
SMP0000207,Prolidase Deficiency (PD),disease,DB00155
SMP0000208,Prolinemia Type II,disease,DB00155
SMP0000357,Argininemia,disease,DB00155
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00155
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00155
SMP0063777,Nitric Oxide Signaling Pathway,signaling,DB00155
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00156
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00156
SMP0000254,Gentamicin Action Pathway,drug_action,DB00156
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00156
SMP0000294,Tetracycline Action Pathway,drug_action,DB00156
SMP0000713,Arbekacin Action Pathway,drug_action,DB00156
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00156
SMP0000731,Josamycin Action Pathway,drug_action,DB00156
SMP0000247,Azithromycin Action Pathway,drug_action,DB00156
SMP0000249,Clindamycin Action Pathway,drug_action,DB00156
SMP0000250,Erythromycin Action Pathway,drug_action,DB00156
SMP0000255,Kanamycin Action Pathway,drug_action,DB00156
SMP0000256,Neomycin Action Pathway,drug_action,DB00156
SMP0000257,Netilmicin Action Pathway,drug_action,DB00156
SMP0000259,Streptomycin Action Pathway,drug_action,DB00156
SMP0000262,Clomocycline Action Pathway,drug_action,DB00156
SMP0000452,Threonine and 2-Oxobutanoate Degradation,metabolic,DB00156
SMP0000711,Tobramycin Action Pathway,drug_action,DB00156
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB00156
SMP0000252,Telithromycin Action Pathway,drug_action,DB00156
SMP0000253,Amikacin Action Pathway,drug_action,DB00156
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00156
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00156
SMP0000291,Doxycycline Action Pathway,drug_action,DB00156
SMP0000292,Minocycline Action Pathway,drug_action,DB00156
SMP0000295,Lymecycline Action Pathway,drug_action,DB00156
SMP0000712,Tigecycline Action Pathway,drug_action,DB00156
SMP0000714,Paromomycin Action Pathway,drug_action,DB00156
SMP0000727,Methacycline Action Pathway,drug_action,DB00156
SMP0000728,Lincomycin Action Pathway,drug_action,DB00156
SMP0000010,Nucleotide Sugars Metabolism,metabolic,DB00157
SMP0000013,Cysteine Metabolism,metabolic,DB00157
SMP0000028,Caffeine Metabolism,metabolic,DB00157
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00157
SMP0000037,Lysine Degradation,metabolic,DB00157
SMP0000040,Glycolysis,metabolic,DB00157
SMP0000053,Folate Metabolism,metabolic,DB00157
SMP0000063,Tryptophan Metabolism,metabolic,DB00157
SMP0000064,Fructose and Mannose Degradation,metabolic,DB00157
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB00157
SMP0000124,Glycerol Phosphate Shuttle,metabolic,DB00157
SMP0000129,Malate-Aspartate Shuttle,metabolic,DB00157
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00157
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB00157
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00157
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00157
SMP0000181,Ethylmalonic Encephalopathy,disease,DB00157
SMP0000185,Glutaric Aciduria Type I,disease,DB00157
SMP0000187,Glycerol Kinase Deficiency,disease,DB00157
SMP0000199,Maple Syrup Urine Disease,disease,DB00157
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB00157
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00157
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00157
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB00157
SMP0000235,Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB00157
SMP0000236,Propionic Acidemia,disease,DB00157
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB00157
SMP0000238,Isovaleric Aciduria,disease,DB00157
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00157
SMP0000316,Zellweger Syndrome,disease,DB00157
SMP0000543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00158
SMP0000053,Folate Metabolism,metabolic,DB00158
SMP0000432,Methotrexate Action Pathway,drug_action,DB00158
SMP0000724,"Folate Malabsorption, Hereditary",disease,DB00158
SMP0000018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00159
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00160
SMP0000003,Argininosuccinic Aciduria,disease,DB00160
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00160
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00160
SMP0000072,Glutamate Metabolism,metabolic,DB00160
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00160
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00160
SMP0000254,Gentamicin Action Pathway,drug_action,DB00160
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00160
SMP0000294,Tetracycline Action Pathway,drug_action,DB00160
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00160
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB00160
SMP0000713,Arbekacin Action Pathway,drug_action,DB00160
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00160
SMP0000731,Josamycin Action Pathway,drug_action,DB00160
SMP0002298,Glutaminolysis and Cancer,disease,DB00160
SMP0000015,Glutathione Metabolism,metabolic,DB00160
SMP0000055,Alanine Metabolism,metabolic,DB00160
SMP0000063,Tryptophan Metabolism,metabolic,DB00160
SMP0000143,5-Oxoprolinuria,disease,DB00160
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00160
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00160
SMP0000247,Azithromycin Action Pathway,drug_action,DB00160
SMP0000249,Clindamycin Action Pathway,drug_action,DB00160
SMP0000250,Erythromycin Action Pathway,drug_action,DB00160
SMP0000255,Kanamycin Action Pathway,drug_action,DB00160
SMP0000256,Neomycin Action Pathway,drug_action,DB00160
SMP0000257,Netilmicin Action Pathway,drug_action,DB00160
SMP0000259,Streptomycin Action Pathway,drug_action,DB00160
SMP0000262,Clomocycline Action Pathway,drug_action,DB00160
SMP0000016,Propanoate Metabolism,metabolic,DB00161
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00161
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00161
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00161
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00161
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00161
SMP0000254,Gentamicin Action Pathway,drug_action,DB00161
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00161
SMP0000294,Tetracycline Action Pathway,drug_action,DB00161
SMP0000524,Isovaleric Acidemia,disease,DB00161
SMP0000713,Arbekacin Action Pathway,drug_action,DB00161
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00161
SMP0000731,Josamycin Action Pathway,drug_action,DB00161
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00161
SMP0000198,Malonic Aciduria,disease,DB00161
SMP0000200,Methylmalonic Aciduria,disease,DB00161
SMP0000252,Telithromycin Action Pathway,drug_action,DB00161
SMP0000253,Amikacin Action Pathway,drug_action,DB00161
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00161
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00161
SMP0000291,Doxycycline Action Pathway,drug_action,DB00161
SMP0000292,Minocycline Action Pathway,drug_action,DB00161
SMP0000295,Lymecycline Action Pathway,drug_action,DB00161
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00161
SMP0000712,Tigecycline Action Pathway,drug_action,DB00161
SMP0000714,Paromomycin Action Pathway,drug_action,DB00161
SMP0000727,Methacycline Action Pathway,drug_action,DB00161
SMP0000728,Lincomycin Action Pathway,drug_action,DB00161
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB00161
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00161
SMP0000074,Retinol Metabolism,metabolic,DB00162
SMP0000336,Vitamin A Deficiency,disease,DB00162
SMP0000017,Vitamin B6 Metabolism,metabolic,DB00165
SMP0000503,Hypophosphatasia,disease,DB00165
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00167
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB00167
SMP0000173,beta-Ketothiolase Deficiency,disease,DB00167
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00167
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00167
SMP0000254,Gentamicin Action Pathway,drug_action,DB00167
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00167
SMP0000294,Tetracycline Action Pathway,drug_action,DB00167
SMP0000524,Isovaleric Acidemia,disease,DB00167
SMP0000713,Arbekacin Action Pathway,drug_action,DB00167
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00167
SMP0000731,Josamycin Action Pathway,drug_action,DB00167
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB00167
SMP0000200,Methylmalonic Aciduria,disease,DB00167
SMP0000252,Telithromycin Action Pathway,drug_action,DB00167
SMP0000253,Amikacin Action Pathway,drug_action,DB00167
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00167
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00167
SMP0000291,Doxycycline Action Pathway,drug_action,DB00167
SMP0000292,Minocycline Action Pathway,drug_action,DB00167
SMP0000295,Lymecycline Action Pathway,drug_action,DB00167
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB00167
SMP0000712,Tigecycline Action Pathway,drug_action,DB00167
SMP0000714,Paromomycin Action Pathway,drug_action,DB00167
SMP0000727,Methacycline Action Pathway,drug_action,DB00167
SMP0000728,Lincomycin Action Pathway,drug_action,DB00167
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB00167
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB00167
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB00167
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB00167
SMP0000099,Lovastatin Action Pathway,drug_action,DB00169
SMP0000111,Cerivastatin Action Pathway,drug_action,DB00169
SMP0000209,Hypercholesterolemia,disease,DB00169
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB00169
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB00169
SMP0000510,Mevalonic Aciduria,disease,DB00169
SMP0000082,Simvastatin Action Pathway,drug_action,DB00169
SMP0000089,Pravastatin Action Pathway,drug_action,DB00169
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB00169
SMP0000107,Zoledronate Action Pathway,drug_action,DB00169
SMP0000117,Pamidronate Action Pathway,drug_action,DB00169
SMP0000119,Fluvastatin Action Pathway,drug_action,DB00169
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB00169
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB00169
SMP0000023,Steroid Biosynthesis,metabolic,DB00169
SMP0000079,Ibandronate Action Pathway,drug_action,DB00169
SMP0000095,Alendronate Action Pathway,drug_action,DB00169
SMP0000112,Risedronate Action Pathway,drug_action,DB00169
SMP0000131,Atorvastatin Action Pathway,drug_action,DB00169
SMP0000386,Desmosterolosis,disease,DB00169
SMP0000387,CHILD Syndrome,disease,DB00169
SMP0000509,Hyper-IgD Syndrome,disease,DB00169
SMP0000511,Wolman Disease,disease,DB00169
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00171
SMP0000003,Argininosuccinic Aciduria,disease,DB00171
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00171
SMP0000009,Ammonia Recycling,metabolic,DB00171
SMP0000011,Inositol Metabolism,metabolic,DB00171
SMP0000016,Propanoate Metabolism,metabolic,DB00171
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00171
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00171
SMP0000031,Pentose Phosphate Pathway,metabolic,DB00171
SMP0000039,Glycerolipid Metabolism,metabolic,DB00171
SMP0000043,Galactose Metabolism,metabolic,DB00171
SMP0000044,Histidine Metabolism,metabolic,DB00171
SMP0000046,Pyrimidine Metabolism,metabolic,DB00171
SMP0000050,Purine Metabolism,metabolic,DB00171
SMP0000051,Fatty Acid Metabolism,metabolic,DB00171
SMP0000057,Citric Acid Cycle,metabolic,DB00171
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB00171
SMP0000060,Pyruvate Metabolism,metabolic,DB00171
SMP0000072,Glutamate Metabolism,metabolic,DB00171
SMP0000073,Butyrate Metabolism,metabolic,DB00171
SMP0000076,Thiamine Metabolism,metabolic,DB00171
SMP0000082,Simvastatin Action Pathway,drug_action,DB00171
SMP0000089,Pravastatin Action Pathway,drug_action,DB00171
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB00171
SMP0000107,Zoledronate Action Pathway,drug_action,DB00171
SMP0000117,Pamidronate Action Pathway,drug_action,DB00171
SMP0000119,Fluvastatin Action Pathway,drug_action,DB00171
SMP0000123,Betaine Metabolism,metabolic,DB00171
SMP0000128,Gluconeogenesis,metabolic,DB00171
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB00171
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00172
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00172
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00172
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00172
SMP0000254,Gentamicin Action Pathway,drug_action,DB00172
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00172
SMP0000294,Tetracycline Action Pathway,drug_action,DB00172
SMP0000360,Hyperprolinemia Type II,disease,DB00172
SMP0000361,Hyperprolinemia Type I,disease,DB00172
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00172
SMP0000713,Arbekacin Action Pathway,drug_action,DB00172
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00172
SMP0000731,Josamycin Action Pathway,drug_action,DB00172
SMP0002292,The Oncogenic Action of Succinate,disease,DB00172
SMP0000247,Azithromycin Action Pathway,drug_action,DB00172
SMP0000249,Clindamycin Action Pathway,drug_action,DB00172
SMP0000250,Erythromycin Action Pathway,drug_action,DB00172
SMP0000255,Kanamycin Action Pathway,drug_action,DB00172
SMP0000256,Neomycin Action Pathway,drug_action,DB00172
SMP0000257,Netilmicin Action Pathway,drug_action,DB00172
SMP0000259,Streptomycin Action Pathway,drug_action,DB00172
SMP0000262,Clomocycline Action Pathway,drug_action,DB00172
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00172
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00172
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00172
SMP0000711,Tobramycin Action Pathway,drug_action,DB00172
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB00172
SMP0002295,The Oncogenic Action of Fumarate,disease,DB00172
SMP0000207,Prolidase Deficiency (PD),disease,DB00172
SMP0000208,Prolinemia Type II,disease,DB00172
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00173
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00173
SMP0000512,Xanthinuria Type I,disease,DB00173
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB00173
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB00173
SMP0000050,Purine Metabolism,metabolic,DB00173
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00173
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00173
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00173
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00173
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00173
SMP0000144,Adenosine Deaminase Deficiency,disease,DB00173
SMP0000168,AICA-Ribosiduria,disease,DB00173
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB00173
SMP0000427,Azathioprine Action Pathway,drug_action,DB00173
SMP0000430,Thioguanine Action Pathway,drug_action,DB00173
SMP0000513,Xanthinuria Type II,disease,DB00173
SMP0000009,Ammonia Recycling,metabolic,DB00174
SMP0000248,Clarithromycin Action Pathway,drug_action,DB00174
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00174
SMP0000254,Gentamicin Action Pathway,drug_action,DB00174
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00174
SMP0000294,Tetracycline Action Pathway,drug_action,DB00174
SMP0000713,Arbekacin Action Pathway,drug_action,DB00174
SMP0000730,Troleandomycin Action Pathway,drug_action,DB00174
SMP0000731,Josamycin Action Pathway,drug_action,DB00174
SMP0000247,Azithromycin Action Pathway,drug_action,DB00174
SMP0000249,Clindamycin Action Pathway,drug_action,DB00174
SMP0000250,Erythromycin Action Pathway,drug_action,DB00174
SMP0000255,Kanamycin Action Pathway,drug_action,DB00174
SMP0000256,Neomycin Action Pathway,drug_action,DB00174
SMP0000257,Netilmicin Action Pathway,drug_action,DB00174
SMP0000259,Streptomycin Action Pathway,drug_action,DB00174
SMP0000262,Clomocycline Action Pathway,drug_action,DB00174
SMP0000711,Tobramycin Action Pathway,drug_action,DB00174
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB00174
SMP0000067,Aspartate Metabolism,metabolic,DB00174
SMP0000175,Canavan Disease,disease,DB00174
SMP0000192,Hypoacetylaspartia,disease,DB00174
SMP0000252,Telithromycin Action Pathway,drug_action,DB00174
SMP0000253,Amikacin Action Pathway,drug_action,DB00174
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00174
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00174
SMP0000291,Doxycycline Action Pathway,drug_action,DB00174
SMP0000292,Minocycline Action Pathway,drug_action,DB00174
SMP0000295,Lymecycline Action Pathway,drug_action,DB00174
SMP0000712,Tigecycline Action Pathway,drug_action,DB00174
SMP0000089,Pravastatin Action Pathway,drug_action,DB00175
SMP0000165,Valsartan Action Pathway,drug_action,DB00177
SMP0000154,Ramipril Action Pathway,drug_action,DB00178
SMP0000597,Ramipril Metabolism Pathway,drug_metabolism,DB00178
SMP0000431,Nicotine Action Pathway,drug_action,DB00184
SMP0000628,Nicotine Metabolism Pathway,drug_metabolism,DB00184
SMP0000301,Esmolol Action Pathway,drug_action,DB00187
SMP0000671,Tramadol Action Action Pathway,drug_action,DB00193
SMP0000637,Tramadol Metabolism Pathway,drug_metabolism,DB00193
SMP0000299,Betaxolol Action Pathway,drug_action,DB00195
SMP0000250,Erythromycin Action Pathway,drug_action,DB00199
SMP0000028,Caffeine Metabolism,metabolic,DB00201
SMP0000247,Azithromycin Action Pathway,drug_action,DB00207
SMP0000261,Ticlopidine Action Pathway,drug_action,DB00208
SMP0000611,Ticlopidine Metabolism Pathway,drug_metabolism,DB00208
SMP0000615,Pantoprazole Metabolism Pathway,drug_metabolism,DB00213
SMP0000228,Pantoprazole Action Pathway,drug_action,DB00213
SMP0000118,Torsemide Action Pathway,drug_action,DB00214
SMP0000424,Citalopram Action Pathway,drug_action,DB00215
SMP0000627,Citalopram Metabolism Pathway,drug_metabolism,DB00215
SMP0000099,Lovastatin Action Pathway,drug_action,DB00227
SMP0000081,Methyclothiazide Action Pathway,drug_action,DB00232
SMP0000642,Nevirapine Metabolism Pathway,drug_metabolism,DB00238
SMP0000743,Nevirapine  Action Pathway,drug_action,DB00238
SMP0000327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00252
SMP0000326,Fosphenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00252
SMP0000618,Fosphenytoin (Antiarrhythmic) Metabolism Pathway,drug_metabolism,DB00252
SMP0000291,Doxycycline Action Pathway,drug_action,DB00254
SMP0000295,Lymecycline Action Pathway,drug_action,DB00256
SMP0000302,Metoprolol Action Pathway,drug_action,DB00264
SMP0000270,Dicumarol Action Pathway,drug_action,DB00266
SMP0000656,Dicoumarol Action Pathway,drug_action,DB00266
SMP0000378,Isradipine Action Pathway,drug_action,DB00270
SMP0000736,Betazole Action Pathway,drug_action,DB00272
SMP0000163,Olmesartan Action Pathway,drug_action,DB00275
SMP0000028,Caffeine Metabolism,metabolic,DB00277
SMP0000276,Argatroban Action Pathway,drug_action,DB00278
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB00279
SMP0000325,Disopyramide Action Pathway,drug_action,DB00280
SMP0000328,Lidocaine (Antiarrhythmic) Action Pathway,drug_action,DB00281
SMP0000398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB00281
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,drug_metabolism,DB00281
SMP0000117,Pamidronate Action Pathway,drug_action,DB00282
SMP0058891,Clemastine H1-Antihistamine Action,drug_action,DB00283
SMP0000636,Venlafaxine Metabolism Pathway,drug_metabolism,DB00285
SMP0000406,Morphine Action Pathway,drug_action,DB00295
SMP0000405,Codeine Action Pathway,drug_action,DB00295
SMP0000623,Heroin Metabolism Pathway,drug_metabolism,DB00295
SMP0000407,Heroin Action Pathway,drug_action,DB00295
SMP0000621,Codeine Metabolism Pathway,drug_metabolism,DB00295
SMP0000622,Morphine Metabolism Pathway,drug_metabolism,DB00295
SMP0000404,Ropivacaine Action Pathway,drug_action,DB00296
SMP0000393,Bupivacaine Action Pathway,drug_action,DB00297
SMP0000630,Tenofovir Metabolism Pathway,drug_metabolism,DB00300
SMP0000287,Tranexamic Acid Action Pathway,drug_action,DB00302
SMP0000332,Ibutilide Action Pathway,drug_action,DB00308
SMP0000438,Vindesine Action Pathway,drug_action,DB00309
SMP0000122,Chlorthalidone Action Pathway,drug_action,DB00310
SMP0000635,Valproic Acid Metabolism Pathway,drug_metabolism,DB00313
SMP0000640,Acetaminophen Metabolism Pathway,drug_metabolism,DB00316
SMP0000710,Acetaminophen  Action Pathway,drug_action,DB00316
SMP0000473,Gefitinib Action Pathway,drug_action,DB00317
SMP0000621,Codeine Metabolism Pathway,drug_metabolism,DB00318
SMP0000405,Codeine Action Pathway,drug_action,DB00318
SMP0000410,Hydromorphone Action Pathway,drug_action,DB00327
SMP0000104,Indomethacin Action Pathway,drug_action,DB00328
SMP0000408,Methadone Action Pathway,drug_action,DB00333
SMP0000624,Methadone Metabolism Pathway,drug_metabolism,DB00333
SMP0000298,Atenolol Action Pathway,drug_action,DB00335
SMP0000613,Omeprazole Metabolism Pathway,drug_metabolism,DB00338
SMP0000226,Omeprazole Action Pathway,drug_action,DB00338
SMP0059058,Cetirizine H1-Antihistamine Action,drug_action,DB00341
SMP0060208,Terfenadine H1-Antihistamine Action,drug_action,DB00342
SMP0000359,Diltiazem Action Pathway,drug_action,DB00343
SMP0000430,Thioguanine Action Pathway,drug_action,DB00352
SMP0000647,Thioguanine Metabolism Pathway,drug_metabolism,DB00352
SMP0058964,Buclizine H1-Antihistamine Action,drug_action,DB00354
SMP0000063,Tryptophan Metabolism,metabolic,DB00360
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00360
SMP0000486,DOPA-Responsive Dystonia,disease,DB00360
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00360
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00360
SMP0000650,Doxorubicin Metabolism Pathway,drug_metabolism,DB00360
SMP0000006,Tyrosine Metabolism,metabolic,DB00360
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00360
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00360
SMP0000218,Tyrosinemia Type I,disease,DB00360
SMP0000360,Hyperprolinemia Type II,disease,DB00360
SMP0000361,Hyperprolinemia Type I,disease,DB00360
SMP0000429,Disulfiram Action Pathway,drug_action,DB00360
SMP0000487,Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency,disease,DB00360
SMP0000488,Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps),disease,DB00360
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00360
SMP0000005,Pterine Biosynthesis,metabolic,DB00360
SMP0000169,Alkaptonuria,disease,DB00360
SMP0000190,Hawkinsinuria,disease,DB00360
SMP0000207,Prolidase Deficiency (PD),disease,DB00360
SMP0000208,Prolinemia Type II,disease,DB00360
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00360
SMP0000489,Hyperphenylalaninemia Due to DHPR-Deficiency,disease,DB00360
SMP0000490,Segawa Syndrome,disease,DB00360
SMP0000491,Sepiapterin Reductase Deficiency,disease,DB00360
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00360
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00360
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00360
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00360
SMP0063777,Nitric Oxide Signaling Pathway,signaling,DB00360
SMP0000439,Vinorelbine Action Pathway,drug_action,DB00361
SMP0058803,Doxylamine H1-Antihistamine Action,drug_action,DB00366
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00368
SMP0000392,Benzocaine Action Pathway,drug_action,DB00368
SMP0000393,Bupivacaine Action Pathway,drug_action,DB00368
SMP0000398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB00368
SMP0000403,Proparacaine Action Pathway,drug_action,DB00368
SMP0000405,Codeine Action Pathway,drug_action,DB00368
SMP0000410,Hydromorphone Action Pathway,drug_action,DB00368
SMP0000415,Fentanyl Action Pathway,drug_action,DB00368
SMP0000417,Sufentanil Action Pathway,drug_action,DB00368
SMP0000678,Methadyl Acetate Action Pathway,drug_action,DB00368
SMP0000680,Dimethylthiambutene Action Pathway,drug_action,DB00368
SMP0000689,Dihydromorphine Action Pathway,drug_action,DB00368
SMP0000690,Ketobemidone  Action Pathway,drug_action,DB00368
SMP0000169,Alkaptonuria,disease,DB00368
SMP0000190,Hawkinsinuria,disease,DB00368
SMP0000400,Oxybuprocaine Action Pathway,drug_action,DB00368
SMP0000406,Morphine Action Pathway,drug_action,DB00368
SMP0000411,Hydrocodone Action Pathway,drug_action,DB00368
SMP0000412,Oxymorphone Action Pathway,drug_action,DB00368
SMP0000416,Remifentanil Action Pathway,drug_action,DB00368
SMP0000426,Fluoxetine Action Pathway,drug_action,DB00368
SMP0000431,Nicotine Action Pathway,drug_action,DB00368
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00368
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB00368
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00368
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00368
SMP0000672,Propoxyphene Action Pathway,drug_action,DB00368
SMP0000674,Anileridine Action Pathway,drug_action,DB00368
SMP0000679,3-Methylthiofentanyl Action Pathway,drug_action,DB00368
SMP0000683,Levallorphan Action Pathway,drug_action,DB00368
SMP0062885,Mirtazapine H1-Antihistamine Action,drug_action,DB00370
SMP0000469,Capecitabine Action Pathway,drug_action,DB00371
SMP0000607,Capecitabine Metabolism Pathway,drug_metabolism,DB00371
SMP0000659,Timolol Action Pathway,drug_action,DB00373
SMP0000329,Mexiletine Action Pathway,drug_action,DB00379
SMP0000376,Amlodipine Action Pathway,drug_action,DB00381
SMP0000132,Triamterene Action Pathway,drug_action,DB00384
SMP0000380,Nimodipine Action Pathway,drug_action,DB00393
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB00396
SMP0000575,11-beta-Hydroxylase Deficiency (CYP11B1),disease,DB00396
SMP0000717,Apparent Mineralocorticoid Excess Syndrome,disease,DB00396
SMP0000372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency,disease,DB00396
SMP0000577,Corticosterone Methyl Oxidase I Deficiency (CMO I),disease,DB00396
SMP0000718,3-beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB00396
SMP0000130,Steroidogenesis,metabolic,DB00396
SMP0000373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency,disease,DB00396
SMP0000566,17-alpha-Hydroxylase Deficiency (CYP17),disease,DB00396
SMP0000576,21-Hydroxylase Deficiency (CYP21),disease,DB00396
SMP0000578,Corticosterone Methyl Oxidase II Deficiency (CMO II),disease,DB00396
SMP0000648,Sorafenib Metabolism Pathway,drug_metabolism,DB00398
SMP0000107,Zoledronate Action Pathway,drug_action,DB00399
SMP0000381,Nisoldipine Action Pathway,drug_action,DB00401
SMP0057580,Dexbrompheniramine H1-Antihistamine Action,drug_action,DB00405
SMP0000272,Enoxaparin Action Pathway,drug_action,DB00407
SMP0000275,Ardeparin Action Pathway,drug_action,DB00407
SMP0000653,Rosiglitazone Metabolism Pathway,drug_metabolism,DB00412
SMP0000134,Spironolactone Action Pathway,drug_action,DB00421
SMP0057581,Triprolidine H1-Antihistamine Action,drug_action,DB00427
SMP0059694,Cyproheptadine H1-Antihistamine Action,drug_action,DB00434
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00435
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB00435
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB00435
SMP0000020,Arginine and Proline Metabolism,metabolic,DB00435
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00435
SMP0000360,Hyperprolinemia Type II,disease,DB00435
SMP0000361,Hyperprolinemia Type I,disease,DB00435
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB00435
SMP0000207,Prolidase Deficiency (PD),disease,DB00435
SMP0000208,Prolinemia Type II,disease,DB00435
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00435
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB00435
SMP0063777,Nitric Oxide Signaling Pathway,signaling,DB00435
SMP0000090,Bendroflumethiazide Action Pathway,drug_action,DB00436
SMP0000111,Cerivastatin Action Pathway,drug_action,DB00439
SMP0000603,Gemcitabine Metabolism Pathway,drug_metabolism,DB00441
SMP0000446,Gemcitabine Action Pathway,drug_action,DB00441
SMP0000443,Teniposide Action Pathway,drug_action,DB00444
SMP0000602,Teniposide Metabolism Pathway,drug_metabolism,DB00444
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB00446
SMP0000614,Lansoprazole Metabolism Pathway,drug_metabolism,DB00448
SMP0000227,Lansoprazole Action Pathway,drug_action,DB00448
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB00451
SMP0000256,Neomycin Action Pathway,drug_action,DB00452
SMP0000262,Clomocycline Action Pathway,drug_action,DB00453
SMP0060195,Loratadine H1-Antihistamine Action,drug_action,DB00455
SMP0000422,Imipramine Action Pathway,drug_action,DB00458
SMP0000625,Imipramine Metabolism Pathway,drug_metabolism,DB00458
SMP0000114,Nabumetone Action Pathway,drug_action,DB00461
SMP0000098,Ketorolac Action Pathway,drug_action,DB00465
SMP0000706,Tenoxicam Action Pathway,drug_action,DB00469
SMP0000646,Fluoxetine Metabolism Pathway,drug_metabolism,DB00472
SMP0000426,Fluoxetine Action Pathway,drug_action,DB00472
SMP0000253,Amikacin Action Pathway,drug_action,DB00479
SMP0000096,Celecoxib Action Pathway,drug_action,DB00482
SMP0000644,Celecoxib Metabolism Pathway,drug_metabolism,DB00482
SMP0000660,Sotalol Action Pathway,drug_action,DB00489
SMP0000149,Fosinopril Action Pathway,drug_action,DB00492
SMP0000594,Fosinopril Metabolism Pathway,drug_metabolism,DB00492
SMP0000747,Zidovudine Action Pathway,drug_action,DB00495
SMP0000409,Oxycodone Action Pathway,drug_action,DB00497
SMP0000655,Phenindione Action Pathway,drug_action,DB00498
SMP0000704,Tolmetin Action Pathway,drug_action,DB00500
SMP0000232,Cimetidine Action Pathway,drug_action,DB00501
SMP0000617,Cimetidine Metabolism Pathway,drug_metabolism,DB00501
SMP0000683,Levallorphan Action Pathway,drug_action,DB00504
SMP0000286,Aminocaproic Acid Action Pathway,drug_action,DB00513
SMP0000157,Trandolapril Action Pathway,drug_action,DB00519
SMP0000599,Trandolapril Metabolism Pathway,drug_metabolism,DB00519
SMP0000658,Carteolol Action Pathway,drug_action,DB00521
SMP0000074,Retinol Metabolism,metabolic,DB00523
SMP0000336,Vitamin A Deficiency,disease,DB00523
SMP0000105,Metolazone Action Pathway,drug_action,DB00524
SMP0000396,Dibucaine Action Pathway,drug_action,DB00527
SMP0000472,Erlotinib Action Pathway,drug_action,DB00530
SMP0000447,Cyclophosphamide Action Pathway,drug_action,DB00531
SMP0000604,Cyclophosphamide Metabolism Pathway,drug_metabolism,DB00531
SMP0000087,Rofecoxib Action Pathway,drug_action,DB00533
SMP0000437,Vincristine Action Pathway,drug_action,DB00541
SMP0000145,Benazepril Action Pathway,drug_action,DB00542
SMP0000591,Benazepril Metabolism Pathway,drug_metabolism,DB00542
SMP0000469,Capecitabine Action Pathway,drug_action,DB00544
SMP0000470,Fluorouracil Action Pathway,drug_action,DB00544
SMP0000607,Capecitabine Metabolism Pathway,drug_metabolism,DB00544
SMP0000608,Fluorouracil Metabolism Pathway,drug_metabolism,DB00544
SMP0000077,Piroxicam Action Pathway,drug_action,DB00554
SMP0058936,Hydroxyzine H1-Antihistamine Action,drug_action,DB00557
SMP0000712,Tigecycline Action Pathway,drug_action,DB00560
SMP0000432,Methotrexate Action Pathway,drug_action,DB00563
SMP0000634,Carbamazepine Metabolism Pathway,drug_metabolism,DB00564
SMP0059110,Cinnarizine H1-Antihistamine Action,drug_action,DB00568
SMP0000273,Fondaparinux Action Pathway,drug_action,DB00569
SMP0000436,Vinblastine Action Pathway,drug_action,DB00570
SMP0000307,Propranolol Action Pathway,drug_action,DB00571
SMP0000696,Fenoprofen Action Pathway,drug_action,DB00573
SMP0000116,Valdecoxib Action Pathway,drug_action,DB00580
SMP0000052,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB00583
SMP0000539,Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD),disease,DB00583
SMP0000541,Carnitine Palmitoyl Transferase Deficiency II,disease,DB00583
SMP0000051,Fatty Acid Metabolism,metabolic,DB00583
SMP0000465,Carnitine Synthesis,metabolic,DB00583
SMP0000482,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,metabolic,DB00583
SMP0000538,Carnitine Palmitoyl Transferase Deficiency I,disease,DB00583
SMP0000540,Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD),disease,DB00583
SMP0000545,Trifunctional Protein Deficiency,disease,DB00583
SMP0000030,Oxidation of Branched-Chain Fatty Acids,metabolic,DB00583
SMP0000181,Ethylmalonic Encephalopathy,disease,DB00583
SMP0000185,Glutaric Aciduria Type I,disease,DB00583
SMP0000235,Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB00583
SMP0000516,"Adrenoleukodystrophy, X-Linked",disease,DB00583
SMP0000517,Carnitine-Acylcarnitine Translocase Deficiency,disease,DB00583
SMP0000542,Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD),disease,DB00583
SMP0000593,Enalapril Metabolism Pathway,drug_metabolism,DB00584
SMP0000148,Enalapril Action Pathway,drug_action,DB00584
SMP0000233,Nizatidine Action Pathway,drug_action,DB00585
SMP0000093,Diclofenac Action Pathway,drug_action,DB00586
SMP0000133,Amiloride Action Pathway,drug_action,DB00594
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB00595
SMP0000368,Labetalol Action Pathway,drug_action,DB00598
SMP0000094,Sulindac Action Pathway,drug_action,DB00605
SMP0000103,Cyclothiazide Action Pathway,drug_action,DB00606
SMP0000300,Bisoprolol Action Pathway,drug_action,DB00612
SMP0000290,Demeclocycline Action Pathway,drug_action,DB00618
SMP0031694,Imatinib Inhibition of BCR-ABL,drug_action,DB00619
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00624
SMP0030406,Androstenedione Metabolism,metabolic,DB00624
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB00624
SMP0000565,Aromatase Deficiency,disease,DB00624
SMP0000740,Efavirenz Action Pathway,drug_action,DB00625
SMP0000048,Nicotinate and Nicotinamide Metabolism,metabolic,DB00627
SMP0000095,Alendronate Action Pathway,drug_action,DB00630
SMP0000440,Prednisone Action Pathway,drug_action,DB00635
SMP0000631,Prednisone Metabolism Pathway,drug_metabolism,DB00635
SMP0059897,Astemizole H1-Antihistamine Action,drug_action,DB00637
SMP0000033,Methionine Metabolism,metabolic,DB00640
SMP0000144,Adenosine Deaminase Deficiency,disease,DB00640
SMP0000168,AICA-Ribosiduria,disease,DB00640
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB00640
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB00640
SMP0000427,Azathioprine Action Pathway,drug_action,DB00640
SMP0000430,Thioguanine Action Pathway,drug_action,DB00640
SMP0000513,Xanthinuria Type II,disease,DB00640
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB00640
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00640
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00640
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB00640
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00640
SMP0000341,Hypermethioninemia,disease,DB00640
SMP0000512,Xanthinuria Type I,disease,DB00640
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB00640
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB00640
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB00640
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB00640
SMP0000050,Purine Metabolism,metabolic,DB00640
SMP0000123,Betaine Metabolism,metabolic,DB00640
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB00640
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00640
SMP0000320,Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,signaling,DB00640
SMP0000321,Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,signaling,DB00640
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB00640
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB00640
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB00640
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB00640
SMP0000082,Simvastatin Action Pathway,drug_action,DB00641
SMP0000672,Propoxyphene Action Pathway,drug_action,DB00647
SMP0000745,Stavudine Action Pathway,drug_action,DB00649
SMP0000543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00650
SMP0000053,Folate Metabolism,metabolic,DB00650
SMP0000432,Methotrexate Action Pathway,drug_action,DB00650
SMP0000724,"Folate Malabsorption, Hereditary",disease,DB00650
SMP0000686,Pentazocine Action Pathway,drug_action,DB00652
SMP0000532,Sulfite Oxidase Deficiency,disease,DB00655
SMP0030880,Estrone Metabolism,metabolic,DB00655
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB00655
SMP0000565,Aromatase Deficiency,disease,DB00655
SMP0000041,Sulfate/Sulfite Metabolism,metabolic,DB00655
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00655
SMP0030406,Androstenedione Metabolism,metabolic,DB00655
SMP0000375,Verapamil Action Pathway,drug_action,DB00661
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00668
SMP0000006,Tyrosine Metabolism,metabolic,DB00668
SMP0000012,Catecholamine Biosynthesis,metabolic,DB00668
SMP0000218,Tyrosinemia Type I,disease,DB00668
SMP0000429,Disulfiram Action Pathway,drug_action,DB00668
SMP0000169,Alkaptonuria,disease,DB00668
SMP0000190,Hawkinsinuria,disease,DB00668
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00668
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB00668
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00668
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00668
SMP0000661,Epinephrine Action Pathway,drug_action,DB00668
SMP0000246,Pirenzepine Action Pathway,drug_action,DB00670
SMP0000606,Tamoxifen Metabolism Pathway,drug_metabolism,DB00675
SMP0000471,Tamoxifen Action Pathway,drug_action,DB00675
SMP0000162,Losartan Action Pathway,drug_action,DB00678
SMP0000268,Warfarin Action Pathway,drug_action,DB00682
SMP0000711,Tobramycin Action Pathway,drug_action,DB00684
SMP0000652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB00688
SMP0000151,Moexipril Action Pathway,drug_action,DB00691
SMP0000595,Moexipril Metabolism Pathway,drug_metabolism,DB00691
SMP0000115,Furosemide Action Pathway,drug_action,DB00695
SMP0000135,Eplerenone Action Pathway,drug_action,DB00700
SMP0000687,Naltrexone Action Pathway,drug_action,DB00704
SMP0000738,Delavirdine Action Pathway,drug_action,DB00705
SMP0000417,Sufentanil Action Pathway,drug_action,DB00708
SMP0000649,Lamivudine Metabolism Pathway,drug_metabolism,DB00709
SMP0000742,Lamivudine  Action Pathway,drug_action,DB00709
SMP0000079,Ibandronate Action Pathway,drug_action,DB00710
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB00712
SMP0000629,Adefovir Dipivoxil Metabolism Pathway,drug_metabolism,DB00718
SMP0059865,Azatadine H1-Antihistamine Action,drug_action,DB00719
SMP0000402,Procaine Action Pathway,drug_action,DB00721
SMP0000150,Lisinopril Action Pathway,drug_action,DB00722
SMP0000453,Nateglinide Action Pathway,drug_action,DB00731
SMP0000612,Esomeprazole Metabolism Pathway,drug_metabolism,DB00736
SMP0000225,Esomeprazole Action Pathway,drug_action,DB00736
SMP0058956,Meclizine H1-Antihistamine Action,drug_action,DB00737
SMP0000372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency,disease,DB00741
SMP0000577,Corticosterone Methyl Oxidase I Deficiency (CMO I),disease,DB00741
SMP0000718,3-beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB00741
SMP0000310,Corticotropin Activation of Cortisol Production,signaling,DB00741
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB00741
SMP0000575,11-beta-Hydroxylase Deficiency (CYP11B1),disease,DB00741
SMP0000717,Apparent Mineralocorticoid Excess Syndrome,disease,DB00741
SMP0000130,Steroidogenesis,metabolic,DB00741
SMP0000373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency,disease,DB00741
SMP0000566,17-alpha-Hydroxylase Deficiency (CYP17),disease,DB00741
SMP0000576,21-Hydroxylase Deficiency (CYP21),disease,DB00741
SMP0000578,Corticosterone Methyl Oxidase II Deficiency (CMO II),disease,DB00741
SMP0058797,Carbinoxamine H1-Antihistamine Action,drug_action,DB00748
SMP0000084,Etodolac Action Pathway,drug_action,DB00749
SMP0000401,Prilocaine Action Pathway,drug_action,DB00750
SMP0061191,Epinastine H1-Antihistamine Action,drug_action,DB00751
SMP0000074,Retinol Metabolism,metabolic,DB00755
SMP0000336,Vitamin A Deficiency,disease,DB00755
SMP0000260,Clopidogrel Action Pathway,drug_action,DB00758
SMP0000610,Clopidogrel Metabolism Pathway,drug_metabolism,DB00758
SMP0000294,Tetracycline Action Pathway,drug_action,DB00759
SMP0000600,Irinotecan Metabolism Pathway,drug_metabolism,DB00762
SMP0000433,Irinotecan Action Pathway,drug_action,DB00762
SMP0060740,Olopatadine H1-Antihistamine Action,drug_action,DB00768
SMP0000601,Etoposide Metabolism Pathway,drug_metabolism,DB00773
SMP0000442,Etoposide Action Pathway,drug_action,DB00773
SMP0000108,Hydroflumethiazide Action Pathway,drug_action,DB00774
SMP0000267,Tirofiban Action Pathway,drug_action,DB00775
SMP0000634,Carbamazepine Metabolism Pathway,drug_metabolism,DB00776
SMP0062625,Propiomazine H1-Antihistamine Action,drug_action,DB00777
SMP0000251,Roxithromycin Action Pathway,drug_action,DB00778
SMP0030880,Estrone Metabolism,metabolic,DB00783
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00783
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB00783
SMP0000565,Aromatase Deficiency,disease,DB00783
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB00784
SMP0000120,Naproxen Action Pathway,drug_action,DB00788
SMP0000152,Perindopril Action Pathway,drug_action,DB00790
SMP0057587,Tripelennamine H1-Antihistamine Action,drug_action,DB00792
SMP0000158,Candesartan Action Pathway,drug_action,DB00796
SMP0000254,Gentamicin Action Pathway,drug_action,DB00798
SMP0000413,Alfentanil Action Pathway,drug_action,DB00802
SMP0000403,Proparacaine Action Pathway,drug_action,DB00807
SMP0000110,Indapamide Action Pathway,drug_action,DB00808
SMP0000701,Phenylbutazone Action Pathway,drug_action,DB00812
SMP0000415,Fentanyl Action Pathway,drug_action,DB00813
SMP0000106,Meloxicam Action Pathway,drug_action,DB00814
SMP0000694,Carprofen Action Pathway,drug_action,DB00821
SMP0000429,Disulfiram Action Pathway,drug_action,DB00822
SMP0057579,Brompheniramine H1-Antihistamine Action,drug_action,DB00835
SMP0000662,Dobutamine Action Pathway,drug_action,DB00841
SMP0000691,Nalbuphine Action Pathway,drug_action,DB00844
SMP0000021,Taurine and Hypotaurine Metabolism,metabolic,DB00847
SMP0000027,Pantothenate and CoA Biosynthesis,metabolic,DB00847
SMP0000673,Levorphanol Action Pathway,drug_action,DB00854
SMP0000004,Glycine and Serine Metabolism,metabolic,DB00855
SMP0000024,Porphyrin Metabolism,metabolic,DB00855
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB00855
SMP0000244,Sarcosinemia,disease,DB00855
SMP0000344,Acute Intermittent Porphyria,disease,DB00855
SMP0000346,Porphyria Variegata (PV),disease,DB00855
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00855
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00855
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB00855
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB00855
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00855
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB00855
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB00855
SMP0000440,Prednisone Action Pathway,drug_action,DB00860
SMP0000441,Prednisolone Action Pathway,drug_action,DB00860
SMP0000631,Prednisone Metabolism Pathway,drug_metabolism,DB00860
SMP0000632,Prednisolone Metabolism Pathway,drug_metabolism,DB00860
SMP0000289,Diflunisal Action Pathway,drug_action,DB00861
SMP0000230,Ranitidine Action Pathway,drug_action,DB00863
SMP0000297,Alprenolol Action Pathway,drug_action,DB00866
SMP0000101,Suprofen Action Pathway,drug_action,DB00870
SMP0000159,Eprosartan Action Pathway,drug_action,DB00876
SMP0000741,Emtricitabine Action Pathway,drug_action,DB00879
SMP0000078,Chlorothiazide Action Pathway,drug_action,DB00880
SMP0000596,Quinapril Metabolism Pathway,drug_metabolism,DB00881
SMP0000153,Quinapril Action Pathway,drug_action,DB00881
SMP0000112,Risedronate Action Pathway,drug_action,DB00884
SMP0000088,Bumetanide Action Pathway,drug_action,DB00887
SMP0000400,Oxybuprocaine Action Pathway,drug_action,DB00892
SMP0000429,Disulfiram Action Pathway,drug_action,DB00898
SMP0000449,Ethanol Degradation,metabolic,DB00898
SMP0000416,Remifentanil Action Pathway,drug_action,DB00899
SMP0000739,Didanosine Action Pathway,drug_action,DB00900
SMP0059730,Methdilazine H1-Antihistamine Action,drug_action,DB00902
SMP0000097,Ethacrynic Acid Action Pathway,drug_action,DB00903
SMP0000395,Cocaine Action Pathway,drug_action,DB00907
SMP0000323,Quinidine Action Pathway,drug_action,DB00908
SMP0000454,Repaglinide Action Pathway,drug_action,DB00912
SMP0000674,Anileridine Action Pathway,drug_action,DB00913
SMP0000077,Piroxicam Action Pathway,drug_action,DB00917
SMP0000087,Rofecoxib Action Pathway,drug_action,DB00917
SMP0000093,Diclofenac Action Pathway,drug_action,DB00917
SMP0000094,Sulindac Action Pathway,drug_action,DB00917
SMP0000114,Nabumetone Action Pathway,drug_action,DB00917
SMP0000116,Valdecoxib Action Pathway,drug_action,DB00917
SMP0000692,Antipyrine Action Pathway,drug_action,DB00917
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB00917
SMP0000702,Nepafenac Action Pathway,drug_action,DB00917
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB00917
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB00917
SMP0000098,Ketorolac Action Pathway,drug_action,DB00917
SMP0000102,Bromfenac Action Pathway,drug_action,DB00917
SMP0000106,Meloxicam Action Pathway,drug_action,DB00917
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB00917
SMP0000113,Oxaprozin Action Pathway,drug_action,DB00917
SMP0000120,Naproxen Action Pathway,drug_action,DB00917
SMP0000694,Carprofen Action Pathway,drug_action,DB00917
SMP0000695,Etoricoxib Action Pathway,drug_action,DB00917
SMP0000699,Lumiracoxib Action Pathway,drug_action,DB00917
SMP0000701,Phenylbutazone Action Pathway,drug_action,DB00917
SMP0000707,Salsalate Action Pathway,drug_action,DB00917
SMP0000708,Salicylate-Sodium Action Pathway,drug_action,DB00917
SMP0000710,Acetaminophen  Action Pathway,drug_action,DB00917
SMP0000084,Etodolac Action Pathway,drug_action,DB00917
SMP0000085,Ketoprofen Action Pathway,drug_action,DB00917
SMP0000086,Ibuprofen Action Pathway,drug_action,DB00917
SMP0000096,Celecoxib Action Pathway,drug_action,DB00917
SMP0000101,Suprofen Action Pathway,drug_action,DB00917
SMP0000104,Indomethacin Action Pathway,drug_action,DB00917
SMP0000258,Spectinomycin Action Pathway,drug_action,DB00919
SMP0059868,Ketotifen H1-Antihistamine Action,drug_action,DB00920
SMP0000684,Buprenorphine Action Pathway,drug_action,DB00921
SMP0000231,Famotidine Action Pathway,drug_action,DB00927
SMP0000727,Methacycline Action Pathway,drug_action,DB00931
SMP0000709,Salicylic Acid Action Pathway,drug_action,DB00936
SMP0000746,Zalcitabine Action Pathway,drug_action,DB00943
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB00945
SMP0000271,Phenprocoumon Action Pathway,drug_action,DB00946
SMP0000633,Felbamate Metabolism Pathway,drug_metabolism,DB00949
SMP0060218,Fexofenadine H1-Antihistamine Action,drug_action,DB00950
SMP0000257,Netilmicin Action Pathway,drug_action,DB00955
SMP0000411,Hydrocodone Action Pathway,drug_action,DB00956
SMP0000306,Pindolol Action Pathway,drug_action,DB00960
SMP0000399,Mepivacaine Action Pathway,drug_action,DB00961
SMP0000102,Bromfenac Action Pathway,drug_action,DB00963
SMP0000164,Telmisartan Action Pathway,drug_action,DB00966
SMP0060201,Desloratadine H1-Antihistamine Action,drug_action,DB00967
SMP0060741,Azelastine H1-Antihistamine Action,drug_action,DB00972
SMP0000264,Dipyridamole (Antiplatelet) Action Pathway,drug_action,DB00975
SMP0000252,Telithromycin Action Pathway,drug_action,DB00976
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00988
SMP0000392,Benzocaine Action Pathway,drug_action,DB00988
SMP0000393,Bupivacaine Action Pathway,drug_action,DB00988
SMP0000398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB00988
SMP0000403,Proparacaine Action Pathway,drug_action,DB00988
SMP0000405,Codeine Action Pathway,drug_action,DB00988
SMP0000410,Hydromorphone Action Pathway,drug_action,DB00988
SMP0000415,Fentanyl Action Pathway,drug_action,DB00988
SMP0000417,Sufentanil Action Pathway,drug_action,DB00988
SMP0000678,Methadyl Acetate Action Pathway,drug_action,DB00988
SMP0000680,Dimethylthiambutene Action Pathway,drug_action,DB00988
SMP0000689,Dihydromorphine Action Pathway,drug_action,DB00988
SMP0000690,Ketobemidone  Action Pathway,drug_action,DB00988
SMP0000169,Alkaptonuria,disease,DB00988
SMP0000190,Hawkinsinuria,disease,DB00988
SMP0000308,Dopamine Activation of Neurological Reward System,signaling,DB00988
SMP0000400,Oxybuprocaine Action Pathway,drug_action,DB00988
SMP0000406,Morphine Action Pathway,drug_action,DB00988
SMP0000411,Hydrocodone Action Pathway,drug_action,DB00988
SMP0000412,Oxymorphone Action Pathway,drug_action,DB00988
SMP0000416,Remifentanil Action Pathway,drug_action,DB00988
SMP0000426,Fluoxetine Action Pathway,drug_action,DB00988
SMP0000431,Nicotine Action Pathway,drug_action,DB00988
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB00988
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB00988
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB00988
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB00988
SMP0000672,Propoxyphene Action Pathway,drug_action,DB00988
SMP0000674,Anileridine Action Pathway,drug_action,DB00988
SMP0000679,3-Methylthiofentanyl Action Pathway,drug_action,DB00988
SMP0000113,Oxaprozin Action Pathway,drug_action,DB00991
SMP0000427,Azathioprine Action Pathway,drug_action,DB00993
SMP0000645,Azathioprine Metabolism Pathway,drug_metabolism,DB00993
SMP0000650,Doxorubicin Metabolism Pathway,drug_metabolism,DB00997
SMP0000100,Hydrochlorothiazide Action Pathway,drug_action,DB00999
SMP0000397,Levobupivacaine Action Pathway,drug_action,DB01002
SMP0000085,Ketoprofen Action Pathway,drug_action,DB01009
SMP0000460,Glibenclamide Action Pathway,drug_action,DB01016
SMP0000292,Minocycline Action Pathway,drug_action,DB01017
SMP0000121,Trichlormethiazide Action Pathway,drug_action,DB01021
SMP0000272,Enoxaparin Action Pathway,drug_action,DB01022
SMP0000273,Fondaparinux Action Pathway,drug_action,DB01022
SMP0000278,Lepirudin Action Pathway,drug_action,DB01022
SMP0000280,Alteplase Action Pathway,drug_action,DB01022
SMP0000281,Anistreplase Action Pathway,drug_action,DB01022
SMP0000284,Urokinase Action Pathway,drug_action,DB01022
SMP0000655,Phenindione Action Pathway,drug_action,DB01022
SMP0000268,Warfarin Action Pathway,drug_action,DB01022
SMP0000269,Acenocoumarol Action Pathway,drug_action,DB01022
SMP0000270,Dicumarol Action Pathway,drug_action,DB01022
SMP0000276,Argatroban Action Pathway,drug_action,DB01022
SMP0000279,Ximelagatran Action Pathway,drug_action,DB01022
SMP0000283,Tenecteplase Action Pathway,drug_action,DB01022
SMP0000286,Aminocaproic Acid Action Pathway,drug_action,DB01022
SMP0000656,Dicoumarol Action Pathway,drug_action,DB01022
SMP0000271,Phenprocoumon Action Pathway,drug_action,DB01022
SMP0000274,Heparin Action Pathway,drug_action,DB01022
SMP0000275,Ardeparin Action Pathway,drug_action,DB01022
SMP0000277,Bivalirudin Action Pathway,drug_action,DB01022
SMP0000282,Streptokinase Action Pathway,drug_action,DB01022
SMP0000285,Reteplase Action Pathway,drug_action,DB01022
SMP0000287,Tranexamic Acid Action Pathway,drug_action,DB01022
SMP0000288,Aprotinin Action Pathway,drug_action,DB01022
SMP0000464,Vitamin K Metabolism,metabolic,DB01022
SMP0000586,Coagulation,physiological,DB01022
SMP0000619,Felodipine Metabolism Pathway,drug_metabolism,DB01023
SMP0000377,Felodipine Action Pathway,drug_action,DB01023
SMP0000652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB01024
SMP0000161,Irbesartan Action Pathway,drug_action,DB01029
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB01033
SMP0000645,Azathioprine Metabolism Pathway,drug_metabolism,DB01033
SMP0000427,Azathioprine Action Pathway,drug_action,DB01033
SMP0000430,Thioguanine Action Pathway,drug_action,DB01033
SMP0000609,Mercaptopurine Metabolism Pathway,drug_metabolism,DB01033
SMP0000324,Procainamide (Antiarrhythmic) Action Pathway,drug_action,DB01035
SMP0000737,Abacavir Action Pathway,drug_action,DB01048
SMP0000086,Ibuprofen Action Pathway,drug_action,DB01050
SMP0000590,Ibuprofen Metabolism Pathway,drug_metabolism,DB01050
SMP0000382,Nitrendipine Action Pathway,drug_action,DB01054
SMP0000330,Tocainide Action Pathway,drug_action,DB01056
SMP0000663,Isoprenaline Action Pathway,drug_action,DB01064
SMP0000063,Tryptophan Metabolism,metabolic,DB01065
SMP0059211,Promethazine H1-Antihistamine Action,drug_action,DB01069
SMP0059720,Mequitazine H1-Antihistamine Action,drug_action,DB01071
SMP0058785,Diphenhydramine H1-Antihistamine Action,drug_action,DB01075
SMP0000675,Diphenoxylate Action Pathway,drug_action,DB01081
SMP0000259,Streptomycin Action Pathway,drug_action,DB01082
SMP0061040,Emedastine H1-Antihistamine Action,drug_action,DB01084
SMP0000392,Benzocaine Action Pathway,drug_action,DB01086
SMP0000119,Fluvastatin Action Pathway,drug_action,DB01095
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB01098
SMP0000469,Capecitabine Action Pathway,drug_action,DB01101
SMP0000607,Capecitabine Metabolism Pathway,drug_metabolism,DB01101
SMP0000664,Arbutamine Action Pathway,drug_action,DB01102
SMP0060224,Levocabastine H1-Antihistamine Action,drug_action,DB01106
SMP0000274,Heparin Action Pathway,drug_action,DB01109
SMP0000358,Fc Epsilon Receptor I Signaling in Mast Cells,signaling,DB01109
SMP0056661,Chlorphenamine H1-Antihistamine Action,drug_action,DB01114
SMP0000379,Nifedipine Action Pathway,drug_action,DB01115
SMP0000665,Amiodarone Action Pathway,drug_action,DB01118
SMP0000461,Gliclazide Action Pathway,drug_action,DB01120
SMP0000616,Rabeprazole Metabolism Pathway,drug_metabolism,DB01129
SMP0000229,Rabeprazole Action Pathway,drug_action,DB01129
SMP0000367,Carvedilol Action Pathway,drug_action,DB01136
SMP0059872,Doxepin H1-Antihistamine Action,drug_action,DB01142
SMP0000641,Doxepin Metabolism Pathway,drug_metabolism,DB01142
SMP0058908,Diphenylpyraline H1-Antihistamine Action,drug_action,DB01146
SMP0000422,Imipramine Action Pathway,drug_action,DB01151
SMP0000423,Desipramine Action Pathway,drug_action,DB01151
SMP0000625,Imipramine Metabolism Pathway,drug_metabolism,DB01151
SMP0000626,Desipramine Metabolism Pathway,drug_metabolism,DB01151
SMP0000394,Chloroprocaine Action Pathway,drug_action,DB01161
SMP0000263,Cilostazol Action Pathway,drug_action,DB01166
SMP0000255,Kanamycin Action Pathway,drug_action,DB01172
SMP0058808,Orphenadrine H1-Antihistamine Action,drug_action,DB01173
SMP0000425,Escitalopram Action Pathway,drug_action,DB01175
SMP0058923,Cyclizine H1-Antihistamine Action,drug_action,DB01176
SMP0000155,Rescinnamine Action Pathway,drug_action,DB01180
SMP0000605,Ifosfamide Metabolism Pathway,drug_metabolism,DB01181
SMP0000448,Ifosfamide Action Pathway,drug_action,DB01181
SMP0000688,Naloxone Action Pathway,drug_action,DB01183
SMP0000249,Clindamycin Action Pathway,drug_action,DB01190
SMP0000412,Oxymorphone Action Pathway,drug_action,DB01192
SMP0000296,Acebutolol Action Pathway,drug_action,DB01193
SMP0000331,Flecainide Action Pathway,drug_action,DB01195
SMP0000146,Captopril Action Pathway,drug_action,DB01197
SMP0000303,Nadolol Action Pathway,drug_action,DB01203
SMP0000676,Dezocine Action Pathway,drug_action,DB01209
SMP0000666,Levobunolol Action Pathway,drug_action,DB01210
SMP0000248,Clarithromycin Action Pathway,drug_action,DB01211
SMP0000667,Metipranolol Action Pathway,drug_action,DB01214
SMP0062884,Quetiapine H1-Antihistamine Action,drug_action,DB01224
SMP0000677,Levomethadyl Acetate Action Action Pathway,drug_action,DB01227
SMP0000638,Levomethadyl Acetate Metabolism Pathway,drug_metabolism,DB01227
SMP0000434,Paclitaxel Action Pathway,drug_action,DB01229
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB01235
SMP0000006,Tyrosine Metabolism,metabolic,DB01235
SMP0000012,Catecholamine Biosynthesis,metabolic,DB01235
SMP0000218,Tyrosinemia Type I,disease,DB01235
SMP0000429,Disulfiram Action Pathway,drug_action,DB01235
SMP0000169,Alkaptonuria,disease,DB01235
SMP0000190,Hawkinsinuria,disease,DB01235
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB01235
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB01235
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB01235
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB01235
SMP0058813,Bromodiphenhydramine H1-Antihistamine Action,drug_action,DB01237
SMP0000639,Clomipramine Metabolism Pathway,drug_metabolism,DB01242
SMP0059689,Alimemazine H1-Antihistamine Action,drug_action,DB01246
SMP0000435,Docetaxel Action Pathway,drug_action,DB01248
SMP0031696,Dasatinib Inhibition of BCR-ABL,drug_action,DB01254
SMP0000475,Panitumumab Action Pathway,drug_action,DB01269
SMP0000699,Lumiracoxib Action Pathway,drug_action,DB01283
SMP0000668,Bevantolol Action Pathway,drug_action,DB01295
SMP0000045,Amino Sugar Metabolism,metabolic,DB01296
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB01296
SMP0000216,Sialuria or French Type Sialuria,disease,DB01296
SMP0000217,Sialuria or French Type Sialuria,disease,DB01296
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB01296
SMP0000390,Tay-Sachs Disease,disease,DB01296
SMP0000669,Practolol Action Pathway,drug_action,DB01297
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB01301
SMP0000326,Fosphenytoin (Antiarrhythmic) Action Pathway,drug_action,DB01320
SMP0000618,Fosphenytoin (Antiarrhythmic) Metabolism Pathway,drug_metabolism,DB01320
SMP0000731,Josamycin Action Pathway,drug_action,DB01321
SMP0000080,Polythiazide Action Pathway,drug_action,DB01324
SMP0000091,Quinethazone Action Pathway,drug_action,DB01325
SMP0000147,Cilazapril Action Pathway,drug_action,DB01340
SMP0000592,Cilazapril Metabolism Pathway,drug_metabolism,DB01340
SMP0000160,Forasartan Action Pathway,drug_action,DB01342
SMP0000040,Glycolysis,metabolic,DB01345
SMP0000081,Methyclothiazide Action Pathway,drug_action,DB01345
SMP0000100,Hydrochlorothiazide Action Pathway,drug_action,DB01345
SMP0000105,Metolazone Action Pathway,drug_action,DB01345
SMP0000115,Furosemide Action Pathway,drug_action,DB01345
SMP0000118,Torsemide Action Pathway,drug_action,DB01345
SMP0000132,Triamterene Action Pathway,drug_action,DB01345
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01345
SMP0000189,Hartnup Disorder,disease,DB01345
SMP0000197,Lysinuric Protein Intolerance,disease,DB01345
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB01345
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01345
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB01345
SMP0000225,Esomeprazole Action Pathway,drug_action,DB01345
SMP0000226,Omeprazole Action Pathway,drug_action,DB01345
SMP0000227,Lansoprazole Action Pathway,drug_action,DB01345
SMP0000228,Pantoprazole Action Pathway,drug_action,DB01345
SMP0000229,Rabeprazole Action Pathway,drug_action,DB01345
SMP0000230,Ranitidine Action Pathway,drug_action,DB01345
SMP0000231,Famotidine Action Pathway,drug_action,DB01345
SMP0000245,Glucose Transporter Defect (SGLT2),disease,DB01345
SMP0000246,Pirenzepine Action Pathway,drug_action,DB01345
SMP0000297,Alprenolol Action Pathway,drug_action,DB01345
SMP0000324,Procainamide (Antiarrhythmic) Action Pathway,drug_action,DB01345
SMP0000328,Lidocaine (Antiarrhythmic) Action Pathway,drug_action,DB01345
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB01345
SMP0000341,Hypermethioninemia,disease,DB01345
SMP0000380,Nimodipine Action Pathway,drug_action,DB01345
SMP0000381,Nisoldipine Action Pathway,drug_action,DB01345
SMP0000392,Benzocaine Action Pathway,drug_action,DB01345
SMP0000156,Spirapril Action Pathway,drug_action,DB01348
SMP0000598,Spirapril Metabolism Pathway,drug_metabolism,DB01348
SMP0000305,Penbutolol Action Pathway,drug_action,DB01359
SMP0000018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB01373
SMP0000034,Sphingolipid Metabolism,metabolic,DB01373
SMP0000053,Folate Metabolism,metabolic,DB01373
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB01373
SMP0000070,Riboflavin Metabolism,metabolic,DB01373
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB01373
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB01373
SMP0000098,Ketorolac Action Pathway,drug_action,DB01373
SMP0000102,Bromfenac Action Pathway,drug_action,DB01373
SMP0000106,Meloxicam Action Pathway,drug_action,DB01373
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB01373
SMP0000113,Oxaprozin Action Pathway,drug_action,DB01373
SMP0000120,Naproxen Action Pathway,drug_action,DB01373
SMP0000129,Malate-Aspartate Shuttle,metabolic,DB01373
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01373
SMP0000206,Phenylketonuria,disease,DB01373
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01373
SMP0000271,Phenprocoumon Action Pathway,drug_action,DB01373
SMP0000274,Heparin Action Pathway,drug_action,DB01373
SMP0000275,Ardeparin Action Pathway,drug_action,DB01373
SMP0000277,Bivalirudin Action Pathway,drug_action,DB01373
SMP0000282,Streptokinase Action Pathway,drug_action,DB01373
SMP0000285,Reteplase Action Pathway,drug_action,DB01373
SMP0000287,Tranexamic Acid Action Pathway,drug_action,DB01373
SMP0000288,Aprotinin Action Pathway,drug_action,DB01373
SMP0000297,Alprenolol Action Pathway,drug_action,DB01373
SMP0000324,Procainamide (Antiarrhythmic) Action Pathway,drug_action,DB01373
SMP0000328,Lidocaine (Antiarrhythmic) Action Pathway,drug_action,DB01373
SMP0000349,Gaucher Disease,disease,DB01373
SMP0000358,Fc Epsilon Receptor I Signaling in Mast Cells,signaling,DB01373
SMP0000010,Nucleotide Sugars Metabolism,metabolic,DB01378
SMP0000030,Oxidation of Branched-Chain Fatty Acids,metabolic,DB01378
SMP0000034,Sphingolipid Metabolism,metabolic,DB01378
SMP0000040,Glycolysis,metabolic,DB01378
SMP0000045,Amino Sugar Metabolism,metabolic,DB01378
SMP0000053,Folate Metabolism,metabolic,DB01378
SMP0000064,Fructose and Mannose Degradation,metabolic,DB01378
SMP0000070,Riboflavin Metabolism,metabolic,DB01378
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB01378
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB01378
SMP0000098,Ketorolac Action Pathway,drug_action,DB01378
SMP0000099,Lovastatin Action Pathway,drug_action,DB01378
SMP0000102,Bromfenac Action Pathway,drug_action,DB01378
SMP0000106,Meloxicam Action Pathway,drug_action,DB01378
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB01378
SMP0000111,Cerivastatin Action Pathway,drug_action,DB01378
SMP0000113,Oxaprozin Action Pathway,drug_action,DB01378
SMP0000120,Naproxen Action Pathway,drug_action,DB01378
SMP0000126,Phenylacetate Metabolism,metabolic,DB01378
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01378
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB01378
SMP0000181,Ethylmalonic Encephalopathy,disease,DB01378
SMP0000185,Glutaric Aciduria Type I,disease,DB01378
SMP0000206,Phenylketonuria,disease,DB01378
SMP0000209,Hypercholesterolemia,disease,DB01378
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB01378
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01378
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB01378
SMP0000235,Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB01378
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB01378
SMP0000698,Magnesium Salicylate Action Pathway,drug_action,DB01397
SMP0000707,Salsalate Action Pathway,drug_action,DB01399
SMP0000703,Trisalicylate-Choline Action Pathway,drug_action,DB01401
SMP0000028,Caffeine Metabolism,metabolic,DB01412
SMP0000269,Acenocoumarol Action Pathway,drug_action,DB01418
SMP0000693,Antrafenine Action Pathway,drug_action,DB01419
SMP0000714,Paromomycin Action Pathway,drug_action,DB01421
SMP0000678,Methadyl Acetate Action Pathway,drug_action,DB01433
SMP0000692,Antipyrine Action Pathway,drug_action,DB01435
SMP0000679,3-Methylthiofentanyl Action Pathway,drug_action,DB01439
SMP0000680,Dimethylthiambutene Action Pathway,drug_action,DB01444
SMP0000407,Heroin Action Pathway,drug_action,DB01452
SMP0000623,Heroin Metabolism Pathway,drug_metabolism,DB01452
SMP0000681,Ethylmorphine Action Pathway,drug_action,DB01466
SMP0000414,Carfentanil Action Pathway,drug_action,DB01535
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB01536
SMP0030406,Androstenedione Metabolism,metabolic,DB01536
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB01536
SMP0000565,Aromatase Deficiency,disease,DB01536
SMP0030406,Androstenedione Metabolism,metabolic,DB01561
SMP0000689,Dihydromorphine Action Pathway,drug_action,DB01565
SMP0000304,Oxprenolol Action Pathway,drug_action,DB01580
SMP0000010,Nucleotide Sugars Metabolism,metabolic,DB01592
SMP0000013,Cysteine Metabolism,metabolic,DB01592
SMP0000030,Oxidation of Branched-Chain Fatty Acids,metabolic,DB01592
SMP0000063,Tryptophan Metabolism,metabolic,DB01592
SMP0000099,Lovastatin Action Pathway,drug_action,DB01592
SMP0000111,Cerivastatin Action Pathway,drug_action,DB01592
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB01592
SMP0000206,Phenylketonuria,disease,DB01592
SMP0000209,Hypercholesterolemia,disease,DB01592
SMP0000316,Zellweger Syndrome,disease,DB01592
SMP0000336,Vitamin A Deficiency,disease,DB01592
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB01592
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB01592
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB01592
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB01592
SMP0000496,Galactosemia III,disease,DB01592
SMP0000510,Mevalonic Aciduria,disease,DB01592
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB01592
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB01592
SMP0000722,"Cystinosis, Ocular Nonnephropathic",disease,DB01592
SMP0002295,The Oncogenic Action of Fumarate,disease,DB01592
SMP0000006,Tyrosine Metabolism,metabolic,DB01592
SMP0000011,Inositol Metabolism,metabolic,DB01592
SMP0000012,Catecholamine Biosynthesis,metabolic,DB01592
SMP0000021,Taurine and Hypotaurine Metabolism,metabolic,DB01592
SMP0000024,Porphyrin Metabolism,metabolic,DB01592
SMP0000031,Pentose Phosphate Pathway,metabolic,DB01592
SMP0000043,Galactose Metabolism,metabolic,DB01592
SMP0000046,Pyrimidine Metabolism,metabolic,DB01592
SMP0000082,Simvastatin Action Pathway,drug_action,DB01592
SMP0000005,Pterine Biosynthesis,metabolic,DB01593
SMP0000007,beta-Alanine Metabolism,metabolic,DB01593
SMP0000017,Vitamin B6 Metabolism,metabolic,DB01593
SMP0000033,Methionine Metabolism,metabolic,DB01593
SMP0000067,Aspartate Metabolism,metabolic,DB01593
SMP0000074,Retinol Metabolism,metabolic,DB01593
SMP0000077,Piroxicam Action Pathway,drug_action,DB01593
SMP0000087,Rofecoxib Action Pathway,drug_action,DB01593
SMP0000093,Diclofenac Action Pathway,drug_action,DB01593
SMP0000094,Sulindac Action Pathway,drug_action,DB01593
SMP0000114,Nabumetone Action Pathway,drug_action,DB01593
SMP0000116,Valdecoxib Action Pathway,drug_action,DB01593
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB01593
SMP0000144,Adenosine Deaminase Deficiency,disease,DB01593
SMP0000145,Benazepril Action Pathway,drug_action,DB01593
SMP0000153,Quinapril Action Pathway,drug_action,DB01593
SMP0000154,Ramipril Action Pathway,drug_action,DB01593
SMP0000155,Rescinnamine Action Pathway,drug_action,DB01593
SMP0000159,Eprosartan Action Pathway,drug_action,DB01593
SMP0000161,Irbesartan Action Pathway,drug_action,DB01593
SMP0000162,Losartan Action Pathway,drug_action,DB01593
SMP0000165,Valsartan Action Pathway,drug_action,DB01593
SMP0000168,AICA-Ribosiduria,disease,DB01593
SMP0000169,Alkaptonuria,disease,DB01593
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB01593
SMP0000175,Canavan Disease,disease,DB01593
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB01593
SMP0000182,Galactosemia,disease,DB01593
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB01593
SMP0000190,Hawkinsinuria,disease,DB01593
SMP0000705,Tiaprofenic Acid Action Pathway,drug_action,DB01600
SMP0061190,Phenindamine H1-Antihistamine Action,drug_action,DB01619
SMP0056662,Pheniramine H1-Antihistamine Action,drug_action,DB01620
SMP0000728,Lincomycin Action Pathway,drug_action,DB01627
SMP0000695,Etoricoxib Action Pathway,drug_action,DB01628
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01632
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01632
SMP0000385,Homocarnosinosis,disease,DB01632
SMP0000512,Xanthinuria Type I,disease,DB01632
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB01632
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB01632
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB01632
SMP0000031,Pentose Phosphate Pathway,metabolic,DB01632
SMP0000046,Pyrimidine Metabolism,metabolic,DB01632
SMP0000050,Purine Metabolism,metabolic,DB01632
SMP0000072,Glutamate Metabolism,metabolic,DB01632
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01632
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB01632
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB01632
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB01632
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB01632
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB01632
SMP0000519,Ribose-5-phosphate Isomerase Deficiency,disease,DB01632
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB01632
SMP0000048,Nicotinate and Nicotinamide Metabolism,metabolic,DB01632
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB01632
SMP0000144,Adenosine Deaminase Deficiency,disease,DB01632
SMP0000168,AICA-Ribosiduria,disease,DB01632
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB01632
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB01632
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB01632
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01632
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB01632
SMP0000427,Azathioprine Action Pathway,drug_action,DB01632
SMP0000430,Thioguanine Action Pathway,drug_action,DB01632
SMP0000182,Galactosemia,disease,DB01638
SMP0000064,Fructose and Mannose Degradation,metabolic,DB01638
SMP0000043,Galactose Metabolism,metabolic,DB01638
SMP0000561,Fructosuria,disease,DB01638
SMP0000725,"Fructose Intolerance, Hereditary",disease,DB01638
SMP0000046,Pyrimidine Metabolism,metabolic,DB01643
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01643
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB01643
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB01643
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01643
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01700
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01700
SMP0000512,Xanthinuria Type I,disease,DB01700
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB01700
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB01700
SMP0000050,Purine Metabolism,metabolic,DB01700
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB01700
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB01700
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB01700
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB01700
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB01700
SMP0000144,Adenosine Deaminase Deficiency,disease,DB01700
SMP0000168,AICA-Ribosiduria,disease,DB01700
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB01700
SMP0000427,Azathioprine Action Pathway,drug_action,DB01700
SMP0000430,Thioguanine Action Pathway,drug_action,DB01700
SMP0000513,Xanthinuria Type II,disease,DB01700
SMP0000006,Tyrosine Metabolism,metabolic,DB01702
SMP0000218,Tyrosinemia Type I,disease,DB01702
SMP0000429,Disulfiram Action Pathway,drug_action,DB01702
SMP0000169,Alkaptonuria,disease,DB01702
SMP0000190,Hawkinsinuria,disease,DB01702
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB01702
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB01702
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB01702
SMP0000128,Gluconeogenesis,metabolic,DB01709
SMP0000574,"Glycogenosis, Type IC",disease,DB01709
SMP0000581,"Glycogenosis, Type IA. Von Gierke Disease",disease,DB01709
SMP0000040,Glycolysis,metabolic,DB01709
SMP0000531,"Glycogenosis, Type VII. Tarui Disease",disease,DB01709
SMP0000560,Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1),disease,DB01709
SMP0000573,"Glycogenosis, Type IB",disease,DB01709
SMP0000374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB01709
SMP0000562,"Fructose-1,6-diphosphatase Deficiency",disease,DB01709
SMP0000563,Triosephosphate Isomerase,disease,DB01709
SMP0000572,Fanconi-Bickel Syndrome,disease,DB01709
SMP0000654,Warburg Effect,metabolic,DB01709
SMP0000011,Inositol Metabolism,metabolic,DB01729
SMP0000462,Inositol Phosphate Metabolism,metabolic,DB01729
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB01758
SMP0000006,Tyrosine Metabolism,metabolic,DB01762
SMP0000073,Butyrate Metabolism,metabolic,DB01762
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB01762
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB01762
SMP0000173,beta-Ketothiolase Deficiency,disease,DB01762
SMP0000218,Tyrosinemia Type I,disease,DB01762
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB01762
SMP0000429,Disulfiram Action Pathway,drug_action,DB01762
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB01762
SMP0000524,Isovaleric Acidemia,disease,DB01762
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB01762
SMP0000071,Ketone Body Metabolism,metabolic,DB01762
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB01762
SMP0000169,Alkaptonuria,disease,DB01762
SMP0000190,Hawkinsinuria,disease,DB01762
SMP0000200,Methylmalonic Aciduria,disease,DB01762
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB01762
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB01762
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB01762
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB01762
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB01762
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB01762
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB01762
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB01762
SMP0000199,Maple Syrup Urine Disease,disease,DB01762
SMP0000206,Phenylketonuria,disease,DB01762
SMP0000236,Propionic Acidemia,disease,DB01762
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB01762
SMP0000238,Isovaleric Aciduria,disease,DB01762
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB01762
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB01783
SMP0000007,beta-Alanine Metabolism,metabolic,DB01783
SMP0000027,Pantothenate and CoA Biosynthesis,metabolic,DB01783
SMP0000351,GABA-Transaminase Deficiency,disease,DB01783
SMP0000492,Ureidopropionase Deficiency,disease,DB01783
SMP0000099,Lovastatin Action Pathway,drug_action,DB01785
SMP0000111,Cerivastatin Action Pathway,drug_action,DB01785
SMP0000209,Hypercholesterolemia,disease,DB01785
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB01785
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB01785
SMP0000510,Mevalonic Aciduria,disease,DB01785
SMP0000082,Simvastatin Action Pathway,drug_action,DB01785
SMP0000089,Pravastatin Action Pathway,drug_action,DB01785
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB01785
SMP0000107,Zoledronate Action Pathway,drug_action,DB01785
SMP0000117,Pamidronate Action Pathway,drug_action,DB01785
SMP0000119,Fluvastatin Action Pathway,drug_action,DB01785
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB01785
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB01785
SMP0000023,Steroid Biosynthesis,metabolic,DB01785
SMP0000079,Ibandronate Action Pathway,drug_action,DB01785
SMP0000095,Alendronate Action Pathway,drug_action,DB01785
SMP0000112,Risedronate Action Pathway,drug_action,DB01785
SMP0000131,Atorvastatin Action Pathway,drug_action,DB01785
SMP0000386,Desmosterolosis,disease,DB01785
SMP0000387,CHILD Syndrome,disease,DB01785
SMP0000509,Hyper-IgD Syndrome,disease,DB01785
SMP0000511,Wolman Disease,disease,DB01785
SMP0000048,Nicotinate and Nicotinamide Metabolism,metabolic,DB01796
SMP0000063,Tryptophan Metabolism,metabolic,DB01796
SMP0000374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB01819
SMP0000562,"Fructose-1,6-diphosphatase Deficiency",disease,DB01819
SMP0000563,Triosephosphate Isomerase,disease,DB01819
SMP0000572,Fanconi-Bickel Syndrome,disease,DB01819
SMP0000654,Warburg Effect,metabolic,DB01819
SMP0000040,Glycolysis,metabolic,DB01819
SMP0000045,Amino Sugar Metabolism,metabolic,DB01819
SMP0000531,"Glycogenosis, Type VII. Tarui Disease",disease,DB01819
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB01819
SMP0000559,Pyruvate Kinase Deficiency,disease,DB01819
SMP0000560,Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1),disease,DB01819
SMP0000573,"Glycogenosis, Type IB",disease,DB01819
SMP0000060,Pyruvate Metabolism,metabolic,DB01819
SMP0000128,Gluconeogenesis,metabolic,DB01819
SMP0000196,Leigh Syndrome,disease,DB01819
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB01819
SMP0000216,Sialuria or French Type Sialuria,disease,DB01819
SMP0000217,Sialuria or French Type Sialuria,disease,DB01819
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB01819
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB01819
SMP0000390,Tay-Sachs Disease,disease,DB01819
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB01819
SMP0000574,"Glycogenosis, Type IC",disease,DB01819
SMP0000581,"Glycogenosis, Type IA. Von Gierke Disease",disease,DB01819
SMP0000464,Vitamin K Metabolism,metabolic,DB01822
SMP0000627,Citalopram Metabolism Pathway,drug_metabolism,DB01828
SMP0000006,Tyrosine Metabolism,metabolic,DB01828
SMP0000218,Tyrosinemia Type I,disease,DB01828
SMP0000424,Citalopram Action Pathway,drug_action,DB01828
SMP0000429,Disulfiram Action Pathway,drug_action,DB01828
SMP0000169,Alkaptonuria,disease,DB01828
SMP0000190,Hawkinsinuria,disease,DB01828
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB01828
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB01828
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB01828
SMP0000559,Pyruvate Kinase Deficiency,disease,DB01839
SMP0000060,Pyruvate Metabolism,metabolic,DB01839
SMP0000196,Leigh Syndrome,disease,DB01839
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB01839
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB01839
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB01839
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB01849
SMP0000046,Pyrimidine Metabolism,metabolic,DB01849
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01849
SMP0000007,beta-Alanine Metabolism,metabolic,DB01849
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB01849
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB01849
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01849
SMP0000351,GABA-Transaminase Deficiency,disease,DB01849
SMP0000492,Ureidopropionase Deficiency,disease,DB01849
SMP0000043,Galactose Metabolism,metabolic,DB01861
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB01861
SMP0000348,Globoid Cell Leukodystrophy,disease,DB01861
SMP0000444,Lactose Synthesis,metabolic,DB01861
SMP0000552,Glycogen Synthetase Deficiency,disease,DB01861
SMP0000553,"Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis",disease,DB01861
SMP0000182,Galactosemia,disease,DB01861
SMP0000347,Metachromatic Leukodystrophy (MLD),disease,DB01861
SMP0000495,Galactosemia II (GALK),disease,DB01861
SMP0000556,Mucopolysaccharidosis VI. Sly Syndrome,disease,DB01861
SMP0000557,Sucrase-Isomaltase Deficiency,disease,DB01861
SMP0000580,GLUT-1 Deficiency Syndrome,disease,DB01861
SMP0000010,Nucleotide Sugars Metabolism,metabolic,DB01861
SMP0000034,Sphingolipid Metabolism,metabolic,DB01861
SMP0000349,Gaucher Disease,disease,DB01861
SMP0000496,Galactosemia III,disease,DB01861
SMP0000525,Fabry Disease,disease,DB01861
SMP0000526,Krabbe Disease,disease,DB01861
SMP0000554,"Glycogenosis, Type IV. Amylopectinosis, Anderson Disease",disease,DB01861
SMP0000555,"Glycogenosis, Type VI. Hers Disease",disease,DB01861
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB01861
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB01917
SMP0000033,Methionine Metabolism,metabolic,DB01917
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB01917
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB01917
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB01917
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB01917
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB01917
SMP0000341,Hypermethioninemia,disease,DB01917
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB01917
SMP0000082,Simvastatin Action Pathway,drug_action,DB01942
SMP0000089,Pravastatin Action Pathway,drug_action,DB01942
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB01942
SMP0000107,Zoledronate Action Pathway,drug_action,DB01942
SMP0000117,Pamidronate Action Pathway,drug_action,DB01942
SMP0000119,Fluvastatin Action Pathway,drug_action,DB01942
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB01942
SMP0000487,Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency,disease,DB01942
SMP0000488,Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps),disease,DB01942
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB01942
SMP0000543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB01942
SMP0000053,Folate Metabolism,metabolic,DB01942
SMP0000063,Tryptophan Metabolism,metabolic,DB01942
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB01942
SMP0000099,Lovastatin Action Pathway,drug_action,DB01942
SMP0000111,Cerivastatin Action Pathway,drug_action,DB01942
SMP0000209,Hypercholesterolemia,disease,DB01942
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB01942
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB01942
SMP0000486,DOPA-Responsive Dystonia,disease,DB01942
SMP0000510,Mevalonic Aciduria,disease,DB01942
SMP0000565,Aromatase Deficiency,disease,DB01942
SMP0000005,Pterine Biosynthesis,metabolic,DB01942
SMP0000023,Steroid Biosynthesis,metabolic,DB01942
SMP0000079,Ibandronate Action Pathway,drug_action,DB01942
SMP0000095,Alendronate Action Pathway,drug_action,DB01942
SMP0000112,Risedronate Action Pathway,drug_action,DB01942
SMP0000131,Atorvastatin Action Pathway,drug_action,DB01942
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB01942
SMP0000386,Desmosterolosis,disease,DB01942
SMP0000316,Zellweger Syndrome,disease,DB01956
SMP0000021,Taurine and Hypotaurine Metabolism,metabolic,DB01956
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB01956
SMP0000720,27-Hydroxylase Deficiency,disease,DB01956
SMP0000035,Bile Acid Biosynthesis,metabolic,DB01956
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB01956
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB01956
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB01956
SMP0000009,Ammonia Recycling,metabolic,DB01971
SMP0000044,Histidine Metabolism,metabolic,DB01971
SMP0000191,Histidinemia,disease,DB01971
SMP0000050,Purine Metabolism,metabolic,DB01972
SMP0000072,Glutamate Metabolism,metabolic,DB01972
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB01972
SMP0000248,Clarithromycin Action Pathway,drug_action,DB01972
SMP0000251,Roxithromycin Action Pathway,drug_action,DB01972
SMP0000254,Gentamicin Action Pathway,drug_action,DB01972
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB01972
SMP0000294,Tetracycline Action Pathway,drug_action,DB01972
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB01972
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB01972
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB01972
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB01972
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB01972
SMP0000713,Arbekacin Action Pathway,drug_action,DB01972
SMP0000730,Troleandomycin Action Pathway,drug_action,DB01972
SMP0000731,Josamycin Action Pathway,drug_action,DB01972
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB01972
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01972
SMP0000247,Azithromycin Action Pathway,drug_action,DB01972
SMP0000249,Clindamycin Action Pathway,drug_action,DB01972
SMP0000250,Erythromycin Action Pathway,drug_action,DB01972
SMP0000255,Kanamycin Action Pathway,drug_action,DB01972
SMP0000256,Neomycin Action Pathway,drug_action,DB01972
SMP0000257,Netilmicin Action Pathway,drug_action,DB01972
SMP0000259,Streptomycin Action Pathway,drug_action,DB01972
SMP0000262,Clomocycline Action Pathway,drug_action,DB01972
SMP0000385,Homocarnosinosis,disease,DB01972
SMP0000512,Xanthinuria Type I,disease,DB01972
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB01972
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB01972
SMP0000077,Piroxicam Action Pathway,drug_action,DB02056
SMP0000087,Rofecoxib Action Pathway,drug_action,DB02056
SMP0000093,Diclofenac Action Pathway,drug_action,DB02056
SMP0000094,Sulindac Action Pathway,drug_action,DB02056
SMP0000114,Nabumetone Action Pathway,drug_action,DB02056
SMP0000116,Valdecoxib Action Pathway,drug_action,DB02056
SMP0000692,Antipyrine Action Pathway,drug_action,DB02056
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB02056
SMP0000702,Nepafenac Action Pathway,drug_action,DB02056
SMP0000084,Etodolac Action Pathway,drug_action,DB02056
SMP0000085,Ketoprofen Action Pathway,drug_action,DB02056
SMP0000086,Ibuprofen Action Pathway,drug_action,DB02056
SMP0000096,Celecoxib Action Pathway,drug_action,DB02056
SMP0000101,Suprofen Action Pathway,drug_action,DB02056
SMP0000104,Indomethacin Action Pathway,drug_action,DB02056
SMP0000289,Diflunisal Action Pathway,drug_action,DB02056
SMP0000353,Leukotriene C4 Synthesis Deficiency,disease,DB02056
SMP0000693,Antrafenine Action Pathway,drug_action,DB02056
SMP0000696,Fenoprofen Action Pathway,drug_action,DB02056
SMP0000698,Magnesium Salicylate Action Pathway,drug_action,DB02056
SMP0000700,Lornoxicam Action Pathway,drug_action,DB02056
SMP0000703,Trisalicylate-Choline Action Pathway,drug_action,DB02056
SMP0000704,Tolmetin Action Pathway,drug_action,DB02056
SMP0000705,Tiaprofenic Acid Action Pathway,drug_action,DB02056
SMP0000706,Tenoxicam Action Pathway,drug_action,DB02056
SMP0000709,Salicylic Acid Action Pathway,drug_action,DB02056
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB02056
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB02056
SMP0000098,Ketorolac Action Pathway,drug_action,DB02056
SMP0000102,Bromfenac Action Pathway,drug_action,DB02056
SMP0000063,Tryptophan Metabolism,metabolic,DB02070
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB02074
SMP0000004,Glycine and Serine Metabolism,metabolic,DB02083
SMP0000123,Betaine Metabolism,metabolic,DB02083
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB02083
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB02083
SMP0000033,Methionine Metabolism,metabolic,DB02083
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB02083
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB02083
SMP0000244,Sarcosinemia,disease,DB02083
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02083
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB02083
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB02083
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02083
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB02083
SMP0000341,Hypermethioninemia,disease,DB02083
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02083
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB02083
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB02083
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB02083
SMP0000046,Pyrimidine Metabolism,metabolic,DB02129
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02129
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB02129
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB02129
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02129
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB02134
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02134
SMP0000512,Xanthinuria Type I,disease,DB02134
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB02134
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB02134
SMP0000050,Purine Metabolism,metabolic,DB02134
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02134
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB02134
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB02134
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB02134
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB02134
SMP0000144,Adenosine Deaminase Deficiency,disease,DB02134
SMP0000168,AICA-Ribosiduria,disease,DB02134
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB02134
SMP0000427,Azathioprine Action Pathway,drug_action,DB02134
SMP0000430,Thioguanine Action Pathway,drug_action,DB02134
SMP0000513,Xanthinuria Type II,disease,DB02134
SMP0000017,Vitamin B6 Metabolism,metabolic,DB02142
SMP0000503,Hypophosphatasia,disease,DB02142
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB02175
SMP0000739,Didanosine Action Pathway,drug_action,DB02189
SMP0000017,Vitamin B6 Metabolism,metabolic,DB02209
SMP0000503,Hypophosphatasia,disease,DB02209
SMP0000006,Tyrosine Metabolism,metabolic,DB02232
SMP0000218,Tyrosinemia Type I,disease,DB02232
SMP0000429,Disulfiram Action Pathway,drug_action,DB02232
SMP0000169,Alkaptonuria,disease,DB02232
SMP0000190,Hawkinsinuria,disease,DB02232
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB02232
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB02232
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB02232
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB02238
SMP0000033,Methionine Metabolism,metabolic,DB02238
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB02238
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB02238
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB02238
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB02238
SMP0000341,Hypermethioninemia,disease,DB02238
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB02238
SMP0000046,Pyrimidine Metabolism,metabolic,DB02262
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02262
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB02262
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB02262
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02262
SMP0000374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB02263
SMP0000520,Transaldolase Deficiency,disease,DB02263
SMP0000562,"Fructose-1,6-diphosphatase Deficiency",disease,DB02263
SMP0000563,Triosephosphate Isomerase,disease,DB02263
SMP0000572,Fanconi-Bickel Syndrome,disease,DB02263
SMP0000654,Warburg Effect,metabolic,DB02263
SMP0000040,Glycolysis,metabolic,DB02263
SMP0000064,Fructose and Mannose Degradation,metabolic,DB02263
SMP0000124,Glycerol Phosphate Shuttle,metabolic,DB02263
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB02263
SMP0000531,"Glycogenosis, Type VII. Tarui Disease",disease,DB02263
SMP0000560,Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1),disease,DB02263
SMP0000573,"Glycogenosis, Type IB",disease,DB02263
SMP0000031,Pentose Phosphate Pathway,metabolic,DB02263
SMP0000128,Gluconeogenesis,metabolic,DB02263
SMP0000355,Mitochondrial Electron Transport Chain,metabolic,DB02263
SMP0000519,Ribose-5-phosphate Isomerase Deficiency,disease,DB02263
SMP0000561,Fructosuria,disease,DB02263
SMP0000574,"Glycogenosis, Type IC",disease,DB02263
SMP0000581,"Glycogenosis, Type IA. Von Gierke Disease",disease,DB02263
SMP0000725,"Fructose Intolerance, Hereditary",disease,DB02263
SMP0000024,Porphyrin Metabolism,metabolic,DB02285
SMP0000344,Acute Intermittent Porphyria,disease,DB02285
SMP0000346,Porphyria Variegata (PV),disease,DB02285
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB02285
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB02285
SMP0000043,Galactose Metabolism,metabolic,DB02317
SMP0000444,Lactose Synthesis,metabolic,DB02317
SMP0000182,Galactosemia,disease,DB02317
SMP0000495,Galactosemia II (GALK),disease,DB02317
SMP0000580,GLUT-1 Deficiency Syndrome,disease,DB02317
SMP0000010,Nucleotide Sugars Metabolism,metabolic,DB02317
SMP0000496,Galactosemia III,disease,DB02317
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB02317
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB02345
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB02377
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02377
SMP0000512,Xanthinuria Type I,disease,DB02377
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB02377
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB02377
SMP0000050,Purine Metabolism,metabolic,DB02377
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02377
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB02377
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB02377
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB02377
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB02377
SMP0000144,Adenosine Deaminase Deficiency,disease,DB02377
SMP0000168,AICA-Ribosiduria,disease,DB02377
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB02377
SMP0000427,Azathioprine Action Pathway,drug_action,DB02377
SMP0000430,Thioguanine Action Pathway,drug_action,DB02377
SMP0000513,Xanthinuria Type II,disease,DB02377
SMP0000486,DOPA-Responsive Dystonia,disease,DB02385
SMP0000487,Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency,disease,DB02385
SMP0000488,Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps),disease,DB02385
SMP0000005,Pterine Biosynthesis,metabolic,DB02385
SMP0000489,Hyperphenylalaninemia Due to DHPR-Deficiency,disease,DB02385
SMP0000490,Segawa Syndrome,disease,DB02385
SMP0000491,Sepiapterin Reductase Deficiency,disease,DB02385
SMP0000046,Pyrimidine Metabolism,metabolic,DB02431
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02431
SMP0000216,Sialuria or French Type Sialuria,disease,DB02431
SMP0000217,Sialuria or French Type Sialuria,disease,DB02431
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB02431
SMP0000248,Clarithromycin Action Pathway,drug_action,DB02431
SMP0000251,Roxithromycin Action Pathway,drug_action,DB02431
SMP0000254,Gentamicin Action Pathway,drug_action,DB02431
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB02431
SMP0000294,Tetracycline Action Pathway,drug_action,DB02431
SMP0000390,Tay-Sachs Disease,disease,DB02431
SMP0000713,Arbekacin Action Pathway,drug_action,DB02431
SMP0000730,Troleandomycin Action Pathway,drug_action,DB02431
SMP0000731,Josamycin Action Pathway,drug_action,DB02431
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB02431
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB02431
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB02431
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB02431
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB02431
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB02431
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB02431
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02431
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB02431
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB02431
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB02431
SMP0014245,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0),metabolic,DB02431
SMP0014248,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0),metabolic,DB02431
SMP0014249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB02431
SMP0014255,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB02431
SMP0014267,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z))",metabolic,DB02431
SMP0000124,Glycerol Phosphate Shuttle,metabolic,DB02515
SMP0000187,Glycerol Kinase Deficiency,disease,DB02515
SMP0015901,De Novo Triacylglycerol Biosynthesis TG(16:0/16:0/16:0),metabolic,DB02515
SMP0015910,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/18:0),metabolic,DB02515
SMP0015911,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/20:0),metabolic,DB02515
SMP0015912,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/18:1(9Z)),metabolic,DB02515
SMP0015915,"De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015916,De Novo Triacylglycerol Biosynthesis TG(16:0/20:0/20:0),metabolic,DB02515
SMP0015918,"De Novo Triacylglycerol Biosynthesis TG(16:0/20:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015922,De Novo Triacylglycerol Biosynthesis TG(16:0/16:1(9Z)/18:1(9Z)),metabolic,DB02515
SMP0015924,"De Novo Triacylglycerol Biosynthesis TG(16:0/16:1(9Z)/18:2(9Z,12Z))",metabolic,DB02515
SMP0015926,De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0),metabolic,DB02515
SMP0015935,"De Novo Triacylglycerol Biosynthesis TG(16:0/18:2(9Z,12Z)/18:2(9Z,12Z))",metabolic,DB02515
SMP0015938,De Novo Triacylglycerol Biosynthesis TG(18:0/18:0/18:0),metabolic,DB02515
SMP0015939,De Novo Triacylglycerol Biosynthesis TG(18:0/18:0/20:0),metabolic,DB02515
SMP0015949,De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/20:1(11Z)),metabolic,DB02515
SMP0015950,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/18:2(9Z,12Z))",metabolic,DB02515
SMP0015951,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015952,De Novo Triacylglycerol Biosynthesis TG(18:0/20:1(11Z)/20:1(11Z)),metabolic,DB02515
SMP0015957,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015960,De Novo Triacylglycerol Biosynthesis TG(20:0/20:0/20:1(11Z)),metabolic,DB02515
SMP0015962,De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:1(11Z)),metabolic,DB02515
SMP0015963,"De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015971,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/20:0/20:0),metabolic,DB02515
SMP0015972,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/20:0/20:1(11Z)),metabolic,DB02515
SMP0015973,"De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB02515
SMP0015983,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:1(9Z)/18:1(9Z)),metabolic,DB02515
SMP0015984,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:1(9Z)/20:1(11Z)),metabolic,DB02515
SMP0015985,"De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:1(9Z)/18:2(9Z,12Z))",metabolic,DB02515
SMP0015987,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/20:1(11Z)/20:1(11Z)),metabolic,DB02515
SMP0000144,Adenosine Deaminase Deficiency,disease,DB02527
SMP0000168,AICA-Ribosiduria,disease,DB02527
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB02527
SMP0000308,Dopamine Activation of Neurological Reward System,signaling,DB02527
SMP0000309,Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,signaling,DB02527
SMP0000354,Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,signaling,DB02527
SMP0000427,Azathioprine Action Pathway,drug_action,DB02527
SMP0000430,Thioguanine Action Pathway,drug_action,DB02527
SMP0000513,Xanthinuria Type II,disease,DB02527
SMP0063756,Lysophosphatidic Acid LPA4 Signalling,signaling,DB02527
SMP0063757,Lysophosphatidic Acid LPA5 Signalling,signaling,DB02527
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB02527
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02527
SMP0000312,Excitatory Neural Signalling Through 5-HTR 6 and Serotonin,signaling,DB02527
SMP0000322,Vasopressin Regulation of Water Homeostasis,signaling,DB02527
SMP0000335,Intracellular Signalling Through Histamine H2 Receptor and Histamine,signaling,DB02527
SMP0000343,Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,signaling,DB02527
SMP0000512,Xanthinuria Type I,disease,DB02527
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB02527
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB02527
SMP0063746,Lysophosphatidic Acid LPA1 Signalling,signaling,DB02527
SMP0063753,Lysophosphatidic Acid LPA2 Signalling,signaling,DB02527
SMP0063759,Lysophosphatidic Acid LPA6 Signalling,signaling,DB02527
SMP0000050,Purine Metabolism,metabolic,DB02527
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02527
SMP0000310,Corticotropin Activation of Cortisol Production,signaling,DB02527
SMP0000311,Excitatory Neural Signalling Through 5-HTR 7 and Serotonin,signaling,DB02527
SMP0000320,Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,signaling,DB02527
SMP0000321,Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,signaling,DB02527
SMP0000333,Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,signaling,DB02527
SMP0000385,Homocarnosinosis,disease,DB02530
SMP0000072,Glutamate Metabolism,metabolic,DB02530
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB02530
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB02530
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB02530
SMP0000567,Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB02530
SMP0000099,Lovastatin Action Pathway,drug_action,DB02552
SMP0000111,Cerivastatin Action Pathway,drug_action,DB02552
SMP0000209,Hypercholesterolemia,disease,DB02552
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB02552
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB02552
SMP0000510,Mevalonic Aciduria,disease,DB02552
SMP0000082,Simvastatin Action Pathway,drug_action,DB02552
SMP0000089,Pravastatin Action Pathway,drug_action,DB02552
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB02552
SMP0000107,Zoledronate Action Pathway,drug_action,DB02552
SMP0000117,Pamidronate Action Pathway,drug_action,DB02552
SMP0000119,Fluvastatin Action Pathway,drug_action,DB02552
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB02552
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB02552
SMP0000023,Steroid Biosynthesis,metabolic,DB02552
SMP0000079,Ibandronate Action Pathway,drug_action,DB02552
SMP0000095,Alendronate Action Pathway,drug_action,DB02552
SMP0000112,Risedronate Action Pathway,drug_action,DB02552
SMP0000131,Atorvastatin Action Pathway,drug_action,DB02552
SMP0000386,Desmosterolosis,disease,DB02552
SMP0000387,CHILD Syndrome,disease,DB02552
SMP0000509,Hyper-IgD Syndrome,disease,DB02552
SMP0000511,Wolman Disease,disease,DB02552
SMP0000020,Arginine and Proline Metabolism,metabolic,DB02577
SMP0000024,Porphyrin Metabolism,metabolic,DB02577
SMP0000050,Purine Metabolism,metabolic,DB02577
SMP0000082,Simvastatin Action Pathway,drug_action,DB02577
SMP0000084,Etodolac Action Pathway,drug_action,DB02577
SMP0000085,Ketoprofen Action Pathway,drug_action,DB02577
SMP0000086,Ibuprofen Action Pathway,drug_action,DB02577
SMP0000089,Pravastatin Action Pathway,drug_action,DB02577
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB02577
SMP0000096,Celecoxib Action Pathway,drug_action,DB02577
SMP0000101,Suprofen Action Pathway,drug_action,DB02577
SMP0000104,Indomethacin Action Pathway,drug_action,DB02577
SMP0000107,Zoledronate Action Pathway,drug_action,DB02577
SMP0000117,Pamidronate Action Pathway,drug_action,DB02577
SMP0000119,Fluvastatin Action Pathway,drug_action,DB02577
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB02577
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02577
SMP0000289,Diflunisal Action Pathway,drug_action,DB02577
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB02577
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB02577
SMP0000327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB02577
SMP0000353,Leukotriene C4 Synthesis Deficiency,disease,DB02577
SMP0000355,Mitochondrial Electron Transport Chain,metabolic,DB02577
SMP0000360,Hyperprolinemia Type II,disease,DB02577
SMP0000361,Hyperprolinemia Type I,disease,DB02577
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB02577
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB02577
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB02577
SMP0000408,Methadone Action Pathway,drug_action,DB02577
SMP0000422,Imipramine Action Pathway,drug_action,DB02577
SMP0000605,Ifosfamide Metabolism Pathway,drug_metabolism,DB02579
SMP0000447,Cyclophosphamide Action Pathway,drug_action,DB02579
SMP0000448,Ifosfamide Action Pathway,drug_action,DB02579
SMP0000604,Cyclophosphamide Metabolism Pathway,drug_metabolism,DB02579
SMP0000067,Aspartate Metabolism,metabolic,DB02655
SMP0000175,Canavan Disease,disease,DB02655
SMP0000192,Hypoacetylaspartia,disease,DB02655
SMP0000316,Zellweger Syndrome,disease,DB02659
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB02659
SMP0000720,27-Hydroxylase Deficiency,disease,DB02659
SMP0000035,Bile Acid Biosynthesis,metabolic,DB02659
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB02659
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB02659
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB02659
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB02688
SMP0000074,Retinol Metabolism,metabolic,DB02699
SMP0000336,Vitamin A Deficiency,disease,DB02699
SMP0000048,Nicotinate and Nicotinamide Metabolism,metabolic,DB02701
SMP0000046,Pyrimidine Metabolism,metabolic,DB02745
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02745
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB02745
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB02745
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02745
SMP0000004,Glycine and Serine Metabolism,metabolic,DB02751
SMP0000020,Arginine and Proline Metabolism,metabolic,DB02751
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB02751
SMP0000360,Hyperprolinemia Type II,disease,DB02751
SMP0000361,Hyperprolinemia Type I,disease,DB02751
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB02751
SMP0000207,Prolidase Deficiency (PD),disease,DB02751
SMP0000208,Prolinemia Type II,disease,DB02751
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB02751
SMP0000244,Sarcosinemia,disease,DB02751
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB02751
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB02751
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02751
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02751
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB02751
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02751
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB02751
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB02751
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB02751
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB02751
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB02767
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB02838
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB02838
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB02838
SMP0000207,Prolidase Deficiency (PD),disease,DB02838
SMP0000208,Prolinemia Type II,disease,DB02838
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB02838
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB02838
SMP0000020,Arginine and Proline Metabolism,metabolic,DB02838
SMP0000036,D-Arginine and D-Ornithine Metabolism,metabolic,DB02838
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB02838
SMP0000360,Hyperprolinemia Type II,disease,DB02838
SMP0000361,Hyperprolinemia Type I,disease,DB02838
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB02838
SMP0030406,Androstenedione Metabolism,metabolic,DB02854
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB02857
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02857
SMP0000512,Xanthinuria Type I,disease,DB02857
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB02857
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB02857
SMP0000050,Purine Metabolism,metabolic,DB02857
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02857
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB02857
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB02857
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB02857
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB02857
SMP0000144,Adenosine Deaminase Deficiency,disease,DB02857
SMP0000168,AICA-Ribosiduria,disease,DB02857
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB02857
SMP0000427,Azathioprine Action Pathway,drug_action,DB02857
SMP0000430,Thioguanine Action Pathway,drug_action,DB02857
SMP0000513,Xanthinuria Type II,disease,DB02857
SMP0000064,Fructose and Mannose Degradation,metabolic,DB02867
SMP0000561,Fructosuria,disease,DB02867
SMP0000725,"Fructose Intolerance, Hereditary",disease,DB02867
SMP0000559,Pyruvate Kinase Deficiency,disease,DB02897
SMP0000060,Pyruvate Metabolism,metabolic,DB02897
SMP0000196,Leigh Syndrome,disease,DB02897
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB02897
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB02897
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB02897
SMP0000004,Glycine and Serine Metabolism,metabolic,DB02951
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB02951
SMP0000244,Sarcosinemia,disease,DB02951
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02951
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02951
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02951
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB02951
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB02951
SMP0000004,Glycine and Serine Metabolism,metabolic,DB02957
SMP0000046,Pyrimidine Metabolism,metabolic,DB02957
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02957
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB02957
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB02957
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02957
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB02957
SMP0000244,Sarcosinemia,disease,DB02957
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02957
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02957
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02957
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB02957
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB02957
SMP0000063,Tryptophan Metabolism,metabolic,DB02959
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB03017
SMP0000052,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB03017
SMP0000481,Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,metabolic,DB03017
SMP0000516,"Adrenoleukodystrophy, X-Linked",disease,DB03017
SMP0000517,Carnitine-Acylcarnitine Translocase Deficiency,disease,DB03017
SMP0000559,Pyruvate Kinase Deficiency,disease,DB03066
SMP0000060,Pyruvate Metabolism,metabolic,DB03066
SMP0000196,Leigh Syndrome,disease,DB03066
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03066
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03066
SMP0000459,Pyruvaldehyde Degradation,metabolic,DB03066
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB03066
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB03088
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB03088
SMP0000500,5-Oxoprolinase Deficiency,disease,DB03088
SMP0000015,Glutathione Metabolism,metabolic,DB03088
SMP0000143,5-Oxoprolinuria,disease,DB03088
SMP0000337,Glutathione Synthetase Deficiency,disease,DB03088
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB03101
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB03101
SMP0000512,Xanthinuria Type I,disease,DB03101
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB03101
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB03101
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB03101
SMP0000031,Pentose Phosphate Pathway,metabolic,DB03101
SMP0000046,Pyrimidine Metabolism,metabolic,DB03101
SMP0000050,Purine Metabolism,metabolic,DB03101
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03101
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB03101
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB03101
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB03101
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB03101
SMP0000519,Ribose-5-phosphate Isomerase Deficiency,disease,DB03101
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB03101
SMP0000048,Nicotinate and Nicotinamide Metabolism,metabolic,DB03101
SMP0000144,Adenosine Deaminase Deficiency,disease,DB03101
SMP0000168,AICA-Ribosiduria,disease,DB03101
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03101
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03101
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB03101
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03101
SMP0000427,Azathioprine Action Pathway,drug_action,DB03101
SMP0000430,Thioguanine Action Pathway,drug_action,DB03101
SMP0000513,Xanthinuria Type II,disease,DB03101
SMP0000520,Transaldolase Deficiency,disease,DB03101
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03107
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB03107
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB03107
SMP0000016,Propanoate Metabolism,metabolic,DB03107
SMP0000044,Histidine Metabolism,metabolic,DB03107
SMP0000046,Pyrimidine Metabolism,metabolic,DB03107
SMP0000191,Histidinemia,disease,DB03107
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03107
SMP0000007,beta-Alanine Metabolism,metabolic,DB03107
SMP0000067,Aspartate Metabolism,metabolic,DB03107
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03107
SMP0000175,Canavan Disease,disease,DB03107
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03107
SMP0000192,Hypoacetylaspartia,disease,DB03107
SMP0000198,Malonic Aciduria,disease,DB03107
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03107
SMP0000351,GABA-Transaminase Deficiency,disease,DB03107
SMP0000492,Ureidopropionase Deficiency,disease,DB03107
SMP0000232,Cimetidine Action Pathway,drug_action,DB03128
SMP0000589,Gastric Acid Production,physiological,DB03128
SMP0000736,Betazole Action Pathway,drug_action,DB03128
SMP0000025,Phospholipid Biosynthesis,metabolic,DB03128
SMP0000233,Nizatidine Action Pathway,drug_action,DB03128
SMP0051038,Lafutidine H2-Antihistamine Action,drug_action,DB03128
SMP0000225,Esomeprazole Action Pathway,drug_action,DB03128
SMP0000226,Omeprazole Action Pathway,drug_action,DB03128
SMP0000227,Lansoprazole Action Pathway,drug_action,DB03128
SMP0000228,Pantoprazole Action Pathway,drug_action,DB03128
SMP0000229,Rabeprazole Action Pathway,drug_action,DB03128
SMP0000230,Ranitidine Action Pathway,drug_action,DB03128
SMP0000231,Famotidine Action Pathway,drug_action,DB03128
SMP0000246,Pirenzepine Action Pathway,drug_action,DB03128
SMP0000734,Roxatidine Acetate Action Pathway,drug_action,DB03128
SMP0000735,Metiamide Action Pathway,drug_action,DB03128
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB03144
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB03144
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB03144
SMP0000207,Prolidase Deficiency (PD),disease,DB03144
SMP0000208,Prolinemia Type II,disease,DB03144
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03144
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB03144
SMP0000020,Arginine and Proline Metabolism,metabolic,DB03144
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB03144
SMP0000360,Hyperprolinemia Type II,disease,DB03144
SMP0000361,Hyperprolinemia Type I,disease,DB03144
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB03144
SMP0000015,Glutathione Metabolism,metabolic,DB03147
SMP0000028,Caffeine Metabolism,metabolic,DB03147
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB03147
SMP0000037,Lysine Degradation,metabolic,DB03147
SMP0000053,Folate Metabolism,metabolic,DB03147
SMP0000063,Tryptophan Metabolism,metabolic,DB03147
SMP0000070,Riboflavin Metabolism,metabolic,DB03147
SMP0000099,Lovastatin Action Pathway,drug_action,DB03147
SMP0000111,Cerivastatin Action Pathway,drug_action,DB03147
SMP0000124,Glycerol Phosphate Shuttle,metabolic,DB03147
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB03147
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB03147
SMP0000143,5-Oxoprolinuria,disease,DB03147
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB03147
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03147
SMP0000181,Ethylmalonic Encephalopathy,disease,DB03147
SMP0000185,Glutaric Aciduria Type I,disease,DB03147
SMP0000187,Glycerol Kinase Deficiency,disease,DB03147
SMP0000199,Maple Syrup Urine Disease,disease,DB03147
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03147
SMP0000206,Phenylketonuria,disease,DB03147
SMP0000209,Hypercholesterolemia,disease,DB03147
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB03147
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB03147
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB03147
SMP0000235,Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB03147
SMP0000236,Propionic Acidemia,disease,DB03147
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB03147
SMP0000238,Isovaleric Aciduria,disease,DB03147
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03147
SMP0000067,Aspartate Metabolism,metabolic,DB03166
SMP0000175,Canavan Disease,disease,DB03166
SMP0000192,Hypoacetylaspartia,disease,DB03166
SMP0000045,Amino Sugar Metabolism,metabolic,DB03166
SMP0000449,Ethanol Degradation,metabolic,DB03166
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB03166
SMP0000559,Pyruvate Kinase Deficiency,disease,DB03166
SMP0000623,Heroin Metabolism Pathway,drug_metabolism,DB03166
SMP0000060,Pyruvate Metabolism,metabolic,DB03166
SMP0000196,Leigh Syndrome,disease,DB03166
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03166
SMP0000216,Sialuria or French Type Sialuria,disease,DB03166
SMP0000217,Sialuria or French Type Sialuria,disease,DB03166
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB03166
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03166
SMP0000390,Tay-Sachs Disease,disease,DB03166
SMP0000407,Heroin Action Pathway,drug_action,DB03166
SMP0000429,Disulfiram Action Pathway,drug_action,DB03166
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB03166
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB03166
SMP0000532,Sulfite Oxidase Deficiency,disease,DB03175
SMP0000041,Sulfate/Sulfite Metabolism,metabolic,DB03175
SMP0000482,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,metabolic,DB03193
SMP0000479,Plasmalogen Synthesis,metabolic,DB03193
SMP0000170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB03205
SMP0000006,Tyrosine Metabolism,metabolic,DB03205
SMP0000012,Catecholamine Biosynthesis,metabolic,DB03205
SMP0000218,Tyrosinemia Type I,disease,DB03205
SMP0000429,Disulfiram Action Pathway,drug_action,DB03205
SMP0000169,Alkaptonuria,disease,DB03205
SMP0000190,Hawkinsinuria,disease,DB03205
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB03205
SMP0000497,Tyrosine Hydroxylase Deficiency,disease,DB03205
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB03205
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB03205
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB03229
SMP0000200,Methylmalonic Aciduria,disease,DB03229
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB03229
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB03229
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB03229
SMP0000173,beta-Ketothiolase Deficiency,disease,DB03229
SMP0000524,Isovaleric Acidemia,disease,DB03229
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB03229
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB03229
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB03229
SMP0000199,Maple Syrup Urine Disease,disease,DB03229
SMP0000236,Propionic Acidemia,disease,DB03229
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB03229
SMP0000238,Isovaleric Aciduria,disease,DB03229
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB03229
SMP0000521,3-Hydroxyisobutyric Acid Dehydrogenase Deficiency,disease,DB03229
SMP0000522,3-Hydroxyisobutyric Aciduria,disease,DB03229
SMP0000070,Riboflavin Metabolism,metabolic,DB03247
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB03247
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB03247
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB03247
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB03247
SMP0000650,Doxorubicin Metabolism Pathway,drug_metabolism,DB03247
SMP0000020,Arginine and Proline Metabolism,metabolic,DB03247
SMP0000046,Pyrimidine Metabolism,metabolic,DB03247
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB03247
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03247
SMP0000360,Hyperprolinemia Type II,disease,DB03247
SMP0000361,Hyperprolinemia Type I,disease,DB03247
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB03247
SMP0000007,beta-Alanine Metabolism,metabolic,DB03247
SMP0000017,Vitamin B6 Metabolism,metabolic,DB03247
SMP0000027,Pantothenate and CoA Biosynthesis,metabolic,DB03247
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03247
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03247
SMP0000207,Prolidase Deficiency (PD),disease,DB03247
SMP0000208,Prolinemia Type II,disease,DB03247
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03247
SMP0000351,GABA-Transaminase Deficiency,disease,DB03247
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03247
SMP0000492,Ureidopropionase Deficiency,disease,DB03247
SMP0000503,Hypophosphatasia,disease,DB03247
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB03247
SMP0063777,Nitric Oxide Signaling Pathway,signaling,DB03247
SMP0000532,Sulfite Oxidase Deficiency,disease,DB03255
SMP0000041,Sulfate/Sulfite Metabolism,metabolic,DB03255
SMP0000064,Fructose and Mannose Degradation,metabolic,DB03283
SMP0000561,Fructosuria,disease,DB03283
SMP0000725,"Fructose Intolerance, Hereditary",disease,DB03283
SMP0000556,Mucopolysaccharidosis VI. Sly Syndrome,disease,DB03323
SMP0000557,Sucrase-Isomaltase Deficiency,disease,DB03323
SMP0000554,"Glycogenosis, Type IV. Amylopectinosis, Anderson Disease",disease,DB03323
SMP0000555,"Glycogenosis, Type VI. Hers Disease",disease,DB03323
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB03323
SMP0000552,Glycogen Synthetase Deficiency,disease,DB03323
SMP0000553,"Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis",disease,DB03323
SMP0000716,Thyroid Hormone Synthesis,metabolic,DB03374
SMP0000348,Globoid Cell Leukodystrophy,disease,DB03381
SMP0000347,Metachromatic Leukodystrophy (MLD),disease,DB03381
SMP0000034,Sphingolipid Metabolism,metabolic,DB03381
SMP0000349,Gaucher Disease,disease,DB03381
SMP0000525,Fabry Disease,disease,DB03381
SMP0000526,Krabbe Disease,disease,DB03381
SMP0000072,Glutamate Metabolism,metabolic,DB03408
SMP0000339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB03408
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB03408
SMP0000136,2-Hydroxyglutric Aciduria (D and L Form),disease,DB03408
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB03408
SMP0000243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB03408
SMP0000499,beta-Mercaptolactate-Cysteine Disulfiduria,disease,DB03408
SMP0000500,5-Oxoprolinase Deficiency,disease,DB03408
SMP0000567,Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB03408
SMP0000013,Cysteine Metabolism,metabolic,DB03408
SMP0000015,Glutathione Metabolism,metabolic,DB03408
SMP0000143,5-Oxoprolinuria,disease,DB03408
SMP0000337,Glutathione Synthetase Deficiency,disease,DB03408
SMP0000385,Homocarnosinosis,disease,DB03408
SMP0000722,"Cystinosis, Ocular Nonnephropathic",disease,DB03408
SMP0000076,Thiamine Metabolism,metabolic,DB03416
SMP0000493,"Carnosinuria, Carnosinemia",disease,DB03419
SMP0000046,Pyrimidine Metabolism,metabolic,DB03419
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03419
SMP0000007,beta-Alanine Metabolism,metabolic,DB03419
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03419
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03419
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03419
SMP0000351,GABA-Transaminase Deficiency,disease,DB03419
SMP0000492,Ureidopropionase Deficiency,disease,DB03419
SMP0028021,Cardiolipin Biosynthesis CL(18:0/18:0/18:0/18:0),metabolic,DB03429
SMP0000034,Sphingolipid Metabolism,metabolic,DB03435
SMP0000045,Amino Sugar Metabolism,metabolic,DB03435
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB03435
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB03435
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB03435
SMP0000349,Gaucher Disease,disease,DB03435
SMP0000405,Codeine Action Pathway,drug_action,DB03435
SMP0000442,Etoposide Action Pathway,drug_action,DB03435
SMP0000471,Tamoxifen Action Pathway,drug_action,DB03435
SMP0000525,Fabry Disease,disease,DB03435
SMP0000526,Krabbe Disease,disease,DB03435
SMP0000534,"G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease",disease,DB03435
SMP0000554,"Glycogenosis, Type IV. Amylopectinosis, Anderson Disease",disease,DB03435
SMP0000555,"Glycogenosis, Type VI. Hers Disease",disease,DB03435
SMP0000565,Aromatase Deficiency,disease,DB03435
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB03435
SMP0000635,Valproic Acid Metabolism Pathway,drug_metabolism,DB03435
SMP0000640,Acetaminophen Metabolism Pathway,drug_metabolism,DB03435
SMP0000648,Sorafenib Metabolism Pathway,drug_metabolism,DB03435
SMP0000649,Lamivudine Metabolism Pathway,drug_metabolism,DB03435
SMP0000024,Porphyrin Metabolism,metabolic,DB03435
SMP0000043,Galactose Metabolism,metabolic,DB03435
SMP0000046,Pyrimidine Metabolism,metabolic,DB03435
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB03435
SMP0000086,Ibuprofen Action Pathway,drug_action,DB03435
SMP0000096,Celecoxib Action Pathway,drug_action,DB03435
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03435
SMP0000216,Sialuria or French Type Sialuria,disease,DB03435
SMP0000217,Sialuria or French Type Sialuria,disease,DB03435
SMP0000240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB03435
SMP0000046,Pyrimidine Metabolism,metabolic,DB03462
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03462
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03462
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03462
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03462
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB03566
SMP0000033,Methionine Metabolism,metabolic,DB03566
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB03566
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB03566
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB03566
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB03566
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB03566
SMP0000341,Hypermethioninemia,disease,DB03566
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB03566
SMP0000073,Butyrate Metabolism,metabolic,DB03568
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB03568
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB03587
SMP0000244,Sarcosinemia,disease,DB03587
SMP0000445,Spermidine and Spermine Biosynthesis,metabolic,DB03587
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03587
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03587
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03587
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB03587
SMP0000559,Pyruvate Kinase Deficiency,disease,DB03587
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB03587
SMP0000004,Glycine and Serine Metabolism,metabolic,DB03587
SMP0000060,Pyruvate Metabolism,metabolic,DB03587
SMP0000196,Leigh Syndrome,disease,DB03587
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03587
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03587
SMP0000459,Pyruvaldehyde Degradation,metabolic,DB03587
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB03587
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB03600
SMP0000063,Tryptophan Metabolism,metabolic,DB03644
SMP0000046,Pyrimidine Metabolism,metabolic,DB03685
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03685
SMP0000248,Clarithromycin Action Pathway,drug_action,DB03685
SMP0000251,Roxithromycin Action Pathway,drug_action,DB03685
SMP0000254,Gentamicin Action Pathway,drug_action,DB03685
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB03685
SMP0000294,Tetracycline Action Pathway,drug_action,DB03685
SMP0000444,Lactose Synthesis,metabolic,DB03685
SMP0000713,Arbekacin Action Pathway,drug_action,DB03685
SMP0000730,Troleandomycin Action Pathway,drug_action,DB03685
SMP0000731,Josamycin Action Pathway,drug_action,DB03685
SMP0000247,Azithromycin Action Pathway,drug_action,DB03685
SMP0000249,Clindamycin Action Pathway,drug_action,DB03685
SMP0000250,Erythromycin Action Pathway,drug_action,DB03685
SMP0000255,Kanamycin Action Pathway,drug_action,DB03685
SMP0000256,Neomycin Action Pathway,drug_action,DB03685
SMP0000257,Netilmicin Action Pathway,drug_action,DB03685
SMP0000259,Streptomycin Action Pathway,drug_action,DB03685
SMP0000262,Clomocycline Action Pathway,drug_action,DB03685
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB03685
SMP0000711,Tobramycin Action Pathway,drug_action,DB03685
SMP0000726,Rolitetracycline Action Pathway,drug_action,DB03685
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03685
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03685
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03685
SMP0000252,Telithromycin Action Pathway,drug_action,DB03685
SMP0000253,Amikacin Action Pathway,drug_action,DB03685
SMP0000258,Spectinomycin Action Pathway,drug_action,DB03685
SMP0000290,Demeclocycline Action Pathway,drug_action,DB03685
SMP0000291,Doxycycline Action Pathway,drug_action,DB03685
SMP0000016,Propanoate Metabolism,metabolic,DB03688
SMP0000198,Malonic Aciduria,disease,DB03688
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03688
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB03688
SMP0000016,Propanoate Metabolism,metabolic,DB03766
SMP0000198,Malonic Aciduria,disease,DB03766
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03766
SMP0000464,Vitamin K Metabolism,metabolic,DB03766
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB03766
SMP0000559,Pyruvate Kinase Deficiency,disease,DB03776
SMP0000060,Pyruvate Metabolism,metabolic,DB03776
SMP0000196,Leigh Syndrome,disease,DB03776
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03776
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03776
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB03776
SMP0000099,Lovastatin Action Pathway,drug_action,DB03796
SMP0000111,Cerivastatin Action Pathway,drug_action,DB03796
SMP0000181,Ethylmalonic Encephalopathy,disease,DB03796
SMP0000185,Glutaric Aciduria Type I,disease,DB03796
SMP0000187,Glycerol Kinase Deficiency,disease,DB03796
SMP0000209,Hypercholesterolemia,disease,DB03796
SMP0000235,Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB03796
SMP0000316,Zellweger Syndrome,disease,DB03796
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB03796
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB03796
SMP0000510,Mevalonic Aciduria,disease,DB03796
SMP0000542,Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD),disease,DB03796
SMP0000023,Steroid Biosynthesis,metabolic,DB03796
SMP0000035,Bile Acid Biosynthesis,metabolic,DB03796
SMP0000079,Ibandronate Action Pathway,drug_action,DB03796
SMP0000095,Alendronate Action Pathway,drug_action,DB03796
SMP0000112,Risedronate Action Pathway,drug_action,DB03796
SMP0000131,Atorvastatin Action Pathway,drug_action,DB03796
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB03796
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB03796
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB03796
SMP0000386,Desmosterolosis,disease,DB03796
SMP0000387,CHILD Syndrome,disease,DB03796
SMP0000509,Hyper-IgD Syndrome,disease,DB03796
SMP0000511,Wolman Disease,disease,DB03796
SMP0000529,D-Glyceric Acidura,disease,DB03796
SMP0000539,Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD),disease,DB03796
SMP0000541,Carnitine Palmitoyl Transferase Deficiency II,disease,DB03796
SMP0000544,Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD),disease,DB03796
SMP0000039,Glycerolipid Metabolism,metabolic,DB03796
SMP0000046,Pyrimidine Metabolism,metabolic,DB03800
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03800
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB03800
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB03800
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03800
SMP0000004,Glycine and Serine Metabolism,metabolic,DB03843
SMP0000408,Methadone Action Pathway,drug_action,DB03843
SMP0000422,Imipramine Action Pathway,drug_action,DB03843
SMP0000424,Citalopram Action Pathway,drug_action,DB03843
SMP0000621,Codeine Metabolism Pathway,drug_metabolism,DB03843
SMP0000636,Venlafaxine Metabolism Pathway,drug_metabolism,DB03843
SMP0000639,Clomipramine Metabolism Pathway,drug_metabolism,DB03843
SMP0000646,Fluoxetine Metabolism Pathway,drug_metabolism,DB03843
SMP0000652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB03843
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB03843
SMP0000244,Sarcosinemia,disease,DB03843
SMP0000426,Fluoxetine Action Pathway,drug_action,DB03843
SMP0000431,Nicotine Action Pathway,drug_action,DB03843
SMP0000443,Teniposide Action Pathway,drug_action,DB03843
SMP0000601,Etoposide Metabolism Pathway,drug_metabolism,DB03843
SMP0000602,Teniposide Metabolism Pathway,drug_metabolism,DB03843
SMP0000606,Tamoxifen Metabolism Pathway,drug_metabolism,DB03843
SMP0000628,Nicotine Metabolism Pathway,drug_metabolism,DB03843
SMP0000637,Tramadol Metabolism Pathway,drug_metabolism,DB03843
SMP0000638,Levomethadyl Acetate Metabolism Pathway,drug_metabolism,DB03843
SMP0000651,Artemether Metabolism Pathway,drug_metabolism,DB03843
SMP0000028,Caffeine Metabolism,metabolic,DB03843
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03843
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03843
SMP0000328,Lidocaine (Antiarrhythmic) Action Pathway,drug_action,DB03843
SMP0000398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB03843
SMP0000405,Codeine Action Pathway,drug_action,DB03843
SMP0000442,Etoposide Action Pathway,drug_action,DB03843
SMP0000471,Tamoxifen Action Pathway,drug_action,DB03843
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03843
SMP0000077,Piroxicam Action Pathway,drug_action,DB03866
SMP0000087,Rofecoxib Action Pathway,drug_action,DB03866
SMP0000093,Diclofenac Action Pathway,drug_action,DB03866
SMP0000094,Sulindac Action Pathway,drug_action,DB03866
SMP0000114,Nabumetone Action Pathway,drug_action,DB03866
SMP0000116,Valdecoxib Action Pathway,drug_action,DB03866
SMP0000692,Antipyrine Action Pathway,drug_action,DB03866
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB03866
SMP0000702,Nepafenac Action Pathway,drug_action,DB03866
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB03866
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB03866
SMP0000098,Ketorolac Action Pathway,drug_action,DB03866
SMP0000102,Bromfenac Action Pathway,drug_action,DB03866
SMP0000106,Meloxicam Action Pathway,drug_action,DB03866
SMP0000109,Mefenamic Acid Action Pathway,drug_action,DB03866
SMP0000113,Oxaprozin Action Pathway,drug_action,DB03866
SMP0000120,Naproxen Action Pathway,drug_action,DB03866
SMP0000694,Carprofen Action Pathway,drug_action,DB03866
SMP0000695,Etoricoxib Action Pathway,drug_action,DB03866
SMP0000699,Lumiracoxib Action Pathway,drug_action,DB03866
SMP0000701,Phenylbutazone Action Pathway,drug_action,DB03866
SMP0000707,Salsalate Action Pathway,drug_action,DB03866
SMP0000708,Salicylate-Sodium Action Pathway,drug_action,DB03866
SMP0000710,Acetaminophen  Action Pathway,drug_action,DB03866
SMP0000084,Etodolac Action Pathway,drug_action,DB03866
SMP0000085,Ketoprofen Action Pathway,drug_action,DB03866
SMP0000086,Ibuprofen Action Pathway,drug_action,DB03866
SMP0000096,Celecoxib Action Pathway,drug_action,DB03866
SMP0000101,Suprofen Action Pathway,drug_action,DB03866
SMP0000104,Indomethacin Action Pathway,drug_action,DB03866
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB03884
SMP0000206,Phenylketonuria,disease,DB03884
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB03884
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB03884
SMP0000486,DOPA-Responsive Dystonia,disease,DB03896
SMP0000487,Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency,disease,DB03896
SMP0000488,Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps),disease,DB03896
SMP0000005,Pterine Biosynthesis,metabolic,DB03896
SMP0000489,Hyperphenylalaninemia Due to DHPR-Deficiency,disease,DB03896
SMP0000490,Segawa Syndrome,disease,DB03896
SMP0000491,Sepiapterin Reductase Deficiency,disease,DB03896
SMP0000081,Methyclothiazide Action Pathway,drug_action,DB03904
SMP0000100,Hydrochlorothiazide Action Pathway,drug_action,DB03904
SMP0000105,Metolazone Action Pathway,drug_action,DB03904
SMP0000115,Furosemide Action Pathway,drug_action,DB03904
SMP0000118,Torsemide Action Pathway,drug_action,DB03904
SMP0000132,Triamterene Action Pathway,drug_action,DB03904
SMP0000189,Hartnup Disorder,disease,DB03904
SMP0000197,Lysinuric Protein Intolerance,disease,DB03904
SMP0000245,Glucose Transporter Defect (SGLT2),disease,DB03904
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB03904
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB03904
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB03904
SMP0000583,Blue Diaper Syndrome,disease,DB03904
SMP0000723,Cystinuria,disease,DB03904
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB03904
SMP0000003,Argininosuccinic Aciduria,disease,DB03904
SMP0000020,Arginine and Proline Metabolism,metabolic,DB03904
SMP0000036,D-Arginine and D-Ornithine Metabolism,metabolic,DB03904
SMP0000080,Polythiazide Action Pathway,drug_action,DB03904
SMP0000088,Bumetanide Action Pathway,drug_action,DB03904
SMP0000091,Quinethazone Action Pathway,drug_action,DB03904
SMP0000110,Indapamide Action Pathway,drug_action,DB03904
SMP0000121,Trichlormethiazide Action Pathway,drug_action,DB03904
SMP0000134,Spironolactone Action Pathway,drug_action,DB03904
SMP0000135,Eplerenone Action Pathway,drug_action,DB03904
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB03904
SMP0000360,Hyperprolinemia Type II,disease,DB03904
SMP0000361,Hyperprolinemia Type I,disease,DB03904
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB03904
SMP0000001,Citrullinemia Type I,disease,DB03904
SMP0000004,Glycine and Serine Metabolism,metabolic,DB03915
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB03915
SMP0000244,Sarcosinemia,disease,DB03915
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03915
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03915
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03915
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB03915
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB03915
SMP0000004,Glycine and Serine Metabolism,metabolic,DB03929
SMP0000248,Clarithromycin Action Pathway,drug_action,DB03929
SMP0000251,Roxithromycin Action Pathway,drug_action,DB03929
SMP0000254,Gentamicin Action Pathway,drug_action,DB03929
SMP0000293,Oxytetracycline Action Pathway,drug_action,DB03929
SMP0000294,Tetracycline Action Pathway,drug_action,DB03929
SMP0000713,Arbekacin Action Pathway,drug_action,DB03929
SMP0000730,Troleandomycin Action Pathway,drug_action,DB03929
SMP0000731,Josamycin Action Pathway,drug_action,DB03929
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB03929
SMP0000244,Sarcosinemia,disease,DB03929
SMP0000252,Telithromycin Action Pathway,drug_action,DB03929
SMP0000253,Amikacin Action Pathway,drug_action,DB03929
SMP0000258,Spectinomycin Action Pathway,drug_action,DB03929
SMP0000290,Demeclocycline Action Pathway,drug_action,DB03929
SMP0000291,Doxycycline Action Pathway,drug_action,DB03929
SMP0000292,Minocycline Action Pathway,drug_action,DB03929
SMP0000295,Lymecycline Action Pathway,drug_action,DB03929
SMP0000712,Tigecycline Action Pathway,drug_action,DB03929
SMP0000714,Paromomycin Action Pathway,drug_action,DB03929
SMP0000727,Methacycline Action Pathway,drug_action,DB03929
SMP0000728,Lincomycin Action Pathway,drug_action,DB03929
SMP0000729,Chloramphenicol Action Pathway,drug_action,DB03929
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03929
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03929
SMP0000247,Azithromycin Action Pathway,drug_action,DB03929
SMP0000249,Clindamycin Action Pathway,drug_action,DB03929
SMP0000250,Erythromycin Action Pathway,drug_action,DB03929
SMP0000255,Kanamycin Action Pathway,drug_action,DB03929
SMP0000256,Neomycin Action Pathway,drug_action,DB03929
SMP0000348,Globoid Cell Leukodystrophy,disease,DB03945
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB03945
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB03945
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB03945
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB03945
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB03945
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB03945
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB03945
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB03945
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB03945
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB03945
SMP0014245,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0),metabolic,DB03945
SMP0014248,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0),metabolic,DB03945
SMP0014249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB03945
SMP0014255,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB03945
SMP0014267,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z))",metabolic,DB03945
SMP0014272,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0),metabolic,DB03945
SMP0014274,Phosphatidylcholine Biosynthesis PC(15:0/14:0),metabolic,DB03945
SMP0014277,Phosphatidylcholine Biosynthesis PC(15:0/16:0),metabolic,DB03945
SMP0014278,Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)),metabolic,DB03945
SMP0014279,Phosphatidylcholine Biosynthesis PC(15:0/18:0),metabolic,DB03945
SMP0014287,Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)),metabolic,DB03945
SMP0014290,"Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z))",metabolic,DB03945
SMP0014291,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB03945
SMP0014294,Phosphatidylcholine Biosynthesis PC(15:0/22:0),metabolic,DB03945
SMP0014300,"Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB03945
SMP0014303,Phosphatidylcholine Biosynthesis PC(16:0/14:0),metabolic,DB03945
SMP0014304,Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)),metabolic,DB03945
SMP0014306,Phosphatidylcholine Biosynthesis PC(16:0/16:0),metabolic,DB03945
SMP0014216,Phosphatidylcholine Biosynthesis PC(14:0/14:0),metabolic,DB03994
SMP0014218,Phosphatidylcholine Biosynthesis PC(14:0/15:0),metabolic,DB03994
SMP0014220,Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)),metabolic,DB03994
SMP0014224,"Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z))",metabolic,DB03994
SMP0014228,Phosphatidylcholine Biosynthesis PC(14:0/20:0),metabolic,DB03994
SMP0014229,Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)),metabolic,DB03994
SMP0014230,"Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z))",metabolic,DB03994
SMP0014233,"Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB03994
SMP0014235,"Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB03994
SMP0014240,"Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))",metabolic,DB03994
SMP0014242,"Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB03994
SMP0014245,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0),metabolic,DB03994
SMP0014248,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0),metabolic,DB03994
SMP0014249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB03994
SMP0014255,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB03994
SMP0014267,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z))",metabolic,DB03994
SMP0014272,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0),metabolic,DB03994
SMP0014274,Phosphatidylcholine Biosynthesis PC(15:0/14:0),metabolic,DB03994
SMP0014277,Phosphatidylcholine Biosynthesis PC(15:0/16:0),metabolic,DB03994
SMP0014278,Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)),metabolic,DB03994
SMP0014279,Phosphatidylcholine Biosynthesis PC(15:0/18:0),metabolic,DB03994
SMP0014287,Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)),metabolic,DB03994
SMP0014290,"Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z))",metabolic,DB03994
SMP0014291,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB03994
SMP0014294,Phosphatidylcholine Biosynthesis PC(15:0/22:0),metabolic,DB03994
SMP0014300,"Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",metabolic,DB03994
SMP0014303,Phosphatidylcholine Biosynthesis PC(16:0/14:0),metabolic,DB03994
SMP0014304,Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)),metabolic,DB03994
SMP0014306,Phosphatidylcholine Biosynthesis PC(16:0/16:0),metabolic,DB03994
SMP0014310,Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)),metabolic,DB03994
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB04034
SMP0000031,Pentose Phosphate Pathway,metabolic,DB04034
SMP0000519,Ribose-5-phosphate Isomerase Deficiency,disease,DB04034
SMP0000520,Transaldolase Deficiency,disease,DB04034
SMP0000654,Warburg Effect,metabolic,DB04034
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB04074
SMP0000200,Methylmalonic Aciduria,disease,DB04074
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB04074
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB04074
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB04074
SMP0000173,beta-Ketothiolase Deficiency,disease,DB04074
SMP0000524,Isovaleric Acidemia,disease,DB04074
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB04074
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB04074
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB04074
SMP0000199,Maple Syrup Urine Disease,disease,DB04074
SMP0000236,Propionic Acidemia,disease,DB04074
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB04074
SMP0000238,Isovaleric Aciduria,disease,DB04074
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB04074
SMP0000521,3-Hydroxyisobutyric Acid Dehydrogenase Deficiency,disease,DB04074
SMP0000522,3-Hydroxyisobutyric Aciduria,disease,DB04074
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB04076
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04076
SMP0000512,Xanthinuria Type I,disease,DB04076
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB04076
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB04076
SMP0000050,Purine Metabolism,metabolic,DB04076
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04076
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB04076
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB04076
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB04076
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB04076
SMP0000144,Adenosine Deaminase Deficiency,disease,DB04076
SMP0000168,AICA-Ribosiduria,disease,DB04076
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB04076
SMP0000427,Azathioprine Action Pathway,drug_action,DB04076
SMP0000430,Thioguanine Action Pathway,drug_action,DB04076
SMP0000513,Xanthinuria Type II,disease,DB04076
SMP0000044,Histidine Metabolism,metabolic,DB04151
SMP0000191,Histidinemia,disease,DB04151
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB04160
SMP0000003,Argininosuccinic Aciduria,disease,DB04160
SMP0000004,Glycine and Serine Metabolism,metabolic,DB04160
SMP0000009,Ammonia Recycling,metabolic,DB04160
SMP0000011,Inositol Metabolism,metabolic,DB04160
SMP0000016,Propanoate Metabolism,metabolic,DB04160
SMP0000020,Arginine and Proline Metabolism,metabolic,DB04160
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB04160
SMP0000043,Galactose Metabolism,metabolic,DB04160
SMP0000044,Histidine Metabolism,metabolic,DB04160
SMP0000046,Pyrimidine Metabolism,metabolic,DB04160
SMP0000050,Purine Metabolism,metabolic,DB04160
SMP0000051,Fatty Acid Metabolism,metabolic,DB04160
SMP0000058,Starch and Sucrose Metabolism,metabolic,DB04160
SMP0000060,Pyruvate Metabolism,metabolic,DB04160
SMP0000072,Glutamate Metabolism,metabolic,DB04160
SMP0000073,Butyrate Metabolism,metabolic,DB04160
SMP0000082,Simvastatin Action Pathway,drug_action,DB04160
SMP0000089,Pravastatin Action Pathway,drug_action,DB04160
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB04160
SMP0000107,Zoledronate Action Pathway,drug_action,DB04160
SMP0000117,Pamidronate Action Pathway,drug_action,DB04160
SMP0000119,Fluvastatin Action Pathway,drug_action,DB04160
SMP0000123,Betaine Metabolism,metabolic,DB04160
SMP0000174,Biotinidase Deficiency,disease,DB04160
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB04160
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB04160
SMP0000191,Histidinemia,disease,DB04160
SMP0000196,Leigh Syndrome,disease,DB04160
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB04160
SMP0000138,3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency,disease,DB04183
SMP0000198,Malonic Aciduria,disease,DB04183
SMP0000200,Methylmalonic Aciduria,disease,DB04183
SMP0000523,Isobutyryl-CoA Dehydrogenase Deficiency,disease,DB04183
SMP0000016,Propanoate Metabolism,metabolic,DB04183
SMP0000137,2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency,disease,DB04183
SMP0000139,3-Methylglutaconic Aciduria Type I,disease,DB04183
SMP0000173,beta-Ketothiolase Deficiency,disease,DB04183
SMP0000524,Isovaleric Acidemia,disease,DB04183
SMP0000032,"Valine, Leucine, and Isoleucine Degradation",metabolic,DB04183
SMP0000140,3-Methylglutaconic Aciduria Type III,disease,DB04183
SMP0000141,3-Methylglutaconic Aciduria Type IV,disease,DB04183
SMP0000199,Maple Syrup Urine Disease,disease,DB04183
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04183
SMP0000236,Propionic Acidemia,disease,DB04183
SMP0000237,3-Methylcrotonyl-CoA Carboxylase Deficiency Type I,disease,DB04183
SMP0000238,Isovaleric Aciduria,disease,DB04183
SMP0000384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB04183
SMP0000464,Vitamin K Metabolism,metabolic,DB04183
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB04183
SMP0000521,3-Hydroxyisobutyric Acid Dehydrogenase Deficiency,disease,DB04183
SMP0000522,3-Hydroxyisobutyric Aciduria,disease,DB04183
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB04193
SMP0000033,Methionine Metabolism,metabolic,DB04193
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB04193
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB04193
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB04193
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB04193
SMP0000341,Hypermethioninemia,disease,DB04193
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB04193
SMP0000719,2-Aminoadipic 2-Oxoadipic Aciduria,disease,DB04207
SMP0000186,Glutaric Aciduria Type I,disease,DB04207
SMP0000239,Saccharopinuria/Hyperlysinemia II,disease,DB04207
SMP0000527,"Hyperlysinemia I, Familial",disease,DB04207
SMP0000037,Lysine Degradation,metabolic,DB04207
SMP0000528,Hyperlysinemia II or Saccharopinuria,disease,DB04207
SMP0000571,Pyridoxine Dependency with Seizures,disease,DB04207
SMP0000065,Ubiquinone Biosynthesis,metabolic,DB04242
SMP0000046,Pyrimidine Metabolism,metabolic,DB04252
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB04252
SMP0000067,Aspartate Metabolism,metabolic,DB04252
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB04252
SMP0000175,Canavan Disease,disease,DB04252
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB04252
SMP0000192,Hypoacetylaspartia,disease,DB04252
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB04252
SMP0002295,The Oncogenic Action of Fumarate,disease,DB04272
SMP0002358,The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB04272
SMP0000057,Citric Acid Cycle,metabolic,DB04272
SMP0000550,Pyruvate Dehydrogenase Deficiency (E3),disease,DB04272
SMP0000551,Pyruvate Dehydrogenase Deficiency (E2),disease,DB04272
SMP0002292,The Oncogenic Action of Succinate,disease,DB04272
SMP0002298,Glutaminolysis and Cancer,disease,DB04272
SMP0002359,The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB04272
SMP0000466,Transfer of Acetyl Groups into Mitochondria,metabolic,DB04272
SMP0000546,Congenital Lactic Acidosis,disease,DB04272
SMP0000547,Fumarase Deficiency,disease,DB04272
SMP0000548,Mitochondrial Complex II Deficiency,disease,DB04272
SMP0000549,2-Ketoglutarate Dehydrogenase Complex Deficiency,disease,DB04272
SMP0000654,Warburg Effect,metabolic,DB04272
SMP0002291,The Oncogenic Action of 2-Hydroxyglutarate,disease,DB04272
SMP0000063,Tryptophan Metabolism,metabolic,DB04275
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB04299
SMP0000206,Phenylketonuria,disease,DB04299
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04299
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB04299
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB04299
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB04299
SMP0000512,Xanthinuria Type I,disease,DB04299
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB04299
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB04299
SMP0002295,The Oncogenic Action of Fumarate,disease,DB04299
SMP0002358,The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria,disease,DB04299
SMP0000002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB04299
SMP0000003,Argininosuccinic Aciduria,disease,DB04299
SMP0000006,Tyrosine Metabolism,metabolic,DB04299
SMP0000020,Arginine and Proline Metabolism,metabolic,DB04299
SMP0000050,Purine Metabolism,metabolic,DB04299
SMP0000057,Citric Acid Cycle,metabolic,DB04299
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB04299
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04299
SMP0000218,Tyrosinemia Type I,disease,DB04299
SMP0000355,Mitochondrial Electron Transport Chain,metabolic,DB04299
SMP0000360,Hyperprolinemia Type II,disease,DB04299
SMP0000361,Hyperprolinemia Type I,disease,DB04299
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB04299
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB04299
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB04299
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB04299
SMP0000429,Disulfiram Action Pathway,drug_action,DB04299
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB04299
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB04299
SMP0000040,Glycolysis,metabolic,DB04326
SMP0000064,Fructose and Mannose Degradation,metabolic,DB04326
SMP0000124,Glycerol Phosphate Shuttle,metabolic,DB04326
SMP0000187,Glycerol Kinase Deficiency,disease,DB04326
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB04326
SMP0000531,"Glycogenosis, Type VII. Tarui Disease",disease,DB04326
SMP0000560,Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1),disease,DB04326
SMP0000573,"Glycogenosis, Type IB",disease,DB04326
SMP0015901,De Novo Triacylglycerol Biosynthesis TG(16:0/16:0/16:0),metabolic,DB04326
SMP0015910,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/18:0),metabolic,DB04326
SMP0015911,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/20:0),metabolic,DB04326
SMP0015912,De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/18:1(9Z)),metabolic,DB04326
SMP0015915,"De Novo Triacylglycerol Biosynthesis TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB04326
SMP0015916,De Novo Triacylglycerol Biosynthesis TG(16:0/20:0/20:0),metabolic,DB04326
SMP0015918,"De Novo Triacylglycerol Biosynthesis TG(16:0/20:0/20:4(5Z,8Z,11Z,14Z))",metabolic,DB04326
SMP0015922,De Novo Triacylglycerol Biosynthesis TG(16:0/16:1(9Z)/18:1(9Z)),metabolic,DB04326
SMP0015924,"De Novo Triacylglycerol Biosynthesis TG(16:0/16:1(9Z)/18:2(9Z,12Z))",metabolic,DB04326
SMP0015926,De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0),metabolic,DB04326
SMP0015935,"De Novo Triacylglycerol Biosynthesis TG(16:0/18:2(9Z,12Z)/18:2(9Z,12Z))",metabolic,DB04326
SMP0015938,De Novo Triacylglycerol Biosynthesis TG(18:0/18:0/18:0),metabolic,DB04326
SMP0015939,De Novo Triacylglycerol Biosynthesis TG(18:0/18:0/20:0),metabolic,DB04326
SMP0015949,De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/20:1(11Z)),metabolic,DB04326
SMP0015950,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/18:2(9Z,12Z))",metabolic,DB04326
SMP0015951,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB04326
SMP0015952,De Novo Triacylglycerol Biosynthesis TG(18:0/20:1(11Z)/20:1(11Z)),metabolic,DB04326
SMP0015957,"De Novo Triacylglycerol Biosynthesis TG(18:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB04326
SMP0015960,De Novo Triacylglycerol Biosynthesis TG(20:0/20:0/20:1(11Z)),metabolic,DB04326
SMP0015962,De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:1(11Z)),metabolic,DB04326
SMP0015963,"De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))",metabolic,DB04326
SMP0015971,De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/20:0/20:0),metabolic,DB04326
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB04335
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04335
SMP0000512,Xanthinuria Type I,disease,DB04335
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB04335
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB04335
SMP0000050,Purine Metabolism,metabolic,DB04335
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04335
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB04335
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB04335
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB04335
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB04335
SMP0000144,Adenosine Deaminase Deficiency,disease,DB04335
SMP0000168,AICA-Ribosiduria,disease,DB04335
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB04335
SMP0000427,Azathioprine Action Pathway,drug_action,DB04335
SMP0000430,Thioguanine Action Pathway,drug_action,DB04335
SMP0000513,Xanthinuria Type II,disease,DB04335
SMP0000004,Glycine and Serine Metabolism,metabolic,DB04343
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB04343
SMP0000244,Sarcosinemia,disease,DB04343
SMP0000313,Lactic Acidemia,disease,DB04343
SMP0000352,Primary Hyperoxaluria Type I,disease,DB04343
SMP0000055,Alanine Metabolism,metabolic,DB04343
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB04343
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB04343
SMP0000350,Pyruvate Carboxylase Deficiency,disease,DB04343
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04343
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB04343
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB04343
SMP0000316,Zellweger Syndrome,disease,DB04348
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB04348
SMP0000720,27-Hydroxylase Deficiency,disease,DB04348
SMP0000035,Bile Acid Biosynthesis,metabolic,DB04348
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB04348
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB04348
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB04348
SMP0000362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB04388
SMP0000504,"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",disease,DB04388
SMP0000505,Hyperornithinemia with Gyrate Atrophy (HOGA),disease,DB04388
SMP0000207,Prolidase Deficiency (PD),disease,DB04388
SMP0000208,Prolinemia Type II,disease,DB04388
SMP0000363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB04388
SMP0000506,Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome],disease,DB04388
SMP0000020,Arginine and Proline Metabolism,metabolic,DB04388
SMP0000188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB04388
SMP0000360,Hyperprolinemia Type II,disease,DB04388
SMP0000361,Hyperprolinemia Type I,disease,DB04388
SMP0000507,L-Arginine:Glycine Amidinotransferase Deficiency,disease,DB04388
SMP0000123,Betaine Metabolism,metabolic,DB04401
SMP0002313,Sarcosine Oncometabolite Pathway,disease,DB04401
SMP0000167,Adenylosuccinate Lyase Deficiency,disease,DB04457
SMP0000220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04457
SMP0000512,Xanthinuria Type I,disease,DB04457
SMP0000536,Mitochondrial DNA Depletion Syndrome,disease,DB04457
SMP0000537,Myoadenylate Deaminase Deficiency,disease,DB04457
SMP0000050,Purine Metabolism,metabolic,DB04457
SMP0000210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04457
SMP0000364,Lesch-Nyhan Syndrome (LNS),disease,DB04457
SMP0000365,Gout or Kelley-Seegmiller Syndrome,disease,DB04457
SMP0000428,Mercaptopurine Action Pathway,drug_action,DB04457
SMP0000535,Adenine Phosphoribosyltransferase Deficiency (APRT),disease,DB04457
SMP0000144,Adenosine Deaminase Deficiency,disease,DB04457
SMP0000168,AICA-Ribosiduria,disease,DB04457
SMP0000203,Molybdenum Cofactor Deficiency,disease,DB04457
SMP0000427,Azathioprine Action Pathway,drug_action,DB04457
SMP0000430,Thioguanine Action Pathway,drug_action,DB04457
SMP0000513,Xanthinuria Type II,disease,DB04457
SMP0000024,Porphyrin Metabolism,metabolic,DB04461
SMP0000344,Acute Intermittent Porphyria,disease,DB04461
SMP0000346,Porphyria Variegata (PV),disease,DB04461
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB04461
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB04461
SMP0000579,Congenital Disorder of Glycosylation CDG-IId,disease,DB04465
SMP0000182,Galactosemia,disease,DB04465
SMP0000580,GLUT-1 Deficiency Syndrome,disease,DB04465
SMP0000043,Galactose Metabolism,metabolic,DB04465
SMP0000444,Lactose Synthesis,metabolic,DB04465
SMP0000457,Lactose Degradation,metabolic,DB04465
SMP0000458,Lactose Intolerance,disease,DB04465
SMP0000046,Pyrimidine Metabolism,metabolic,DB04485
SMP0000202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB04485
SMP0000172,beta-Ureidopropionase Deficiency,disease,DB04485
SMP0000178,Dihydropyrimidinase Deficiency,disease,DB04485
SMP0000219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB04485
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB04519
SMP0000004,Glycine and Serine Metabolism,metabolic,DB04522
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB04522
SMP0000244,Sarcosinemia,disease,DB04522
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB04522
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB04522
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04522
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB04522
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB04522
SMP0000198,Malonic Aciduria,disease,DB04524
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04524
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB04524
SMP0000559,Pyruvate Kinase Deficiency,disease,DB04524
SMP0000016,Propanoate Metabolism,metabolic,DB04524
SMP0000060,Pyruvate Metabolism,metabolic,DB04524
SMP0000196,Leigh Syndrome,disease,DB04524
SMP0000212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB04524
SMP0000334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB04524
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB04524
SMP0000558,"Primary Hyperoxaluria II, PH2",disease,DB04524
SMP0000099,Lovastatin Action Pathway,drug_action,DB04540
SMP0000111,Cerivastatin Action Pathway,drug_action,DB04540
SMP0000209,Hypercholesterolemia,disease,DB04540
SMP0000316,Zellweger Syndrome,disease,DB04540
SMP0000372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency,disease,DB04540
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB04540
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB04540
SMP0000510,Mevalonic Aciduria,disease,DB04540
SMP0000577,Corticosterone Methyl Oxidase I Deficiency (CMO I),disease,DB04540
SMP0000718,3-beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04540
SMP0000082,Simvastatin Action Pathway,drug_action,DB04540
SMP0000089,Pravastatin Action Pathway,drug_action,DB04540
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB04540
SMP0000107,Zoledronate Action Pathway,drug_action,DB04540
SMP0000117,Pamidronate Action Pathway,drug_action,DB04540
SMP0000119,Fluvastatin Action Pathway,drug_action,DB04540
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB04540
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB04540
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04540
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB04540
SMP0000575,11-beta-Hydroxylase Deficiency (CYP11B1),disease,DB04540
SMP0000717,Apparent Mineralocorticoid Excess Syndrome,disease,DB04540
SMP0000720,27-Hydroxylase Deficiency,disease,DB04540
SMP0000023,Steroid Biosynthesis,metabolic,DB04540
SMP0000035,Bile Acid Biosynthesis,metabolic,DB04540
SMP0000079,Ibandronate Action Pathway,drug_action,DB04540
SMP0000095,Alendronate Action Pathway,drug_action,DB04540
SMP0000112,Risedronate Action Pathway,drug_action,DB04540
SMP0000130,Steroidogenesis,metabolic,DB04540
SMP0000131,Atorvastatin Action Pathway,drug_action,DB04540
SMP0000004,Glycine and Serine Metabolism,metabolic,DB04553
SMP0000016,Propanoate Metabolism,metabolic,DB04553
SMP0000029,Selenoamino Acid Metabolism,metabolic,DB04553
SMP0000177,Cystathionine beta-Synthase Deficiency,disease,DB04553
SMP0000033,Methionine Metabolism,metabolic,DB04553
SMP0000198,Malonic Aciduria,disease,DB04553
SMP0000221,Methionine Adenosyltransferase Deficiency,disease,DB04553
SMP0000223,Non-Ketotic Hyperglycinemia,disease,DB04553
SMP0000244,Sarcosinemia,disease,DB04553
SMP0000515,"Homocystinuria, Cystathionine beta-Synthase Deficiency",disease,DB04553
SMP0000179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB04553
SMP0000201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04553
SMP0000214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB04553
SMP0000222,Glycine N-Methyltransferase Deficiency,disease,DB04553
SMP0000242,Dimethylglycine Dehydrogenase Deficiency,disease,DB04553
SMP0000340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB04553
SMP0000341,Hypermethioninemia,disease,DB04553
SMP0000452,Threonine and 2-Oxobutanoate Degradation,metabolic,DB04553
SMP0000455,Homocysteine Degradation,metabolic,DB04553
SMP0000484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04553
SMP0000485,"Hyperglycinemia, Non-Ketotic",disease,DB04553
SMP0000502,Malonyl-CoA Decarboxylase Deficiency,disease,DB04553
SMP0000514,gamma-Cystathionase Deficiency (CTH),disease,DB04553
SMP0000570,"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",disease,DB04553
SMP0000721,3-Phosphoglycerate Dehydrogenase Deficiency,disease,DB04553
SMP0000077,Piroxicam Action Pathway,drug_action,DB04557
SMP0000087,Rofecoxib Action Pathway,drug_action,DB04557
SMP0000093,Diclofenac Action Pathway,drug_action,DB04557
SMP0000094,Sulindac Action Pathway,drug_action,DB04557
SMP0000114,Nabumetone Action Pathway,drug_action,DB04557
SMP0000116,Valdecoxib Action Pathway,drug_action,DB04557
SMP0000692,Antipyrine Action Pathway,drug_action,DB04557
SMP0000697,Flurbiprofen Action Pathway,drug_action,DB04557
SMP0000702,Nepafenac Action Pathway,drug_action,DB04557
SMP0000084,Etodolac Action Pathway,drug_action,DB04557
SMP0000085,Ketoprofen Action Pathway,drug_action,DB04557
SMP0000086,Ibuprofen Action Pathway,drug_action,DB04557
SMP0000096,Celecoxib Action Pathway,drug_action,DB04557
SMP0000101,Suprofen Action Pathway,drug_action,DB04557
SMP0000104,Indomethacin Action Pathway,drug_action,DB04557
SMP0000289,Diflunisal Action Pathway,drug_action,DB04557
SMP0000353,Leukotriene C4 Synthesis Deficiency,disease,DB04557
SMP0000693,Antrafenine Action Pathway,drug_action,DB04557
SMP0000696,Fenoprofen Action Pathway,drug_action,DB04557
SMP0000698,Magnesium Salicylate Action Pathway,drug_action,DB04557
SMP0000700,Lornoxicam Action Pathway,drug_action,DB04557
SMP0000703,Trisalicylate-Choline Action Pathway,drug_action,DB04557
SMP0000704,Tolmetin Action Pathway,drug_action,DB04557
SMP0000705,Tiaprofenic Acid Action Pathway,drug_action,DB04557
SMP0000706,Tenoxicam Action Pathway,drug_action,DB04557
SMP0000709,Salicylic Acid Action Pathway,drug_action,DB04557
SMP0000018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB04557
SMP0000075,Arachidonic Acid Metabolism,metabolic,DB04557
SMP0000083,Acetylsalicylic Acid Action Pathway,drug_action,DB04557
SMP0000098,Ketorolac Action Pathway,drug_action,DB04557
SMP0000520,Transaldolase Deficiency,disease,DB04564
SMP0000518,Glucose-6-phosphate Dehydrogenase Deficiency,disease,DB04564
SMP0000031,Pentose Phosphate Pathway,metabolic,DB04564
SMP0000519,Ribose-5-phosphate Isomerase Deficiency,disease,DB04564
SMP0030880,Estrone Metabolism,metabolic,DB04573
SMP0000532,Sulfite Oxidase Deficiency,disease,DB04574
SMP0030880,Estrone Metabolism,metabolic,DB04574
SMP0000041,Sulfate/Sulfite Metabolism,metabolic,DB04574
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB04574
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB04574
SMP0000565,Aromatase Deficiency,disease,DB04574
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04652
SMP0000575,11-beta-Hydroxylase Deficiency (CYP11B1),disease,DB04652
SMP0000717,Apparent Mineralocorticoid Excess Syndrome,disease,DB04652
SMP0000372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency,disease,DB04652
SMP0000577,Corticosterone Methyl Oxidase I Deficiency (CMO I),disease,DB04652
SMP0000718,3-beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04652
SMP0000130,Steroidogenesis,metabolic,DB04652
SMP0000373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency,disease,DB04652
SMP0000566,17-alpha-Hydroxylase Deficiency (CYP17),disease,DB04652
SMP0000576,21-Hydroxylase Deficiency (CYP21),disease,DB04652
SMP0000578,Corticosterone Methyl Oxidase II Deficiency (CMO II),disease,DB04652
SMP0000501,gamma-Glutamyltranspeptidase Deficiency,disease,DB04701
SMP0000183,gamma-Glutamyltransferase Deficiency,disease,DB04701
SMP0000500,5-Oxoprolinase Deficiency,disease,DB04701
SMP0000015,Glutathione Metabolism,metabolic,DB04701
SMP0000143,5-Oxoprolinuria,disease,DB04701
SMP0000337,Glutathione Synthetase Deficiency,disease,DB04701
SMP0000371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04704
SMP0000575,11-beta-Hydroxylase Deficiency (CYP11B1),disease,DB04704
SMP0000717,Apparent Mineralocorticoid Excess Syndrome,disease,DB04704
SMP0000372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency,disease,DB04704
SMP0000577,Corticosterone Methyl Oxidase I Deficiency (CMO I),disease,DB04704
SMP0000718,3-beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04704
SMP0000130,Steroidogenesis,metabolic,DB04704
SMP0000373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency,disease,DB04704
SMP0000566,17-alpha-Hydroxylase Deficiency (CYP17),disease,DB04704
SMP0000576,21-Hydroxylase Deficiency (CYP21),disease,DB04704
SMP0000578,Corticosterone Methyl Oxidase II Deficiency (CMO II),disease,DB04704
SMP0000099,Lovastatin Action Pathway,drug_action,DB04714
SMP0000111,Cerivastatin Action Pathway,drug_action,DB04714
SMP0000209,Hypercholesterolemia,disease,DB04714
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB04714
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB04714
SMP0000510,Mevalonic Aciduria,disease,DB04714
SMP0000082,Simvastatin Action Pathway,drug_action,DB04714
SMP0000089,Pravastatin Action Pathway,drug_action,DB04714
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB04714
SMP0000107,Zoledronate Action Pathway,drug_action,DB04714
SMP0000117,Pamidronate Action Pathway,drug_action,DB04714
SMP0000119,Fluvastatin Action Pathway,drug_action,DB04714
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB04714
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB04714
SMP0000023,Steroid Biosynthesis,metabolic,DB04714
SMP0000079,Ibandronate Action Pathway,drug_action,DB04714
SMP0000095,Alendronate Action Pathway,drug_action,DB04714
SMP0000112,Risedronate Action Pathway,drug_action,DB04714
SMP0000131,Atorvastatin Action Pathway,drug_action,DB04714
SMP0000386,Desmosterolosis,disease,DB04714
SMP0000387,CHILD Syndrome,disease,DB04714
SMP0000509,Hyper-IgD Syndrome,disease,DB04714
SMP0000511,Wolman Disease,disease,DB04714
SMP0058741,Methapyrilene H1-Antihistamine Action,drug_action,DB04819
SMP0062894,Thenalidine H1-Antihistamine Action,drug_action,DB04826
SMP0061047,Flunarizine H1-Antihistamine Action,drug_action,DB04841
SMP0000366,Nebivolol Action Pathway,drug_action,DB04861
SMP0031697,Nilotinib Inhibition of BCR-ABL,drug_action,DB04868
SMP0000421,Vatalanib Action Pathway,drug_action,DB04879
SMP0060058,Bepotastine H1-Antihistamine Action,drug_action,DB04890
SMP0000279,Ximelagatran Action Pathway,drug_action,DB04898
SMP0000600,Irinotecan Metabolism Pathway,drug_metabolism,DB05482
SMP0000433,Irinotecan Action Pathway,drug_action,DB05482
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB05804
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB05804
SMP0000565,Aromatase Deficiency,disease,DB05804
SMP0000685,Alvimopan Action Pathway,drug_action,DB06274
SMP0059114,Levocetirizine H1-Antihistamine Action,drug_action,DB06282
SMP0031698,Bosutinib Inhibition of BCR-ABL,drug_action,DB06616
SMP0057583,Mepyramine H1-Antihistamine Action,drug_action,DB06691
SMP0000288,Aprotinin Action Pathway,drug_action,DB06692
SMP0000713,Arbekacin Action Pathway,drug_action,DB06696
SMP0000651,Artemether Metabolism Pathway,drug_metabolism,DB06697
SMP0060744,Betahistine H1-Antihistamine Action,drug_action,DB06698
SMP0000636,Venlafaxine Metabolism Pathway,drug_metabolism,DB06700
SMP0000700,Lornoxicam Action Pathway,drug_action,DB06725
SMP0000646,Fluoxetine Metabolism Pathway,drug_metabolism,DB06731
SMP0000426,Fluoxetine Action Pathway,drug_action,DB06731
SMP0000690,Ketobemidone  Action Pathway,drug_action,DB06738
SMP0062881,Alcaftadine H1-Antihistamine Action,drug_action,DB06766
SMP0000316,Zellweger Syndrome,disease,DB06777
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB06777
SMP0000720,27-Hydroxylase Deficiency,disease,DB06777
SMP0000035,Bile Acid Biosynthesis,metabolic,DB06777
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB06777
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB06777
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB06777
SMP0000702,Nepafenac Action Pathway,drug_action,DB06802
SMP0030406,Androstenedione Metabolism,metabolic,DB07375
SMP0000356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB07447
SMP0000068,Androgen and Estrogen Metabolism,metabolic,DB07447
SMP0000565,Aromatase Deficiency,disease,DB07447
SMP0000206,Phenylketonuria,disease,DB07718
SMP0000006,Tyrosine Metabolism,metabolic,DB07718
SMP0000218,Tyrosinemia Type I,disease,DB07718
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB07718
SMP0000429,Disulfiram Action Pathway,drug_action,DB07718
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB07718
SMP0000169,Alkaptonuria,disease,DB07718
SMP0000190,Hawkinsinuria,disease,DB07718
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB07718
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB07718
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB07718
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB07718
SMP0000099,Lovastatin Action Pathway,drug_action,DB07780
SMP0000111,Cerivastatin Action Pathway,drug_action,DB07780
SMP0000209,Hypercholesterolemia,disease,DB07780
SMP0000342,Hereditary Coproporphyria (HCP),disease,DB07780
SMP0000345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB07780
SMP0000388,"Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)",disease,DB07780
SMP0000389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB07780
SMP0000510,Mevalonic Aciduria,disease,DB07780
SMP0000024,Porphyrin Metabolism,metabolic,DB07780
SMP0000082,Simvastatin Action Pathway,drug_action,DB07780
SMP0000089,Pravastatin Action Pathway,drug_action,DB07780
SMP0000092,Rosuvastatin Action Pathway,drug_action,DB07780
SMP0000107,Zoledronate Action Pathway,drug_action,DB07780
SMP0000117,Pamidronate Action Pathway,drug_action,DB07780
SMP0000119,Fluvastatin Action Pathway,drug_action,DB07780
SMP0000319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB07780
SMP0000508,Cholesteryl Ester Storage Disease,disease,DB07780
SMP0000023,Steroid Biosynthesis,metabolic,DB07780
SMP0000079,Ibandronate Action Pathway,drug_action,DB07780
SMP0000095,Alendronate Action Pathway,drug_action,DB07780
SMP0000112,Risedronate Action Pathway,drug_action,DB07780
SMP0000131,Atorvastatin Action Pathway,drug_action,DB07780
SMP0000344,Acute Intermittent Porphyria,disease,DB07780
SMP0000346,Porphyria Variegata (PV),disease,DB07780
SMP0000386,Desmosterolosis,disease,DB07780
SMP0000387,CHILD Syndrome,disease,DB07780
SMP0000509,Hyper-IgD Syndrome,disease,DB07780
SMP0000511,Wolman Disease,disease,DB07780
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB07930
SMP0000063,Tryptophan Metabolism,metabolic,DB07950
SMP0000456,Fatty Acid Biosynthesis,metabolic,DB08231
SMP0000206,Phenylketonuria,disease,DB08327
SMP0000006,Tyrosine Metabolism,metabolic,DB08327
SMP0000218,Tyrosinemia Type I,disease,DB08327
SMP0000370,Tyrosinemia Type 3 (TYRO3),disease,DB08327
SMP0000429,Disulfiram Action Pathway,drug_action,DB08327
SMP0000008,Phenylalanine and Tyrosine Metabolism,metabolic,DB08327
SMP0000169,Alkaptonuria,disease,DB08327
SMP0000190,Hawkinsinuria,disease,DB08327
SMP0000369,Tyrosinemia Type 2 (or Richner-Hanhart Syndrome),disease,DB08327
SMP0000494,"Tyrosinemia, Transient, of the Newborn",disease,DB08327
SMP0000498,Dopamine beta-Hydroxylase Deficiency,disease,DB08327
SMP0000533,Monoamine Oxidase-A Deficiency (MAO-A),disease,DB08327
SMP0000063,Tryptophan Metabolism,metabolic,DB08653
SMP0057584,Antazoline H1-Antihistamine Action,drug_action,DB08799
SMP0057585,Chloropyramine H1-Antihistamine Action,drug_action,DB08800
SMP0057582,Dimetindene H1-Antihistamine Action,drug_action,DB08801
SMP0059716,Isothipendyl H1-Antihistamine Action,drug_action,DB08802
SMP0000735,Metiamide Action Pathway,drug_action,DB08805
SMP0000734,Roxatidine Acetate Action Pathway,drug_action,DB08806
SMP0000657,Bopindolol Action Pathway,drug_action,DB08807
SMP0000670,Bupranolol Action Pathway,drug_action,DB08808
SMP0000316,Zellweger Syndrome,disease,DB08833
SMP0000314,Congenital Bile Acid Synthesis Defect Type II,disease,DB08833
SMP0000720,27-Hydroxylase Deficiency,disease,DB08833
SMP0000035,Bile Acid Biosynthesis,metabolic,DB08833
SMP0000315,Cerebrotendinous Xanthomatosis (CTX),disease,DB08833
SMP0000317,Familial Hypercholanemia (FHCA),disease,DB08833
SMP0000318,Congenital Bile Acid Synthesis Defect Type III,disease,DB08833
SMP0000732,Temocapril Metabolism Pathway,drug_metabolism,DB08836
SMP0000733,Temocapril Action Pathway,drug_action,DB08836
SMP0031700,Ponatinib Inhibition of BCR-ABL,drug_action,DB08901
SMP0058931,Chlorcyclizine H1-Antihistamine Action,drug_action,DB08936
SMP0058903,Chlorphenoxamine H1-Antihistamine Action,drug_action,DB09007
SMP0059881,Acrivastine H1-Antihistamine Action,drug_action,DB09488
SMP0058916,Phenyltoloxamine H1-Antihistamine Action,drug_action,DB11160
SMP0058769,Thonzylamine H1-Antihistamine Action,drug_action,DB11235
SMP0060170,Bilastine H1-Antihistamine Action,drug_action,DB11591
SMP0060235,Rupatadine H1-Antihistamine Action,drug_action,DB11614
SMP0062623,Latrepirdine H1-Antihistamine Action,drug_action,DB11725
SMP0060204,Ebastine H1-Antihistamine Action,drug_action,DB11742
SMP0031699,Bafetinib Inhibition of BCR-ABL,drug_action,DB11851
SMP0060230,Mizolastine H1-Antihistamine Action,drug_action,DB12523
SMP0051038,Lafutidine H2-Antihistamine Action,drug_action,DB12770
SMP0059044,Oxatomide H1-Antihistamine Action,drug_action,DB12877
SMP0000011,Inositol Metabolism,metabolic,DB13178
SMP0000043,Galactose Metabolism,metabolic,DB13178
SMP0000182,Galactosemia,disease,DB13178
SMP0000582,Joubert Syndrome,disease,DB13178
SMP0000462,Inositol Phosphate Metabolism,metabolic,DB13178
SMP0000463,Phosphatidylinositol Phosphate Metabolism,metabolic,DB13178
SMP0062886,Pimethixene H1-Antihistamine Action,drug_action,DB13292
SMP0062621,Tolpropamine H1-Antihistamine Action,drug_action,DB13305
SMP0057586,Talastine H1-Antihistamine Action,drug_action,DB13349
SMP0060742,Thiazinamium H1-Antihistamine Action,drug_action,DB13420
SMP0058732,Histapyrrodine H1-Antihistamine Action,drug_action,DB13479
SMP0056811,Dexchlorpheniramine H1-Antihistamine Action,drug_action,DB13679
SMP0062895,Tritoqualine H1-Antihistamine Action,drug_action,DB13711
SMP0061052,Mebhydrolin H1-Antihistamine Action,drug_action,DB13808
SMP0059738,Oxomemazine H1-Antihistamine Action,drug_action,DB13820
SMP0059710,Hydroxyethylpromethazine H1-Antihistamine Action,drug_action,DB13840
